UNITED
STATES

 SECURITIES
AND EXCHANGE COMMISSION

 Washington,
D.C. 20549

 FORM
 10-K/A

 (Amendment
No. 2)

 (Mark
One)

 ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

 For
the fiscal year ended December 31, 2022

 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

 For the transition period from
to

 (Exact
name of registrant as specified in its charter)

 Delaware

 001-39718

 85-1849315

 (State or other jurisdiction of
 incorporation or organization)

 (Commission File Number)

 (I.R.S. Employer
 Identification Number)

 955 W. John Carpenter Fwy., Suite 100-929
 Irving, TX 75039

 75039

 (Address of principal executive offices)

 (Zip Code)

 Registrant's
telephone number, including area code: (619) 500-7747

 Not
Applicable

 (Former
name or former address, if changed since last report)

 Securities
registered pursuant to Section 12(b) of the Act:

 Title of Each Class:

 Trading Symbol:

 Name of Each Exchange on Which Registered:

 Common Stock, par value $0.0001 per share

 BREZ

 The Nasdaq Stock Market LLC

 Rights exchangeable into one-twentieth of one share of common stock

 BREZR

 The Nasdaq Stock Market LLC

 Warrants, each whole warrant exercisable for one share of common stock at an exercise price of $11.50 per whole share

 BREZW

 The Nasdaq Stock Market LLC

 Securities
registered pursuant to Section 12(g) of the Act: None

by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes No

by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Exchange Act. Yes No

by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities
Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports),
and (2) has been subject to such filing requirements for the past 90 days. Yes No

by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule
405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant
was required to submit such files). Yes No

by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company or an emerging growth company. See definition of "large accelerated filer," "accelerated filer, "smaller
reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.

 Large accelerated filer

 Accelerated filer

 Non-accelerated filer

 Smaller reporting company

 Emerging growth company

 If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness
of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered
public accounting firm that prepared or issued its audit report.

 If
securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant
included in the filing reflect the correction of an error to previously issued financial statements.

by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation
received by any of the registrant's executive officers during the relevant recovery period pursuant to § 240.10D-1(b).

by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No

 The
aggregate market value of the common stock outstanding, other than shares held by persons who may be deemed affiliates of the registrant,
computed by reference to the closing sales price for the shares of common stock on June 30, 2022, as reported on the NASDAQ, was $ 48,957,224
(based on the closing sales price of the common stock on June 30, 2022 of $10.27).

 As
of March 24, 2023, 4,320,484 shares of common stock, par value $0.0001, were issued and outstanding.

 EXPLANATORY
NOTE

 Breeze
Holdings Acquisition Corp. (the "Company") is filing this Amendment No. 2 to Annual Report on Form 10-K (the "Amended
10-K") to amend its Annual Report on Form 10-K for the fiscal year ended December 31, 2022, filed with the Securities and Exchange
Commission ("SEC") on March 31, 2023 (the "Original 10-K"). The sole purpose of this Amended 10-K is to furnish
an updated Exhibit 31.1, being the certification of principal executive officer and principal financial officer pursuant to Securities
Exchange Act Rules 13a-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 ("Exhibit 31.1"). In the
Exhibit 31.1 originally filed with the Original 10-K, paragraph 4(b), which relates to the design of internal control over financial
reporting, as required by Item 601(b)(31) of Regulation S-K, was inadvertently omitted. The revised certification is currently dated,
refers to this Amended 10-K, and is being included as an exhibit to this Amended 10-K under Part VI.

 The
Company has made no attempt in this Amended 10-K to modify or update the disclosures presented in the Original 10-K other than as noted
in the previous paragraph. Except as noted above, this Amended 10-K does not reflect events occurring after the filing of the Original
10-K.

 TABLE
OF CONTENTS

 PAGE

 CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

 iii

 Item 1

 Item 1.A.

 Risk Factors

 Item 1.B.

 Unresolved Staff Comments

 Item 2.

 Properties

 Item 3.

 Legal Proceedings

 Item 4.

 Mine Safety Disclosures

 Item 5.

 Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

 Item 6.

 [Reserved]

 Item 7.

 Management's Discussion and Analysis of Financial Condition and Results of Operations

 Item 7A.

 Quantitative and Qualitative Disclosures About Market Risk

 Item 8.

 Financial Statements and Supplementary Data

 Item 9.

 Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

 Item 9A.

 Controls and Procedures

 Item 9B.

 Other Information.

 Item 9C.

 Disclosure Regarding Foreign Jurisdictions That Prevent Inspections.

 Item 10.

 Directors, Executive Officers and Corporate Governance

 Item 11.

 Executive Compensation

 Item 12.

 Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

 Item 13.

 Certain Relationships and Related Transactions, and Director Independence

 Item 14.

 Principal Accountant Fees and Services

 Item 15.

 Exhibits and Financial Statement Schedules

 Item 16.

 Form 10-K Summary

 i

 CERTAIN
TERMS

 Unless
otherwise stated in this Annual Form 10-K (this "Report"), or the context otherwise requires, references to:

 "common
 stock" is to our common stock;

 "founder
 shares" are to shares of our common stock initially purchased by our sponsor in a private placement prior to our Initial Public
 Offering;

 "Initial
 Public Offering" refers to the Initial Public Offering closed on November 25, 2020 (the "Closing Date")

 "initial
 stockholders" are to our holders of our founder shares prior to our Initial Public Offering (or their permitted transferees);

 "management"
 or our "management team" are to our officers and directors;

 "private
 placement warrants" are to the warrants issued to our sponsor and I-Bankers Securities, Inc. ("I-Bankers") in a
 private placement simultaneously with the closing of our Initial Public Offering;

 "public
 shares" are to shares of our common stock sold as part of the units in our Initial Public Offering (whether they were purchased
 in our Initial Public Offering or thereafter in the open market);

 "public
 stockholders" are to the holders of our public shares, including our initial stockholders and management team to the extent
 our initial stockholders and/or members of our management team purchase public shares, provided that each initial stockholder's
 and member of our management team's status as a "public stockholder" shall only exist with respect to such public
 shares;

 "public
 warrants" are to our redeemable warrants sold as part of the units in our Initial Public Offering (whether they were purchased
 in our Initial Public Offering or thereafter in the open market), and to any private placement warrants or warrants issued upon conversion
 of working capital loans that are sold to third parties that are not our sponsor or executive officers or directors (or permitted
 transferees) following the consummation of our initial business combination;

 "sponsor"
 is to Breeze Sponsor, LLC, a Delaware limited liability company formed by our chairman and chief executive officer;

 "warrants"
 are to our redeemable warrants, which includes the public warrants as well as the private placement warrants to the extent they are
 no longer held by the initial purchasers of the private placement warrants or their permitted transferees;

 "rights"
 are to the rights; and

 "Breeze,"
 "we," "us," "company" or "our company" are to Breeze Holdings Acquisition Corp.

 ii

 CAUTIONARY
NOTE REGARDING FORWARD-LOOKING STATEMENTS

 This
Report, including, without limitation, statements under the heading "Item 7. Management's Discussion and Analysis of Financial
Condition and Results of Operations," includes forward-looking statements within the meaning of Section 27A of the Securities
Act of 1933, as amended, (the "Securities Act") and Section 21E of the Securities Exchange Act of 1934, as amended,
(the "Exchange Act"). These forward-looking statements can be identified by the use of forward-looking terminology, including
the words "believes," "estimates," "anticipates," "expects," "intends," "plans,"
"may," "will," "potential," "projects," "predicts," "continue,"
or "should," or, in each case, their negative or other variations or comparable terminology. There can be no assurance that
actual results will not materially differ from expectations. Such statements include, but are not limited to, any statements relating
to our ability to consummate any acquisition or other business combination and any other statements that are not statements of current
or historical facts. These statements are based on management's current expectations, but actual results may differ materially
due to various factors, including, but not limited to:

 our
 ability to complete any initial business combination;

 our
 success in retaining or recruiting, or changes required in, our officers, key employees or directors following our initial business
 combination;

 our
 officers and directors allocating their time to other businesses and potentially having conflicts of interest with our business or
 in approving our initial business combination;

 our
 potential ability to obtain additional financing to complete our initial business combination;

 our
 pool of prospective target businesses;

 the
 ability of our officers and directors to generate a number of potential investment opportunities;

 our
 public securities' potential liquidity and trading;

 the
 lack of a market for our securities;

 the
 use of proceeds not held in the trust account or available to us from interest income on the trust account balance;

 the
 trust account not being subject to claims of third parties; or

 our
 financial performance following our Initial Public Offering.

 The
forward-looking statements contained in this Amendment are based on our current expectations and beliefs concerning future developments
and their potential effects on us. Future developments affecting us may not be those that we have anticipated. These forward-looking
statements involve a number of risks, uncertainties (some of which are beyond our control) and other assumptions that may cause actual
results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and
uncertainties include, but are not limited to, those factors described under the heading "Risk Factors." Should one or more
of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects
from those projected in these forward-looking statements. We undertake no obligation to update or revise any forward-looking statements,
whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. These
risks and others described under "Risk Factors" may not be exhaustive.

 By
their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that
may or may not occur in the future. We caution you that forward-looking statements are not guarantees of future performance and that
our actual results of operations, financial condition and liquidity, and developments in the industry in which we operate may differ
materially from those made in or suggested by the forward-looking statements contained in this Amendment. In addition, even if our results
or operations, financial condition and liquidity, and developments in the industry in which we operate are consistent with the forward-looking
statements contained in this Report, those results or developments may not be indicative of results or developments in subsequent periods.

 iii

 PART
I

 ITEM
1. BUSINESS

 Overview

 We
are a blank check company incorporated on June 11, 2020 as a Delaware corporation and formed for the purpose of effecting a merger,
capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses,
which we refer to throughout this Report as our initial business combination. We have elected to pursue an acquisition in the defense
technology industry.

 On
October 31, 2022, we entered into a Merger Agreement and Plan of Reorganization (the "Merger Agreement"), by and among Breeze,
BH Velocity Merger Sub Inc., a Texas corporation and a direct, wholly-owned subsidiary of Breeze ("Merger Sub"), and TV Ammo,
Inc., a Texas corporation ("TV Ammo"). The Merger Agreement and the transactions contemplated thereby were approved by the
boards of directors of each of Breeze, Merger Sub, and TV Ammo. The Merger Agreement provides that, among other things, at the closing
(the "Closing") of the transactions contemplated by the Merger Agreement, Merger Sub will merge with and into TV Ammo (the
"Merger"), with TV Ammo surviving as a wholly-owned subsidiary of Breeze. In connection with the Merger, Breeze will change
its name to "True Velocity, Inc.", which is hereinafter referred to (on a post-closing basis) as "True Velocity."
The aggregate consideration to be received by the TV Ammo equity holders is based on a pre-transaction equity value of $1,185,234,565,
and results in a combined company equity value of $1,249,556,817. The Merger and the other transactions contemplated by the Merger Agreement
are hereinafter referred to as the "Business Combination." The Business Combination is expected to close in the second quarter
of 2023, subject to customary closing conditions, including the satisfaction of the minimum available cash condition, the receipt of
certain governmental approvals and the required approval by the stockholders of Breeze and TV Ammo. For more information regarding the
Business Combination, please see "Proposed Business Combination with TV Ammo."

 Our
management team has extensive experience in taking companies public, acquisitions, divestitures, corporate sales, and equity and debt
capital markets transactions. Additionally, our management team has well-established banking relationships and procured several billion
dollars of committed capital in connection with prior investments. Our team has experience investing across a variety of commodity price
cycles and a track record of identifying high quality assets and businesses with significant resources, capital and optimization potential.

 In
addition, our management team has an intense focus on cost management which we believe will translate into meaningful reductions in overall
capital and operating costs. Our management team has consistently demonstrated their commitment to cost management. At EXCO Resources,
Inc. ("EXCO"), for example, Dr. Ramsey and Messrs. Griffin and Ross were able to significantly improve EXCO's
drilling and development costs and operating costs through renegotiated rig rates and operating efficiencies.

 Prior
to our initial public offering, 13.9% of our common stock was held by I-Bankers Securities, Inc. I-Bankers is a global provider of financial
and advisory services. I-Bankers' main business focus is generating returns to investors and stockholders by providing a diversified
range of services to clients. I-Bankers acts on behalf of institutional, corporate and retail clients and counterparties around the world.

 I-Bankers
comprises advisory, capital raising and principal investing capabilities. The firm provides varied services to corporate, financial sponsor
and government clients involved in mergers and acquisitions, debt and equity fund raising, corporate restructuring, and project finance.
In the United States, I-Bankers has specialist sector expertise and a comprehensive advisory and capital markets platform.

 The
past performance of the members of our management team, I-Bankers, or their affiliates is not a guarantee that we will be able to identify
a suitable candidate for our initial business combination or of success with respect to any business combination we may consummate. You
should not rely on the historical record of the performance of our management team, I-Bankers, or their affiliates as indicative of our
future performance. None of our directors have any past experience with any blank check companies or special purpose acquisition companies.
In addition, such parties may have conflicts of interest with other entities for which a conflict of interest may or does exist between
such persons and the company, as well as the priority and preference that such entity has with respect to performance of obligations
and presentation of business opportunities to us, please refer to the table and subsequent explanatory paragraph under "Item 10.
Directors, Executive Officers and Corporate Governance—Conflicts of Interest".

Operations

 As
of December 31, 2022, the Company had not commenced any operations. All activity through December 31, 2022 relates to the
Company's formation, the Initial Public Offering ("Initial Public Offering"), which is described below, and, after
the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating
revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate
non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering and from changes in
the fair value of its warrant liability.

 The
registration statement for the Company's Initial Public Offering was declared effective on November 23, 2020. On November 25, 2020,
the Company consummated the Initial Public Offering of 11,500,000 units (the "Units" and, with respect to the shares of common
stock included in the Units sold, the "Public Shares"), generating gross proceeds of $115,000,000.

 Simultaneously
with the closing of the Initial Public Offering, the Company consummated the sale of 5,425,000 warrants (the "Private Placement
Warrants") at a price of $1.00 per Private Placement Warrant in a private placement to Breeze Sponsor, LLC, a Delaware limited
liability company (the "Sponsor") and I-Bankers Securities, Inc, generating gross proceeds of $5,425,000.

the closing of the Initial Public Offering on November 25, 2020, an amount of $115,000,000 ($10.00 per Unit) from the net proceeds of
the sale of the Units in the Initial Public Offering and $1,725,000 from the sale of the Private Placement Warrants was placed in a trust
account (the "Trust Account") and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16)
of the Investment Company Act, with a maturity of 185 days or less or in any open-ended investment company that holds itself out
as a money market fund selected by the Company meeting the conditions of Rule 2a-7 of the Investment Company Act of 1940, as amended
(the "Investment Company Act"), as determined by the Company, until the earlier of: (i) the completion of a Business
Combination or (ii) the distribution of the Trust Account to the Company's stockholders, as described below. As of August 11, 2022,
all trust proceeds were moved into, and remain held in, a non-interest bearing account.

 Transaction
costs incurred in connection with the Initial Public Offering amounted to $4,099,907, consisting of $2,300,000 of underwriting fees,
$1,322,350 of representative share offering costs, and $477,557 of other offering costs. As of December 31, 2022, cash of $14,129 was
held outside of the Trust Account and was available for working capital purposes.

 The
Company's management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering
and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward
consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully.
The Company must complete an initial Business Combination having an aggregate fair market value of at least 80% of the assets held in
the Trust Account (excluding the deferred underwriting commissions and taxes payable) at the time of the agreement to enter into the
initial Business Combination. The Company will only complete a Business Combination if the post-transaction company owns or acquires
50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient
for it not to be required to register as an investment company under the Investment Company Act.

 The
Company will provide its stockholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of a
Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means
of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender
offer will be made by the Company, solely in its discretion. The stockholders will be entitled to redeem their shares for a pro rata
portion of the amount then in the Trust Account (initially $10.15 per share), plus any pro rata interest earned on the funds held in
the Trust Account and not previously released to the Company to pay its tax obligations. The per-share amount to be distributed to stockholders
who redeem their shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters. There
will be no redemption rights upon the completion of a Business Combination with respect to the Company's warrants.

 The
Company will proceed with a Business Combination only if the Company has net tangible assets of at least $5,000,001 upon such consummation
of a Business Combination and, if the Company seeks stockholder approval, a majority of the outstanding shares voted are voted in favor
of the Business Combination. If a stockholder vote is not required and the Company does not decide to hold a stockholder vote for business
or other legal reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation, conduct the redemptions
pursuant to the tender offer rules of the Securities and Exchange Commission ("SEC") and file tender offer documents containing
substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination.
If the Company seeks stockholder approval in connection with a Business Combination, the Company's Sponsor has agreed to vote its
Founder Shares (as defined in Note 5) and any Public Shares purchased by it during or after the Initial Public Offering in favor of approving
a Business Combination. Additionally, each public stockholder may elect to redeem their Public Shares, regardless of whether they vote
for or against a Business Combination.

 If
the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules,
the Company's Amended and Restated Certificate of Incorporation provides that a public stockholder, together with any affiliate
of such stockholder or any other person with whom such stockholder is acting in concert or as a "group" (as defined under
Section 13 of the Securities Exchange Act of 1934, as amended (the "Exchange Act")), will be restricted from seeking
redemption rights with respect to 10% or more of the Public Shares, without the Company's prior written consent.

 The
Sponsor has agreed (a) to waive its redemption rights with respect to any Founder Shares and Public Shares held by it in connection
with the completion of a Business Combination and (b) to waive its liquidation rights with respect to the Founder Shares if the
Company fails to complete a Business Combination by November 25, 2021 (which can be extended up to 6 months) and (c) not to propose
an amendment to the Amended and Restated Certificate of Incorporation (i) to modify the substance or timing of the Company's
obligation to allow redemption in connection with the Company's initial Business Combination or to redeem 100% of its Public Shares
if the Company does not complete a Business Combination or (ii) with respect to any other provision relating to stockholders'
rights or pre-initial business combination activity, unless the Company provides the public stockholders with the opportunity to redeem
their Public Shares in conjunction with any such amendment. However, if the Sponsor acquires Public Shares in or after the Initial Public
Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a
Business Combination within the Combination Period.

 On
November 22, 2021, the Company announced that its sponsor, Breeze Sponsor, LLC, timely deposited an aggregate of $1,150,000 (the "Extension
Payment"), representing $0.10 per public share, into the Trust Account to extend the date by which the Company has to consummate
a business combination from November 25, 2021 to February 25, 2022. The Sponsor loaned the Extension Payment to the Company in exchange
for a promissory note in the amount of the Extension Payment. The loan under the promissory note is non-interest bearing and will be
repaid upon the consummation of a business combination. The Company's stockholders are not entitled to vote on or redeem their
shares in connection with such extension.

 On
February 22, 2022, the Company announced that its sponsor, Breeze Sponsor, LLC, timely deposited an aggregate of $1,150,000 (the "Second
Extension Payment"), representing $0.10 per public share, into the Trust Account to extend the date by which the Company has to
consummate a business combination from February 25, 2022 to May 25, 2022. The Sponsor loaned the Second Extension Payment to the Company
in exchange for a promissory note in the amount of the Second Extension Payment. The loan under the promissory note is non-interest bearing
and will be repaid upon the consummation of a business combination. The Company's stockholders are not entitled to vote on or redeem
their shares in connection with such extension.

 On
May 5, 2022, the Company held a stockholders' meeting at which a proposal to approve the extension of time to consummate the closing
of a Business Combination Agreement to September 26, 2022 was approved. The Company provided its stockholders with the opportunity to
redeem all or a portion of their Public Shares at the time of this stockholders' meeting. The stockholders who elected to redeem
their shares did so for a pro rata portion of the amount then in the Trust Account ($10.35 per share), plus any pro rata interest earned
on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations. In connection with the
extension proposal, 6,732,987 shares of the Company's common stock were redeemed for $69,700,628 (the "Redemption")
with 7,907,013 shares of common stock remaining outstanding after Redemption; 4,767,013 of the 7,907,013 shares of common stock remaining
outstanding after redemption (the "Public Shares") are owned by the public stockholders. The public stockholders will continue
to have the opportunity to redeem all or a portion of their Public Shares upon the completion of an initial business combination at a
per-share price, payable in cash, equal to the aggregate amount on deposit in the Trust Account as of two business days prior to the
consummation of the initial business combination, including interest (which interest shall be net of taxes payable) divided by the number
of then outstanding public shares, subject to the limitations described herein.

 On
September 13, 2022, the Company held its annual stockholders' meeting at which a proposal to approve the extension of time to consummate
the closing of a Business Combination Agreement to March 26, 2023 was approved. The Company provided its stockholders with the opportunity
to redeem all or a portion of their Public Shares at the time of this stockholders' meeting. The stockholders who elected to redeem
their shares did so for a pro rata portion of the amount then in the Trust Account ($10.35 per share), plus any pro rata interest earned
on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations. In connection with the
extension proposal, 3,076,817 shares of the Company's common stock were redeemed for $31,845,056, with 4,830,196 shares of common
stock remaining outstanding after Redemption; 1,690,196 of the 4,830,196 shares of common stock remaining outstanding after redemption
(the "Public Shares") are owned by the public stockholders. The public stockholders will continue to have the opportunity
to redeem all or a portion of their Public Shares upon the completion of an initial business combination at a per-share price, payable
in cash, equal to the aggregate amount on deposit in the Trust Account as of two business days prior to the consummation of the initial
business combination, including interest (which interest shall be net of taxes payable) divided by the number of then outstanding public
shares, subject to the limitations described herein.

the redemptions, approximately $17.5 million remained on deposit in our Trust Account.

 At
the annual meeting of the Company held on September 13, 2022, the Company's stockholders approved (i) a proposal to amend
the Company's Amended and Restated Certificate of Incorporation (the "A&R COI") to authorize the Company to
extend the date of September 26, 2022, up to six (6) times for an additional one (1) month each time (ultimately
until as late as March 26, 2023) by which the Company must (a) consummate a merger, capital stock exchange, asset, stock
purchase, reorganization or other similar business combination, which we refer to as our initial business combination, or
(b) cease its operations except for the purpose of winding up if it fails to complete such initial business combination, and
redeem all of the shares of common stock of the Company included as part of the units sold in the Company's initial public
offering that was consummated on November 25, 2020, and (ii) a proposal to amend the Trust Agreement to authorize the
Extension and its implementation by the Company. The amended Trust Agreement authorizes the Company's Board of Directors
to extend the time to complete the Business Combination up to six (6) times for an additional one (1) month each time (for a maximum
of six one-month extensions), upon the deposit into the Trust Account of $0.035 for each outstanding public share by the Sponsor or
its designees on or prior to September 26, 2022 or such other date as may be extended. Breeze executed its first one month
extension of September 26, 2022 depositing $59,157 in the Trust Account. On October 21, 2022, November 23, 2022 and December 20,
2022 Breeze executed the second, third and fourth one month extensions depositing $59,157 in the Trust Account for each monthly
extension through January 26, 2023. On January 25, 2023 and February 23, 2023 Breeze executed the fifth and sixth one month
extensions depositing $59,157 in the Trust Account for each monthly extension through March 26, 2023. The Company has scheduled a
meeting of its stockholders for March 22, 2023 to consider (i) a proposal to amend the Company's A&R COI to authorize
the Company to extend the date of March 26, 2023, up to six (6) times for an additional one (1) month each time
(ultimately until as late as September 26, 2023).

 On
March 22, 2023, the Company held a stockholders' meeting at which a proposal to approve the extension of time to consummate the
closing of a Business Combination Agreement to September 26, 2023 was approved. The Company provided its stockholders with the opportunity
to redeem all or a portion of their Public Shares at the time of this stockholders' meeting. The stockholders who elected to redeem
their shares did so for a pro rata portion of the amount then in the Trust Account ($10.56 per share), plus any pro rata interest earned
on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations. In connection with the
extension proposal, 509,712 shares of the Company's common stock were redeemed for $5,395,929, with 4,320,484 shares of common
stock remaining outstanding after Redemption; 1,180,484 of the 4,320,484 shares of common stock remaining outstanding after redemption
(the "Public Shares") are owned by the public stockholders. The public stockholders will continue to have the opportunity
to redeem all or a portion of their Public Shares upon the completion of an initial business combination at a per-share price, payable
in cash, equal to the aggregate amount on deposit in the Trust Account as of two business days prior to the consummation of the initial
business combination, including interest (which interest shall be net of taxes payable) divided by the number of then outstanding public
shares, subject to the limitations described herein.

the redemptions, approximately $12.5 million remained on deposit in our Trust Account.

 At
the meeting of the Company held on March 22, 2023, the Company's stockholders approved (i) a proposal to amend the Company's
Amended and Restated Certificate of Incorporation (the "A&R COI") to authorize the Company to extend the date of March
26, 2023, up to six (6) times for an additional one (1) month each time (ultimately until as late as September 26, 2023)
by which the Company must (a) consummate a merger, capital stock exchange, asset, stock purchase, reorganization or other similar
business combination, which we refer to as our initial business combination, or (b) cease its operations except for the purpose
of winding up if it fails to complete such initial business combination, and redeem all of the shares of common stock of the Company
included as part of the units sold in the Company's initial public offering that was consummated on November 25, 2020, and
(ii) a proposal to amend the Trust Agreement to authorize the Extension and its implementation by the Company. The amended Trust
Agreement authorizes the Company's Board of Directors to extend the time to complete the Business Combination up to
six (6) times for an additional one (1) month each time (for a maximum of six one-month extensions), upon the deposit into the Trust
Account of $0.035 for each outstanding public share by the Sponsor or its designees on or prior to September 26, 2023 or such other date
as may be extended.

 The
Company will have until September 26, 2023 (unless the Company's shareholders approve a proposal to amend the A&R COI to permit
an extension of up to six additional one month periods) to complete a Business Combination (the "Combination Period"). If
the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations
except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem
the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including
interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations (less up
to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will
completely extinguish public stockholders' rights as stockholders (including the right to receive further liquidating distributions,
if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company's
remaining stockholders and the Company's board of directors, dissolve and liquidate, subject in each case to the Company's
obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption
rights or liquidating distributions with respect to the Company's warrants, which will expire worthless if the Company fails to
complete a Business Combination within the Combination Period.

 In
order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any
claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the
Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below
(1) $10.35 per Public Share or (2) the actual amount per Public Share held in the Trust Account as of the date of the
liquidation of the Trust Account due to reductions in the value of the trust assets, in each case net of the interest which may be
withdrawn to pay our taxes. This liability will not apply with respect to any claims by a third party who executed a waiver of any
and all rights to seek access to the Trust Account and will not apply to any claims under the Company's indemnity of the
underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as
amended (the "Securities Act"). Moreover, in the event that an executed waiver is deemed to be unenforceable against a
third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek
to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to
have all vendors, service providers (except the Company's independent registered public accounting firm), prospective target
businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title,
interest or claim of any kind in or to monies held in the Trust Account.

 Termination
of Proposed Business Combination with D-Orbit S.p. A.

 As
previously disclosed in our Current Report on Form 8-K filed with the Securities and Exchange Commission (the "SEC") on January
27, 2022, on January 26, 2022, the Company (or "Breeze"), entered into a Business Combination Agreement (as it may be amended,
supplemented or otherwise modified from time to time, the "Combination Agreement"), by and among Breeze, D-Orbit S.p. A, an
Italian Societ per azioni ("D-Orbit"), D-Orbit S.A., a newly-formed joint stock company (soci t anonyme)
governed by the laws of the Grand Duchy of Luxembourg ("Holdco"), Lift-Off Merger Sub, Inc., a Delaware corporation ("Merger
Sub"), and Seraphim Space (Manager) LLP, a UK limited liability partnership. Upon consummation of the transactions contemplated
by the Combination Agreement (the "Business Combination"), Holdco would become the NASDAQ-listed parent company of both Breeze
and D-Orbit, with the former Breeze stockholders (including the Sponsor) owning pro forma approximately 11% and former D-Orbit shareholders
owning approximately 84% of the Holdco Shares outstanding immediately after closing, assuming no redemptions.

 Concurrently
with the execution of the Combination Agreement, certain parties to the Combination Agreement entered into Ancillary Agreements (as defined
in the Combination Agreement) in connection with the Business Combination and as specifically contemplated by the Combination Agreement.

 Prior
to execution of the Combination Agreement, on January 26, 2022, Breeze, Holdco and D-Orbit entered into a securities purchase agreement
(the "Securities Purchase Agreement") with an entity managed by ATW Partners, LLC (the "Debenture Investor"),
pursuant to which the Debenture Investor agreed to purchase, and Holdco agreed to issue and sell to the Debenture Investor, on the Closing
Date an aggregate principal amount of $30,000,000 of Holdco's Original Issue Discount Convertible Debentures (the "Debentures")
due four years from their date of issuance (the "Debenture Financing").

 On
July 28, 2022, the parties to the Securities Purchase Agreement entered into a Termination of Securities Purchase Agreement (the "Securities
Termination Agreement") which terminated the Securities Purchase Agreement, effective as of July 28, 2022. In connection with the
termination, the Debenture Investor refunded to D-Orbit a portion of a commitment fee previously paid by D-Orbit to the Debenture Investor.

 On
August 12, 2022, the parties to the Combination Agreement entered into a Termination Agreement (the "Termination Agreement")
which terminated the Combination Agreement and the Ancillary Agreements, effective as of August 12, 2022. Pursuant to the Termination
Agreement, the Company will not be obligated to remit nor will it be entitled to receive a termination payment.

 Proposed
Business Combination with TV Ammo

 On
October 31, 2022, Breeze Holdings Acquisition Corp., a Delaware corporation ("Breeze"), entered into a Merger Agreement and
Plan of Reorganization (the "Merger Agreement"), by and among Breeze, BH Velocity Merger Sub Inc., a Texas corporation and
a direct, wholly-owned subsidiary of Breeze ("Merger Sub"), and TV Ammo, Inc., a Texas corporation ("TV Ammo").

 The
Merger Agreement and the transactions contemplated thereby were approved by the boards of directors of each of Breeze, Merger Sub, and
TV Ammo.

 The
Merger Agreement provides that, among other things, at the closing (the "Closing") of the transactions contemplated by the
Merger Agreement, Merger Sub will merge with and into TV Ammo (the "Merger"), with TV Ammo surviving as a wholly-owned subsidiary
of Breeze. In connection with the Merger, Breeze will change its name to "True Velocity, Inc.", which is hereinafter referred
to (on a post-closing basis) as "True Velocity." The Merger and the other transactions contemplated by the Merger Agreement
are hereinafter referred to as the "Business Combination."

 The
Business Combination is expected to close in the second or third quarter of 2023, subject to customary closing conditions, including
the satisfaction of the minimum available cash condition, the receipt of certain governmental approvals and the required approval by
the stockholders of Breeze and TV Ammo.

 The
aggregate consideration to be received by the TV Ammo equity holders is based on a pre-transaction equity value of $1,185,234,565,
and results in a combined company equity value of $1,249,556,817. In accordance with the terms and subject to the conditions of the
Merger Agreement, at the effective time of the Merger (the "Effective Time"), (a) each share of issued and outstanding
TV Ammo common stock, par value $0.01 ("TV Ammo Common Stock"), shall be cancelled and converted into a number of shares
of True Velocity common stock, par value $0.0001 ("True Velocity Common Stock"), equal to the Exchange Ratio described
below, (b) each option to purchase shares of TV Ammo Common Stock (each, a "TV Ammo Option") shall be assumed and
converted into an option to purchase a number of shares of True Velocity Common Stock equal to the number of shares of TV Ammo
Common Stock subject to such TV Ammo Option, multiplied by the Exchange Ratio, at an exercise price per share equal to the exercise
price per share in effect immediately before the Effective Time, divided by the Exchange Ratio, (c) each restricted stock unit in
respect of shares of TV Ammo Common Stock (each, a "TV Ammo RSU") shall be assumed and converted into a restricted stock
unit in respect of a number of shares of True Velocity Common Stock equal to the number of shares of TV Ammo Common Stock subject to
such TV Ammo RSU, multiplied by the Exchange Ratio, and (d) each warrant to purchase a number of shares of TV Ammo Common Stock
(each, a "TV Ammo Warrant") shall be converted into a warrant to purchase shares of True Velocity Common Stock equal to
the number of shares of TV Ammo Common Stock subject to such TV Ammo Warrant, multiplied by the Exchange Ratio, at an exercise price
per share equal to the exercise price per share in effect immediately before the Effective Time, divided by the Exchange Ratio. The
Exchange Ratio will be equal to (i) the sum of (A) $1,185,234,565, plus (B) any amounts raised by TV Ammo after the date of the
Merger Agreement and prior to the Closing in permitted financing transactions in excess of $50,000,000, plus (C) the aggregate
dollar amount payable to TV Ammo upon the conversion of all outstanding TV Ammo convertible notes and the exercise of all vested
in-the-money TV Ammo Warrants and vested in-the-money TV Ammo Options, divided by (ii) the number of fully-diluted shares of TV Ammo
Common Stock outstanding as of the Closing, further divided by (iii) an assumed value of True Velocity Common Stock of $10.00 per
share.

 A
pro rata portion of the shares of True Velocity Common Stock received in exchange for the shares of TV Ammo Common Stock are subject
to forfeiture if certain future stock-price based milestones are not achieved as described below (the "Earnout Shares").
The number of Earnout Shares will be equal to the product of (a) 15% and (b) the amount by which 118,523,456 exceeds the number of shares
of True Velocity Common Stock issuable upon the exercise or conversion of securities issued by TV Ammo in permitted financing transactions
after the date of the Merger Agreement and prior to the Closing. The Earnout Shares will be issued at the Closing and subject to forfeiture.
One-half of the Earnout Shares shall become fully vested and no longer subject to forfeiture if, during the three-year period beginning
at the Closing (the "Milestone Event Period"), the True Velocity Common Stock achieves a daily volume weighted average closing
sale price of at least $12.50 per share for any 20 trading days within a 30 consecutive trading day period ("Milestone Event I").
The other half of the Earnout Shares will become fully vested and no longer subject to forfeiture if, during the Milestone Event Period,
the True Velocity Common Stock achieves a daily volume weighted average closing sale price of at least $15.00 per share for a similar
number of days ("Milestone Event II"). The 30 consecutive trading day periods used to satisfy Milestone Event I and Milestone
Event II may not overlap; if both Milestone Event I and Milestone Event II would be satisfied using the same 30 consecutive trading day
period, Milestone Event II will be deemed satisfied and the threshold closing sale price to achieve Milestone Event I shall be increased
to $13.50. Any Earnout Shares that remain unvested at the end of the Milestone Event Period will be forfeited. All of the Earnout Shares
will become fully vested and no longer subject to forfeiture upon the occurrence of a transaction or series of transactions occurring
after the Closing (a) following which a person or "group" (within the meaning of Section 13(d) of the Exchange Act)
of persons (other than True Velocity, TV Ammo or any of their respective subsidiaries), has direct or indirect beneficial ownership of
securities (or rights convertible or exchangeable into securities) representing fifty percent (50%) or more of the voting power of True
Velocity or the right to elect a majority of the True Velocity board of directors or similar governing body of True Velocity, (b) constituting
a sale, merger, business combination, consolidation, liquidation, exchange offer or other similar transaction, however effected, following
which the voting securities of True Velocity immediately prior to such transaction do not continue to represent or are not converted
into at least (50%) of the combined voting power of the then outstanding voting securities of the person resulting from such transaction
or, if the surviving company is a subsidiary, the ultimate parent thereof, or (c) constituting a sale, lease, license or other disposition
of fifty percent (50%) or more of the assets of True Velocity and its subsidiaries taken as a whole (any of the foregoing, a "Subsequent
Transaction").

 The
parties have agreed to take actions such that, effective immediately after the Closing of the Business Combination, True Velocity's
board of directors shall consist of seven directors, consisting of two Breeze designees (at least one of whom shall be an "independent
director"), four TV Ammo designees (at least three of whom shall be "independent directors") and the chief executive
officer of True Velocity. True Velocity's executive management team will be led by the current management of TV Ammo. To qualify
as an "independent director" under the Merger Agreement, a designee shall both (a) qualify as "independent" under
the rules of the Nasdaq Stock Market and (b) not have had any business relationship with either Breeze or TV Ammo or any of their respective
subsidiaries, including as an officer or director thereof, other than for a period of less than six months prior to the date of the Merger
Agreement.

 The
Merger Agreement contains representations, warranties and covenants of each of the parties thereto that are customary for
transactions of this type, including, among others, covenants providing for (a) certain limitations on the operation of the
parties' respective businesses prior to consummation of the Business Combination, (b) the parties' efforts to satisfy
conditions to consummation of the Business Combination, including by obtaining necessary approvals from governmental agencies
(including U.S. federal antitrust authorities and under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the
"HSR Act")), (c) prohibitions on the parties soliciting alternative transactions, (d) Breeze preparing and filing a
registration statement on Form S-4 with the Securities and Exchange Commission (the "SEC") and taking certain other
actions to obtain the requisite approval of Breeze's stockholders to vote in favor of certain matters, including the adoption
of the Merger Agreement and approval of the Business Combination, at a special meeting to be called for the approval of such
matters, and (e) the protection of, and access to, confidential information of the parties.

to the terms and subject to the conditions of the Merger Agreement, Breeze has prepared and filed with the SEC a proxy statement (the
"Extension Proxy Statement"), for the purpose of amending the Breeze organizational documents and the Trust Agreement, in
each case, to extend the time period for Breeze to consummate a Business Combination from March 26, 2023 up to September 26, 2023
(the "Extension Proposal"). Breeze filed and distributed the Extension Proxy Statement to solicit proxies thereunder and
will hold a meeting of the stockholders of Breeze to consider, vote on and approve the Extension Proposal on March 22, 2023.

 The
parties to the Merger Agreement agreed to use their reasonable best efforts to enter into an at-the-market facility ("At-the-Market
Facility") prior to the Closing on terms and conditions reasonably satisfactory to Breeze and TV Ammo.

 In
addition, Breeze's board of directors has agreed to adopt, subject to stockholder approval, an equity incentive plan, as described
in the Merger Agreement, for the purpose of providing a means through which to enhance the ability to attract, retain and motivate persons
who make (or are expected to make) important contributions to True Velocity by providing these individuals with equity ownership opportunities
and/or equity-linked compensatory opportunities.

 The
obligations of Breeze and TV Ammo to consummate the Business Combination are subject to the fulfillment (or waiver) of certain closing
conditions, including, but not limited to, (a) the expiration or termination of the applicable waiting period under the HSR Act, (b)
the approval of Breeze's stockholders, (c) the approval of TV Ammo's stockholders, and (d) Breeze's Form S-4 registration
statement becoming effective.

 In
addition, the obligations of Breeze and Merger Sub to consummate the Business Combination are also subject to the fulfillment (or waiver)
of other closing conditions, including, but not limited to, (a) the representations and warranties of TV Ammo being true and correct
to the standards applicable to such representations and warranties and each of the covenants of TV Ammo having been performed or complied
with in all material respects, (b) delivery of certain ancillary agreements required to be executed and delivered in connection with
the Business Combination; and (c) no Material Adverse Effect (as defined in the Merger Agreement) having occurred.

 The
obligation of TV Ammo to consummate the Business Combination is also subject to the fulfillment (or waiver) of other closing conditions,
including, but not limited to, (a) the representations and warranties of Breeze and Merger Sub being true and correct to the standards
applicable to such representations and warranties and each of the covenants of Breeze and Merger Sub having been performed or complied
with in all material respects, (b) the shares of True Velocity Common Stock issuable in connection with the Business Combination being
listed on the Nasdaq Stock Market, and (c) Breeze having cash on hand (inclusive of proceeds from certain permitted financing transactions)
of at least $30,000,000 (after deducting any amounts paid to Breeze stockholders that exercise their redemption rights in connection
with the Business Combination and net of certain transaction expenses incurred by Breeze or TV Ammo). If Breeze's cash on hand
is less than $30,000,000, (i) after the Breeze stockholder meeting to approve the Business Combination, Breeze may sell additional shares
of Breeze Common Stock to investors for not less than $10.00 per share ("Additional Financing"), and (ii) after the deadline
for Breeze stockholders to elect to redeem their Breeze Common Stock in connection with the Business Combination, Breeze may, with the
consent of TV Ammo, enter into agreements incentivizing redeeming stockholders to unwind their election to redeem. The Sponsor has agreed
to forfeit up to 20% of its shares of Breeze Common Stock to allow Breeze to offer shares in connection with any such incentive agreements.

 The
Merger Agreement may be terminated under certain customary and limited circumstances prior to the Closing of the Business Combination,
including, but not limited to, (a) by mutual written consent of Breeze and TV Ammo, (b) by Breeze, on the one hand, or TV Ammo, on the
other hand, if there is any breach of the representations, warranties, covenants or agreements of the other party as set forth in the
Merger Agreement, in each case, such that certain conditions to Closing cannot be satisfied and the breach or breaches of such representations
or warranties or the failure to perform such covenants or agreements, as applicable, are not cured or cannot be cured within certain
specified time periods, (c) by either Breeze or TV Ammo if the Business Combination is not consummated by April 28, 2023, provided the
failure to close by such date is not due to a breach by the terminating party, (d) by either Breeze or TV Ammo if a meeting of Breeze's
stockholders is held to vote on proposals relating to the Business Combination and the stockholders do not approve the proposals, and
(e) by Breeze if the TV Ammo stockholders do not approve the Merger Agreement and the transactions contemplated thereby within five days
after Breeze's registration statement on Form S-4 becomes effective.

 Under
certain circumstances as described further in the Merger Agreement, if the Merger Agreement is validly terminated by Breeze, TV Ammo
will pay Breeze a fee equal to the actual documented expenses incurred by Breeze in connection with the Business Combination of up to
$1,000,000.

 A
copy of the Merger Agreement is included as Exhibit 2.1 in our Current Report filed with the SEC on Form 8-K on November 1, 2022 and
is incorporated herein by reference, and the foregoing description of the Merger Agreement is qualified in its entirety by reference
thereto. The Merger Agreement contains representations, warranties and covenants that the respective parties made to each other as of
the date of the Merger Agreement or other specific dates. The assertions embodied in those representations, warranties and covenants
were made for purposes of the agreement among the respective parties and are subject to important qualifications and limitations agreed
to by the parties in connection with negotiating such agreement. The representations, warranties and covenants in the Merger Agreement
are also modified in important part by the underlying disclosure schedules which are not filed publicly and which are subject to a contractual
standard of materiality different from that generally applicable to stockholders and were used for the purpose of allocating risk among
the parties rather than establishing matters as facts. Breeze does not believe that these schedules contain information that is material
to an investment decision.

 The
Merger Agreement contemplates that TV Ammo may enter into agreements to raise capital in one or more private placement transactions prior
to the Closing of the Business Combination for aggregate gross proceeds of up to $100,000,000 (the "Permitted Financing").

 Concurrently
with the execution of the Merger Agreement, Breeze, TV Ammo, the Sponsor, I-Bankers and the independent directors of Breeze (current
and former) (collectively, the "Breeze Initial Stockholders") entered into a sponsor support agreement (the "Sponsor
Support Agreement") pursuant to which, among other things, the Breeze Initial Stockholders: (a) agreed to vote all of their
shares of Breeze Common Stock in favor of the proposals to be submitted to the Breeze stockholders in connection with the Business Combination,
including the adoption of the Merger Agreement and the approval of the Business Combination and the Extension Proposal; (b) agreed
to vote against any other matter, action, agreement, transaction or proposal that would reasonably be expected to result in (i) a
breach of any of Breeze's or Merger Sub's representations, warranties, covenants, agreements or obligations under the Merger
Agreement or (ii) any of the mutual or TV Ammo conditions to the Closing in the Merger Agreement not being satisfied; (c) (i) waived,
subject to and conditioned upon the Closing and to the fullest extent permitted by applicable law and the Breeze organizational documents,
and (ii) agreed not to assert or perfect, any rights to adjustment or other anti-dilution protections to which such Breeze Initial
Stockholder may be entitled in connection with the Merger or the other Transactions or the Extension Proposal; (d) agreed to take,
or cause to be taken, all actions and to do, or cause to be done, all things reasonably necessary under applicable laws to consummate
the Merger and the other Transactions on the terms and subject to the conditions set forth in the Merger Agreement prior to any valid
termination of the Merger Agreement; (e) agreed not to transfer or pledge any of their shares of Breeze Common Stock, or enter into
any arrangement with respect thereto, after the execution of the Merger Agreement and prior to the Closing Date, subject to certain customary
conditions and exceptions; and (f) waived their rights to redeem any of their shares of Breeze Common Stock in connection with the
approval of the Breeze Proposals and the Extension Proposal. Additionally, the Sponsor has agreed to: (a) forfeit for no consideration
up to 20% of the aggregate shares of Breeze Common Stock held by it if Breeze reasonably determines that the issuance of additional shares
of Breeze Common Stock to investors or redeeming Breeze stockholders (at a price per share not to be less than $10.00) would be reasonably
required (i) to cause the Breeze Cash on Hand to be at least equal to the Minimum Cash Amount or (ii) to secure any Additional
Financing; (b) forfeit for no consideration up to 20% of the aggregate shares of Breeze Common Stock held by it if, on the six month
anniversary of the Closing, the sum of (i) the Breeze's cash on hand at the Closing plus (ii) the funds requested or
received under the At-the-Market Facility (or other similar equity or hybrid equity-based instrument or facility) at or prior to such
date is less than $50,000,000; and (c) assume and pay all Breeze transaction expenses incurred in connection with the D-Orbit transaction
in full and indemnify Breeze, TV Ammo and their respective subsidiaries from any and all liabilities related thereto, and to not sell
or transfer any of its shares of Breeze Common Stock or distribute any of its assets unless and until such time as it has assumed and
paid in full all such Breeze transaction expenses.

 The
foregoing description of the Sponsor Support Agreement is subject to and qualified in its entirety by reference to the full text of the
Sponsor Support Agreement, a copy of which is included as Exhibit 10.1 in our Current Report filed with the SEC on Form 8-K on November
1, 2022, and the terms of which are incorporated herein by reference.

 On
November 9, 2022, in accordance with the Merger Agreement, Breeze, TV Ammo and certain TV Ammo equity holders representing
approximately 66.34% of the issued and outstanding shares of TV Ammo Common Stock executed a stockholder support agreement, pursuant
to which, among other things, such TV Ammo equity holders: (a) agreed to vote in favor of the adoption of the Merger Agreement
and approve the Merger and the other transactions contemplated by the Merger Agreement or the ancillary agreements referenced
therein to which TV Ammo is a party; (b) agreed to approve, in accordance with the terms and subject to the conditions of the
TV Ammo organizational documents, the conversion of all outstanding shares of TV Ammo preferred stock into shares of TV Ammo Common
Stock to take effect immediately prior to the Closing; (c) agreed to waive any appraisal or similar rights they may have
pursuant to the Texas Business Organizations Code with respect to the Merger and the other transactions contemplated by the Merger
Agreement or the ancillary agreements referenced therein; (d) agreed to vote against any other matter, action, agreement,
transaction or proposal that would reasonably be expected to result in (i) a breach of any of TV Ammo's representations,
warranties, covenants, agreements or obligations under the Merger Agreement or (ii) any of the mutual or Breeze or Merger Sub
conditions to the Closing in the Merger Agreement not being satisfied; and (e) agreed not to sell, assign, transfer or pledge
any of their shares of TV Ammo Common Stock or TV Ammo preferred stock (or enter into any arrangement with respect thereto) after
the execution of the Merger Agreement and prior to the Closing date, subject to certain customary conditions and
exceptions.

 On
November 9, 2022, Breeze, TV Ammo, the Breeze Initial Stockholders and certain TV Ammo equity holders entered into a lock-up agreement
(the "Lock-Up Agreement"), pursuant to which the Breeze Initial Stockholders and such TV Ammo equity holders have agreed,
among other things, to refrain from selling or transferring their shares of True Velocity Common Stock for a period of eight months
following the Closing, subject to early release (a) of 10% of their shares of True Velocity Common Stock if the daily volume weighted
average closing sale price of True Velocity Common Stock quoted on the Nasdaq Stock Market for any 20 trading days within any 30
consecutive trading day period exceeds $12.50 per share, (b) of an additional 10% of their shares of True Velocity Common Stock
if the daily volume weighted average closing sale price of True Velocity Common Stock quoted on the Nasdaq Stock Market for any 20 trading
days within any 30 consecutive trading day period exceeds $15.00 per share; (c) of all of their shares of True Velocity Common
Stock upon the occurrence of a Subsequent Transaction; and (d) upon the determination of the True Velocity board of directors (including
a majority of the independent directors) following the six month anniversary of the Closing date.

 On
November 9, 2022, Breeze, the Breeze Initial Stockholders and certain TV Ammo equity holders entered into an Amended and Restated
Registration Rights Agreement (the "Registration Rights Agreement"), which amended the terms of the Registration Rights Agreement
entered into by Breeze and the Breeze Initial Stockholders on November 23, 2020, pursuant to which, among other things, Breeze will
be obligated to file a registration statement to register the resale of certain securities of Breeze held by the Breeze Initial Stockholders
and such TV Ammo equity holders. The Registration Rights Agreement also provides the Breeze Initial Stockholders and such TV Ammo equity
holders with "piggy-back" registration rights, subject to certain requirements and customary conditions.

 The
foregoing description of the Stockholder Support Agreement, the Lock-Up Agreement and the Registration Rights Agreement are subject to
and qualified in its entirety by reference to the full text of the Stockholder Support Agreement, Lock-Up Agreement and Registration
Rights Agreement, respectively, copies of which are attached to this Annual Report on Form 10-K as Exhibits 10.14, 10.15and 10.16, respectively,
and the terms of which are incorporated herein by reference.

 Except
as specifically discussed, this Annual Report on Form 10-K does not assume the closing of the Business Combination with TV Ammo.

Strategy & Competitive Strengths

 Our
acquisition and value creation strategy is to identify, acquire and, after our initial business combination, build a company in North
America that complements the experience of our management team and can benefit from their operational expertise and/or executive oversight.
Our acquisition strategy leverages our management team's network of potential proprietary and public transaction sources where
we believe a combination of our relationships, knowledge and experience could effect a positive transformation or augmentation of existing
businesses or properties to improve their overall value proposition.

 We
utilized the network and industry experience of our management team and business partners in seeking an initial business combination
and employing our acquisition strategy. Over the course of their careers, the members of our management team and their affiliates have
developed a broad network of contacts and industry relationships that we believe will serve as a useful source of acquisition opportunities.
This network has been developed through our management team's extensive experience. In addition to our industry and lending community
relationships, we leverage relationships with management teams of public and private companies, capital market participants, private
equity groups, investment banking firms, consultants, restructuring advisers, attorneys and accounting firms, which we believe should
provide us with a number of business combination opportunities. Members of our management team are communicating with their networks
of relationships to articulate the parameters for our search for a target business and a potential business combination and have identified
a target and executed a Business Combination Agreement.

 Acquisition
Strategy

 Consistent
with this strategy, we have identified the following general criteria and guidelines that we believe are important in evaluating prospective
target businesses. We use these criteria and guidelines in evaluating acquisition opportunities, but we may decide to enter into our
initial business combination with a target business that does not meet these criteria and guidelines. We intend to acquire one or more
companies that we believe:

 have
 the ability to generate significant current free cash flow;

 have
 potential to generate significant growth in shareholder value following our initial business combination;

 are
 at an inflection point, such as requiring additional management expertise, are able to innovate through new operational techniques
 and technology, or where we believe we can drive improved financial performance;

 can
utilize the extensive networks, operational experience and insights of our management team;

 are
 fundamentally sound but we believe can achieve better results by leveraging the operating and financial experience of our management
 team and their affiliates;

 exhibit
 unrecognized value or other characteristics, desirable returns on capital, and a need for capital to achieve the company's
 growth strategy, that we believe have been misevaluated by the marketplace based on our analysis and due diligence review; and

 can
 offer attractive risk-adjusted returns on investments for our stockholders.

 We
seek to acquire the target on terms and in a manner that leverage our management team's investing experience. Potential upside
from growth in the target business and an improved capital structure will be weighed against any identified downside risks.

 These
criteria are not intended to be exhaustive. Any evaluation relating to the merits of the initial business combination may be based, to
the extent relevant, on these general guidelines as well as other considerations, factors and criteria that our management deems relevant.
In the event that our initial business combination with a target business does not meet the above criteria and guidelines, we will disclose
that the target business does not meet the above criteria in our stockholder communications related to our initial business combination,
which would be in the form of tender offer documents or proxy solicitation materials that we would file with the SEC.

 In
evaluating the target business, we conducted a thorough due diligence review that encompasses, among other things, meetings with incumbent
management and employees, document reviews, inspection of facilities, as well as a review of financial and other information that is
made available to us. In conducting our due diligence review, we leveraged the experience of members of our management team and I-Bankers
on an efficient and cost-effective basis as we deployed them to review matters related to their specific areas of functional expertise.

 We
are not prohibited from pursuing an initial business combination with a company that is affiliated with our sponsor, officers or directors.
In the event we seek to complete our initial business combination with a company that is affiliated with our sponsor, officers or directors,
we, or a committee of independent directors, will obtain an opinion from an independent investment banking firm which is a member of
the Financial Industry Regulatory Authority, or FINRA, or an independent accounting firm (exclusive of our registered independent public
accounting firm) that our initial business combination is fair to our company from a financial point of view.

 Members
of our management team, our sponsor and our independent directors directly or indirectly own founder shares and/or private placement
warrants following our initial public offering and, accordingly, may have a conflict of interest in determining whether the target business
is an appropriate business with which to effectuate our initial business combination. Further, each of our officers and directors may
have a conflict of interest with respect to evaluating the particular business combination target if the retention or resignation of
any such officers and directors was included by a target business as a condition to any agreement with respect to our initial business

 Each
of our officers and directors presently has, and any of them in the future may have additional, fiduciary or contractual obligations
to other entities pursuant to which such officer or director is or will be required to present a business combination opportunity. Accordingly,
if any of our officers or directors becomes aware of a business combination opportunity which is suitable for an entity to which he or
she has then-current fiduciary or contractual obligations, he or she will honor his or her fiduciary or contractual obligations to present
such opportunity to such entity. We do not believe, however, that the fiduciary duties or contractual obligations of our officers or
directors will materially affect our ability to complete our business combination. Our amended and restated certificate of incorporation
provides that we renounce our interest in any corporate opportunity offered to any director or officer unless such opportunity is expressly
offered to such person solely in his or her capacity as a director or officer of our company and such opportunity is one we are legally
and contractually permitted to undertake and would otherwise be reasonable for us to pursue.

 Our
executive officers are not required to commit any specified amount of time to our affairs, and, accordingly, will have conflicts of interest
in allocating management time among various business activities, including identifying potential business combination targets and monitoring
the related due diligence.

 Our
sponsor and executive officers have agreed, pursuant to a written letter agreement, not to participate in the formation of, or become
an officer of, any other blank check company until we have entered into a definitive agreement regarding our initial business combination
or we have failed to complete our initial business combination within 18 months after the closing of our initial public offering; provided
that this agreement would not prevent our executive officers from serving as directors in other blank check companies.

 Neither
I-Bankers nor any of its affiliates has entered into such an agreement, and, accordingly, are not precluded from participating in any
other blank check company or from underwriting an offering by any other blank check company.

 Initial
Business Combination

 As
required by NASDAQ rules, our initial business combination will be approved by a majority of our independent directors. NASDAQ rules
also require that we must complete one or more business combinations having an aggregate fair market value of at least 80% of the value
of the assets held in the trust account (excluding the deferred underwriting commissions and taxes payable) at the time of our signing
a definitive agreement in connection with our initial business combination. Our board of directors will make the determination as to
the fair market value of our initial business combination. If our board of directors is not able to independently determine the fair
market value of our initial business combination, we will obtain an opinion from an independent investment banking firm or another independent
entity that commonly renders valuation opinions with respect to the satisfaction of such criteria. While we consider it unlikely that
our board of directors will not be able to make an independent determination of the fair market value of our initial business combination,
it may be unable to do so if it is less familiar or experienced with the business of a particular target or if there is a significant
amount of uncertainty as to the value of a target's assets or prospects. In addition, we have agreed not to enter into a definitive
agreement regarding an initial business combination without the prior consent of our sponsor.

 We
anticipate structuring our initial business combination either (i) in such a way so that the post-transaction company in which our
public stockholders own shares will own or acquire 100% of the equity interests or assets of the target business or businesses, or (ii) in
such a way so that the post-transaction company owns or acquires less than 100% of such interests or assets of the target business in
order to meet certain objectives of the target management team or stockholders, or for other reasons. However, we will only complete
an initial business combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of
the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment
company under the Investment Company Act of 1940, as amended, or the "Investment Company Act". Even if the post-transaction
company owns or acquires 50% or more of the voting securities of the target, our stockholders prior to the initial business combination
may collectively own a minority interest in the post-transaction company, depending on valuations ascribed to the target and us in the
initial business combination. For example, we could pursue a transaction in which we issue a substantial number of new shares in exchange
for all of the outstanding capital stock of a target. In this case, we would acquire a 100% controlling interest in the target. However,
as a result of the issuance of a substantial number of new shares, our stockholders immediately prior to our initial business combination
could own less than a majority of our outstanding shares subsequent to our initial business combination. If less than 100% of the equity
interests or assets of a target business or businesses are owned or acquired by the post-transaction company, the portion of such business
or businesses that is owned or acquired is what will be taken into account for purposes of NASDAQ's 80% of fair market value test.
If the initial business combination involves more than one target business, the 80% of fair market value test will be based on the aggregate
value of all of the transactions and we will treat the target businesses together as the initial business combination for purposes of
a tender offer or for seeking stockholder approval, as applicable.

 Our
Business Combination Process

 In
evaluating prospective business combinations, we expect to conduct a thorough due diligence review process that may encompass, among
other things, a review of historical and projected financial and operating data, meetings with management and their advisors (if applicable),
on-site inspection of facilities and assets, discussion with customers and suppliers, legal reviews and other reviews as we deem appropriate.

 We
will also leverage our operational and capital allocation experience in order to:

 Assemble
 a team of industry and financial experts: For each potential transaction, we intend to assemble a team of industry and financial
 experts to supplement our management's efforts to identify and resolve key issues facing the company. We intend to construct
 an operating and financial plan which optimizes the potential to grow shareholder value. With extensive experience investing in both
 healthy and underperforming businesses, we expect that our management will be able to demonstrate to the target business and its
 stakeholders that we have the resources and expertise to lead the combined company through complex and often turbulent market conditions
 and provide the strategic and operational direction necessary to grow the business in order to maximize cash flows and improve the
 overall strategic prospects for the business;

 Conduct
 rigorous research and analysis: Performing disciplined, bottom-up fundamental research and analysis is core to our strategy,
 and we intend to conduct extensive due diligence to evaluate the impact that a transaction may have on the target business;

 Acquire
 the target company at an attractive price relative to our view of its intrinsic value: Combining rigorous bottom-up analysis
 as well as input from industry and financial experts, the management team intends to develop its view of the intrinsic value of the
 potential business combination. In doing so, the management team will evaluate future cash flow potential, relative industry valuation
 metrics and precedent transactions to inform its view of intrinsic value, with the intention of creating a business combination at
 an attractive price relative to such view;

 Corporate
Information

 Our
executive offices are located at 955 W. John Carpenter Fwy., Suite 100-929, Irving, TX 75039 and our telephone number is (619) 500-7747.

 We
are an "emerging growth company," as defined in Section 2(a) of the Securities Act of 1933, as amended (the "Securities
Act"), as modified by the Jumpstart Our Business Startups Act of 2012, or the JOBS Act. As such, we are eligible to take advantage
of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth
companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of
the Sarbanes-Oxley Act of 2002, or the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic
reports and proxy statements, and exemptions from the requirements of holding a non-binding advisory vote on executive compensation and
stockholder approval of any golden parachute payments not previously approved. If some investors find our securities less attractive
as a result, there may be a less active trading market for our securities and the prices of our securities may be more volatile.

 In
addition, Section 107 of the JOBS Act also provides that an emerging growth company can take advantage of the extended transition
period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. In other words,
an emerging growth company can delay the adoption of certain accounting standards until those standards would otherwise apply to private
companies. We intend to take advantage of the benefits of this extended transition period.

 We
will remain an emerging growth company until the earlier of (1) the last day of the fiscal year (a) following the fifth anniversary
of the closing of our initial public offering, (b) in which we have total annual gross revenue of at least $1.07 billion, or (c) in
which we are deemed to be a large accelerated filer, which means the market value of our common stock that is held by non-affiliates
exceeds $700 million as of the prior June 30, and (2) the date on which we have issued more than $1.0 billion in non-convertible
debt securities during the prior three-year period. References herein to emerging growth company will have the meaning associated with
it in the JOBS Act.

 Status
as a Public Company

 We
believe our structure will make us an attractive business combination partner to target businesses. As a public company, we offer a target
business an alternative to the traditional initial public offering through a merger or other business combination with us. Following
an initial business combination, we believe the target business would have greater access to capital and additional means of creating
management incentives that are better aligned with stockholders' interests than it would as a private company. A target business
can further benefit by augmenting its profile among potential new customers and vendors and aid in attracting talented employees. In
a business combination transaction with us, the owners of the target business may, for example, exchange their shares of stock in the
target business for our shares of common stock (or shares of a new holding company) or for a combination of our shares of common stock
and cash, allowing us to tailor the consideration to the specific needs of the sellers.

there are various costs and obligations associated with being a public company, we believe target businesses will find this method a
more expeditious and cost-effective method to becoming a public company than the typical initial public offering. The typical initial
public offering process takes a significantly longer period of time than the typical business combination transaction process, and there
are significant expenses in the initial public offering process, including underwriting discounts and commissions, marketing and road
show efforts that may not be present to the same extent in connection with an initial business combination with us.

 Furthermore,
once a proposed initial business combination is completed, the target business will have effectively become public, whereas an initial
public offering is always subject to the underwriters' ability to complete the offering, as well as general market conditions,
which could delay or prevent the offering from occurring or could have negative valuation consequences. Following an initial business
combination, we believe the target business would then have greater access to capital and an additional means of providing management
incentives consistent with stockholders' interests and the ability to use its shares as currency for acquisitions. Being a public
company can offer further benefits by augmenting a company's profile among potential new customers and vendors and aid in attracting
talented employees.

 While
we believe that our structure and our management team's backgrounds will make us an attractive business partner, some potential
target businesses may view our status as a blank check company, such as our lack of an operating history and our ability to seek stockholder
approval of any proposed initial business combination, negatively.

Position

 As
of December 31, 2022, we had approximately $17.7 million held in the trust account. With the funds available, we offer a target
business a variety of options such as creating a liquidity event for its owners, providing capital for the potential growth and
expansion of its operations or strengthening its balance sheet by reducing its debt or leverage ratio. Because we are able to
complete our initial business combination using our cash, debt or equity securities, or a combination of the foregoing, we have the
flexibility to use the most efficient combination that will allow us to tailor the consideration to be paid to the target business
to fit its needs and desires. However, we have not taken any steps to secure third party financing and there can be no assurance it
will be available to us.

 Effecting
Our Initial Business Combination

 We
intend to effectuate our initial business combination using cash from the proceeds of our initial public offering and the private placement
of the private placement warrants, the proceeds of the sale of our shares in connection with our initial business combination, shares
issued to the owners of the target, debt issued to bank or other lenders or the owners of the target, or a combination of the foregoing.
We may seek to complete our initial business combination with a company or business that may be financially unstable or in its early
stages of development or growth, which would subject us to the numerous risks inherent in such companies and businesses.

 If
our initial business combination is paid for using equity or debt securities, or not all of the funds released from the trust account
are used for payment of the consideration in connection with our initial business combination or used for redemptions of our common stock,
we may apply the balance of the cash released to us from the trust account for general corporate purposes, including for maintenance
or expansion of operations of the post-transaction company, the payment of principal or interest due on indebtedness incurred in completing
our initial business combination, to fund the purchase of other companies or for working capital.

 We
may seek to raise additional funds through a private offering of debt or equity securities in connection with the completion of our initial
business combination, and we may effectuate our initial business combination using the proceeds of such offering rather than using the
amounts held in the trust account. In addition, we intend to target businesses larger than we could acquire with the net proceeds of
our initial public offering and the sale of the private placement warrants, and may as a result be required to seek additional financing
to complete such proposed initial business combination. Subject to compliance with applicable securities laws, we would expect to complete
such financing only simultaneously with the completion of our initial business combination. In the case of an initial business combination
funded with assets other than the trust account assets, our proxy materials or tender offer documents disclosing the initial business
combination would disclose the terms of the financing and, only if required by law, we would seek stockholder approval of such financing.
There are no prohibitions on our ability to raise funds privately or through loans in connection with our initial business combination.
At this time, we are not a party to any arrangement or understanding with any third party with respect to raising any additional funds
through the sale of securities or otherwise.

 Sources
of Target Businesses

 We
anticipate that target business candidates will continue to be brought to our attention from various unaffiliated sources, including
investment bankers and investment professionals. Target businesses may be brought to our attention by such unaffiliated sources as a
result of being solicited by us by calls or mailings. These sources may also introduce us to target businesses in which they think we
may be interested on an unsolicited basis, since many of these sources will have read this Report or the final prospectus relating to
our initial public offering and know what types of businesses we are targeting. Our officers and directors, as well as our sponsor and
their affiliates, may also bring to our attention target business candidates that they become aware of through their business contacts
as a result of formal or informal inquiries or discussions they may have, as well as attending trade shows or conventions. In addition,
we expect to receive a number of proprietary deal flow opportunities that would not otherwise necessarily be available to us as a result
of the business relationships of our officers and directors and our sponsor and their respective industry and business contacts as well
as their affiliates. While we do not presently anticipate engaging the services of professional firms or other individuals that specialize
in business acquisitions on any formal basis, we may engage these firms or other individuals in the future, in which event we may pay
a finder's fee, consulting fee, advisory fee or other compensation to be determined in an arms-length negotiation based on the
terms of the transaction. We will engage a finder only to the extent our management determines that the use of a finder may bring opportunities
to us that may not otherwise be available to us or if finders approach us on an unsolicited basis with a potential transaction that our
management determines is in our best interest to pursue. Payment of finder's fees is customarily tied to completion of a transaction;
in which case any such fee will be paid out of the funds held in the trust account. In no event will our sponsor or any of our existing
officers or directors, or any entity with which our sponsor or officers are affiliated, be paid any finder's fee, reimbursement,
consulting fee, monies in respect of any payment of a loan or other compensation by the company prior to, or in connection with any services
rendered for any services they render in order to effectuate, the completion of our initial business combination (regardless of the type
of transaction that it is). Although none of our sponsor, executive officers or directors, or any of their respective affiliates, will
be allowed to receive any compensation, finder's fees or consulting fees from a prospective business combination target in connection
with a contemplated initial business combination, we do not have a policy that prohibits our sponsor, executive officers or directors,
or any of their respective affiliates, from negotiating for the reimbursement of out-of-pocket expenses by a target business. We have
agreed to pay an affiliate of our sponsor a total of $5,000 per month for office space, utilities and secretarial and administrative
support and to reimburse our sponsor for any out-of-pocket expenses related to identifying, investigating and completing an initial business
combination. Some of our officers and directors may enter into employment or consulting agreements with the post-transaction company
following our initial business combination. The presence or absence of any such fees or arrangements will not be used as a criterion
in our selection process of an initial business combination candidate.

 If
any of our officers or directors becomes aware of an initial business combination opportunity that falls within the line of business
of any entity to which he or she has pre-existing fiduciary or contractual obligations, he or she may be required to present such business
combination opportunity to such entity prior to presenting such business combination opportunity to us. Our officers and directors currently
have certain relevant fiduciary duties or contractual obligations that may take priority over their duties to us.

 Lack
of Business Diversification

 For
an indefinite period of time after the completion of our initial business combination, the prospects for our success may depend entirely
on the future performance of a single business. Unlike other entities that have the resources to complete business combinations with
multiple entities in one or several industries, it is probable that we will not have the resources to diversify our operations and mitigate
the risks of being in a single line of business. In addition, we focus our search for an initial business combination in a single industry.
By completing our initial business combination with only a single entity, our lack of diversification may:

 subject
 us to negative economic, competitive and regulatory developments, any or all of which may have a substantial adverse impact on the
 particular industry in which we operate after our initial business combination, and

 cause
 us to depend on the marketing and sale of a single product or limited number of products or services.

 Limited
Ability to Evaluate the Target's Management Team

we intend to closely scrutinize the management of a prospective target business when evaluating the desirability of effecting our initial
business combination with that business, our assessment of the target business' management may not prove to be correct. In addition,
the future management may not have the necessary skills, qualifications or abilities to manage a public company.

 Furthermore,
the future role of members of our management team, if any, in the target business cannot presently be stated with any certainty. The
determination as to whether any of the members of our management team will remain with the combined company will be made at the time
of our initial business combination. While it is possible that one or more of our directors will remain associated in some capacity with
us following our initial business combination, it is unlikely that any of them will devote their full efforts to our affairs subsequent
to our initial business combination. Moreover, we cannot assure you that members of our management team will have significant experience
or knowledge relating to the operations of the particular target business.

 We
cannot assure you that any of our key personnel will remain in senior management or advisory positions with the combined company. The
determination as to whether any of our key personnel will remain with the combined company will be made at the time of our initial business

an initial business combination, we may seek to recruit additional managers to supplement the incumbent management of the target business.
We cannot assure you that we will have the ability to recruit additional managers, or that additional managers will have the requisite
skills, knowledge or experience necessary to enhance the incumbent management.

 Stockholders
May Not Have the Ability to Approve Our Initial Business Combination

 We
may conduct redemptions without a stockholder vote pursuant to the tender offer rules of the SEC. However, we will seek stockholder approval
if it is required by law or applicable stock exchange rule, or we may decide to seek stockholder approval for business or other legal
reasons. Presented in the table below is a graphic explanation of the types of initial business combinations we may consider and whether
stockholder approval is currently required under Delaware law for each such transaction.

 Type of Transaction

 Whether Stockholder
 Approval Is Required

 Purchase of assets

 No

 Purchase of stock of target not involving a merger with the company

 No

 Merger of target into a subsidiary of the company

 No

 Merger of the company with a target

 Yes

 Under
NASDAQ's listing rules, stockholder approval would be required for our initial business combination if, for example:

 we
 issue shares of common stock that will be equal to or in excess of 20% of the number of shares of our common stock then outstanding
 (other than in a public offering);

 any
 of our directors, officers or substantial security holders (as defined by NASDAQ rules) has a 5% or greater interest (or such persons
 collectively have a 10% or greater), directly or indirectly, in the target business or assets to be acquired or otherwise and the
 present potential issuance of common stock could result in an increase in outstanding common shares or voting power of 5% or more;
 or

 the
 issuance or potential issuance of common stock will result in our undergoing a change of control.

 Permitted
Purchases of our Securities

 If
we seek stockholder approval of our initial business combination and we do not conduct redemptions in connection with our initial business
combination pursuant to the tender offer rules, our sponsor, initial stockholders, directors, officers, advisors or their affiliates
may purchase shares or public warrants in privately negotiated transactions or in the open market either prior to or following the completion
of our initial business combination. There is no limit on the number of shares our initial stockholders, directors, officers, advisors
or their affiliates may purchase in such transactions, subject to compliance with applicable law and NASDAQ rules. However, they have
no current commitments, plans or intentions to engage in such transactions and have not formulated any terms or conditions for any such
transactions. If they engage in such transactions, they will not make any such purchases when they are in possession of any material
nonpublic information not disclosed to the seller or if such purchases are prohibited by Regulation M under the Exchange Act. We do not
currently anticipate that such purchases, if any, would constitute a tender offer subject to the tender offer rules under the Exchange
Act or a going-private transaction subject to the going-private rules under the Exchange Act; however, if the purchasers determine at
the time of any such purchases that the purchases are subject to such rules, the purchasers will comply with such rules.

 Any
such purchases will be reported pursuant to Section 13 and Section 16 of the Exchange Act to the extent such purchasers are
subject to such reporting requirements. None of the funds held in the trust account will be used to purchase shares or public warrants
in such transactions prior to completion of our initial business combination.

 The
purpose of any such purchases of shares could be to vote such shares in favor of the initial business combination and thereby increase
the likelihood of obtaining stockholder approval of the initial business combination or to satisfy a closing condition in an agreement
with a target that requires us to have a minimum net worth or a certain amount of cash at the closing of our initial business combination,
where it appears that such requirement would otherwise not be met. The purpose of any such purchases of public warrants could be to reduce
the number of public warrants outstanding or to vote such warrants on any matters submitted to the warrant holders for approval in connection
with our initial business combination. Any such purchases of our securities may result in the completion of our initial business combination
that may not otherwise have been possible. In addition, if such purchases are made, the public "float" of our shares of common
stock or warrants may be reduced and the number of beneficial holders of our securities may be reduced, which may make it difficult to
maintain or obtain the quotation, listing or trading of our securities on a national securities exchange.

 Our
sponsor, officers, directors and/or their affiliates anticipate that they may identify the stockholders with whom our sponsor, officers,
directors or their affiliates may pursue privately negotiated purchases by either the stockholders contacting us directly or by our receipt
of redemption requests submitted by stockholders following our mailing of proxy materials in connection with our initial business combination.
To the extent that our sponsor, officers, directors, advisors or their affiliates enter into a private purchase, they would identify
and contact only potential selling stockholders who have expressed their election to redeem their shares for a pro rata share of the
trust account or vote against our initial business combination, whether or not such stockholder has already submitted a proxy with respect
to our initial business combination. Our sponsor, officers, directors, advisors or their affiliates will only purchase shares if such
purchases comply with Regulation M under the Exchange Act and the other federal securities laws.

 Any
purchases by our sponsor, officers, directors and/or their affiliates who are affiliated purchasers under Rule 10b-18 under the Exchange
Act will only be made to the extent such purchases are able to be made in compliance with Rule 10b-18, which is a safe harbor from liability
for manipulation under Section 9(a)(2) and Rule 10b-5 of the Exchange Act. Rule 10b-18 has certain technical requirements that must
be complied with in order for the safe harbor to be available to the purchaser. Our sponsor, officers, directors and/or their affiliates
will not make purchases of common stock if the purchases would violate Section 9(a)(2) or Rule 10b-5 of the Exchange Act. Any such
purchases will be reported pursuant to Section 13 and Section 16 of the Exchange Act to the extent such purchases are subject
to such reporting requirements

 Redemption
Rights for Public Stockholders upon Completion of our Initial Business Combination

 We
will provide our public stockholders with the opportunity to redeem all or a portion of their shares of common stock upon the completion
of our initial business combination at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust
account as of two business days prior to the consummation of the initial business combination including interest earned on the funds
held in the trust account and not previously released to us to pay our franchise and income taxes, divided by the number of then outstanding
public shares, subject to the limitations described herein. As of February 27, 2023 the amount in the trust account is $10.56 per public
share. The per-share amount we will distribute to investors who properly redeem their shares will not be reduced by the deferred underwriting
commissions we will pay to the underwriters. The redemption rights will include the requirement that a beneficial holder must identify
itself in order to validly redeem its shares. Our sponsor, officers and directors have entered into a letter agreement with us, pursuant
to which they have agreed to waive their redemption rights with respect to any founder shares and any public shares held by them in connection
with the completion of our initial business combination.

 Ability
to Extend Time to Complete Business Combination

 We
had until 12 months from the closing of our initial public offering to consummate our initial business combination. However, by resolution
of our board and at the request by our sponsor, we extended the period of time to 18 months to consummate a business combination exercising
two 3-month extensions. Pursuant to the terms of the trust agreement entered into between us and Continental Stock Transfer &
Trust Company, LLC on the date of our initial public offering, in order to extend the time available for us to consummate our initial
business combination, our initial stockholders or their affiliates or designees, upon five days advance notice prior to the applicable
deadlines, deposited into the trust account for each three-month extension, $1,150,000, or $0.10 per share, on or prior to the date of
the applicable deadline, up to an aggregate of $2,300,000, or $0.20 per share. At the annual meeting of the Company held on September
13, 2022, the Company's stockholders approved a proposal to amend the Company's Amended and Restated Certificate of Incorporation
(the "A&R COI") to authorize the Company to extend the date of September 26, 2022, up to six (6) times for
an additional one (1) month each time (ultimately until as late as March 26, 2023) upon the deposit into the Trust Account
of $0.035 for each outstanding public share by the Sponsor or its designees on or prior to September 26, 2022 or such other date as may
be extended. Any such payments were made in the form of a loan. Any such loans are non-interest bearing and payable upon the consummation
of our initial business combination. If we complete our initial business combination, we will repay such loaned amounts out of the proceeds
of the trust account released to us. If we do not complete a business combination, we will not repay such loans. Furthermore, the letter
agreement with our initial stockholders contains a provision pursuant to which our sponsor has agreed to waive its right to be repaid
for such loans out of the funds held in the trust account in the event that we do not complete a business combination. We issued a press
release announcing our intention to extend in both cases at least three days prior to the applicable deadline. In addition, for each
extension we issued a press release the day after the applicable deadline announcing that the funds had been timely deposited. Investors
do not have the ability to vote or redeem their shares of common stock in connection with either of the three-month extensions. However,
if we seek to complete a business combination during an extension period, investors will still be able to vote and redeem their shares
of common stock in connection with that business combination.

to the terms and subject to the conditions of the Merger Agreement, Breeze has prepared and filed with the SEC the Extension Proxy Statement,
for the purpose of amending the Breeze organizational documents and the Trust Agreement, in each case, to extend the time period for
Breeze to consummate a Business Combination from March 26, 2023 up to September 26, 2023 (the "Extension Proposal").
Breeze filed and distributed the Extension Proxy Statement to solicit proxies thereunder and held a meeting of the stockholders of Breeze
to consider, vote on and approve the Extension Proposal on March 22, 2023. Breeze stockholders approved the Extension Proposal and extended
the time period for Breeze to consummate a Business Combination from March 26, 2023 up to September 26, 2023.

 Manner
of Conducting Redemptions

 We
will provide our public stockholders with the opportunity to redeem all or a portion of their shares of common stock upon the completion
of our initial business combination either (i) in connection with a stockholder meeting called to approve the initial business combination
or (ii) by means of a tender offer. The decision as to whether we will seek stockholder approval of a proposed initial business
combination or conduct a tender offer will be made by us, solely in our discretion, and will be based on a variety of factors such as
the timing of the transaction and whether the terms of the transaction would require us to seek stockholder approval under the law or
stock exchange listing requirement. Under NASDAQ rules, asset acquisitions and stock purchases would not typically require stockholder
approval while direct mergers with our company where we do not survive and any transactions where we issue more than 20% of our outstanding
common stock or seek to amend our amended and restated certificate of incorporation would require stockholder approval. If we structure
an initial business combination with a target company in a manner that requires stockholder approval, we will not have discretion as
to whether to seek a stockholder vote to approve the proposed initial business combination. We may conduct redemptions without a stockholder
vote pursuant to the tender offer rules of the SEC unless stockholder approval is required by law or stock exchange listing requirements
or we choose to seek stockholder approval for business or other legal reasons. So long as we obtain and maintain a listing for our securities
on NASDAQ, we are required to comply with such rules.

 If
a stockholder vote is not required and we do not decide to hold a stockholder vote for business or other legal reasons, we will, pursuant
to our amended and restated certificate of incorporation:

 conduct
 the redemptions pursuant to Rule 13e-4 and Regulation 14E of the Exchange Act, which regulate issuer tender offers, and

 file
 tender offer documents with the SEC prior to completing our initial business combination which contain substantially the same financial
 and other information about the initial business combination and the redemption rights as is required under Regulation 14A of the
 Exchange Act, which regulates the solicitation of proxies.

 Upon
the public announcement of our initial business combination, we or our sponsor will terminate any plan established in accordance with
Rule 10b5-1 to purchase shares of our common stock in the open market if we elect to redeem our public shares through a tender offer,
to comply with Rule 14e-5 under the Exchange Act.

 In
the event we conduct redemptions pursuant to the tender offer rules, our offer to redeem will remain open for at least 20 business days,
in accordance with Rule 14e-1(a) under the Exchange Act, and we will not be permitted to complete our initial business combination until
the expiration of the tender offer period. In addition, the tender offer will be conditioned on public stockholders not tendering more
than a specified number of public shares which are not purchased by our sponsor, which number will be based on the requirement that we
may not redeem public shares in an amount that would cause our net tangible assets to be less than $5,000,001 upon consummation of our
initial business combination and after payment of underwriters' fees and commissions (so that we are not subject to the SEC's
"penny stock" rules) or any greater net tangible asset or cash requirement which may be contained in the agreement relating
to our initial business combination. If public stockholders tender more shares than we have offered to purchase, we will withdraw the
tender offer and not complete the initial business combination.

 If,
however, stockholder approval of the transaction is required by law or stock exchange listing requirement, or we decide to obtain stockholder
approval for business or other legal reasons, we will, pursuant to our amended and restated certificate of incorporation:

 conduct
 the redemptions in conjunction with a proxy solicitation pursuant to Regulation 14A of the Exchange Act, which regulates the solicitation
 of proxies, and not pursuant to the tender offer rules, and

 file
 proxy materials with the SEC.

 In
the event that we seek stockholder approval of our initial business combination, we will distribute proxy materials and, in connection
therewith, provide our public stockholders with the redemption rights described above upon completion of the initial business combination.

 If
we seek stockholder approval, we will complete our initial business combination only if a majority of the outstanding shares of common
stock voted are voted in favor of the initial business combination. A quorum for such meeting will consist of the holders present in
person or by proxy of shares of outstanding capital stock of the company representing a majority of the voting power of all outstanding
shares of capital stock of the company entitled to vote at such meeting. Our initial stockholders will count toward this quorum and pursuant
to the letter agreement, our sponsor, officers and directors have agreed to vote their founder shares and any public shares purchased
during or after our initial public offering (including in open market and privately negotiated transactions) in favor of our initial
business combination. For purposes of seeking approval of the majority of our outstanding shares of common stock voted, non-votes will
have no effect on the approval of our initial business combination once a quorum is obtained. As a result, in addition to our initial
stockholders' founder shares and representative shares, initially we needed to have only 4,187,501, or 36.4%, of the 11,500,000
public shares sold in our initial public offering to be voted in favor of an initial business combination (assuming all outstanding shares
are voted) in order to have our initial business combination approved. As of March 24, 2023, no public shares are required to approve
the business combination. We intend to give approximately 30 days (but not less than 10 days nor more than 60 days) prior written notice
of any such meeting, if required, at which a vote shall be taken to approve our initial business combination. These quorum and voting
thresholds, and the voting agreements of our initial stockholders, may make it more likely that we will consummate our initial business
combination. Each public stockholder may elect to redeem its public shares irrespective of whether they vote for or against the proposed
transaction. In addition, our initial stockholders have entered into a letter agreement with us, pursuant to which they have agreed to
waive their redemption rights with respect to their founder shares and public shares in connection with the completion of a business

 Our
amended and restated certificate of incorporation provides that in no event will we redeem our public shares in an amount that would
cause our net tangible assets to be less than $5,000,001 upon consummation of our initial business combination and after payment of underwriters'
fees and commissions (so that we are not subject to the SEC's "penny stock" rules) or any greater net tangible asset
or cash requirement which may be contained in the agreement relating to our initial business combination. For example, the proposed initial
business combination may require: (i) cash consideration to be paid to the target or its owners, (ii) cash to be transferred
to the target for working capital or other general corporate purposes or (iii) the retention of cash to satisfy other conditions
in accordance with the terms of the proposed initial business combination. In the event the aggregate cash consideration we would be
required to pay for all shares of common stock that are validly submitted for redemption plus any amount required to satisfy cash conditions
pursuant to the terms of the proposed initial business combination exceed the aggregate amount of cash available to us, we will not complete
the initial business combination or redeem any shares, and all shares of common stock submitted for redemption will be returned to the
holders thereof.

 Limitation
on Redemption upon Completion of our Initial Business Combination if we Seek Stockholder Approval

 Notwithstanding
the foregoing, if we seek stockholder approval of our initial business combination and we do not conduct redemptions in connection
with our initial business combination pursuant to the tender offer rules, our amended and restated certificate of incorporation
provides that a public stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder
is acting in concert or as a "group" (as defined under Section 13 of the Exchange Act), will be restricted from
seeking redemption rights with respect to more than an aggregate of 10% of the shares sold in our initial public offering, which we refer
to as the "Excess Shares." Such restriction shall also be applicable to our affiliates. We believe this restriction will
discourage stockholders from accumulating large blocks of shares, and subsequent attempts by such holders to use their ability to
exercise their redemption rights against a proposed initial business combination as a means to force us or our management to
purchase their shares at a significant premium to the then-current market price or on other undesirable terms. Absent this
provision, a public stockholder holding more than an aggregate of 10% of the shares sold in our initial public offering could
threaten to exercise its redemption rights if such holder's shares are not purchased by us or our management at a premium to
the then-current market price or on other undesirable terms. By limiting our stockholders' ability to redeem no more than 10%
of the shares sold in our initial public offering without our prior consent, we believe we will limit the ability of a small group
of stockholders to unreasonably attempt to block our ability to complete our initial business combination, particularly in
connection with an initial business combination with a target that requires as a closing condition that we have a minimum net worth
or a certain amount of cash. However, we would not be restricting our stockholders' ability to vote all of their shares
(including Excess Shares) for or against our initial business combination.

 Tendering
Stock Certificates in Connection with a Tender Offer or Redemption Rights

 We
may require our public stockholders seeking to exercise their redemption rights, whether they are record holders or hold their shares
in "street name," to either tender their certificates to our transfer agent prior to the date set forth in the tender offer
documents or proxy materials mailed to such holders, or up to two business days prior to the initial vote on the proposal to approve
the initial business combination in the event we distribute proxy materials, or to deliver their shares to the transfer agent electronically
using the Depository Trust Company's DWAC (Deposit/Withdrawal At Custodian) System, at the holder's option. The tender offer
or proxy materials, as applicable, that we will furnish to holders of our public shares in connection with our initial business combination
will indicate whether we are requiring public stockholders to satisfy such delivery requirements, which will include the requirement
that a beneficial holder must identify itself in order to validly redeem its shares. Accordingly, a public stockholder would have from
the time we send out our tender offer materials until the close of the tender offer period, or up to two days prior to the vote on the
initial business combination if we distribute proxy materials, as applicable, to tender its shares if it wishes to seek to exercise its
redemption rights. Given the relatively short exercise period, it is advisable for stockholders to use electronic delivery of their public
shares.

 There
is a nominal cost associated with the above-referenced tendering process and the act of certificating the shares or delivering them through
the DWAC System. The transfer agent will typically charge the tendering broker and it would be up to the broker whether or not to pass
this cost on to the redeeming holder. However, this fee would be incurred regardless of whether or not we require holders seeking to
exercise redemption rights to tender their shares. The need to deliver shares is a requirement of exercising redemption rights regardless
of the timing of when such delivery must be effectuated.

 The
foregoing is different from the procedures used by many blank check companies. In order to perfect redemption rights in connection with
their business combinations, many blank check companies would distribute proxy materials for the stockholders' vote on an initial
business combination, and a holder could simply vote against a proposed initial business combination and check a box on the proxy card
indicating such holder was seeking to exercise his or her redemption rights. After the initial business combination was approved, the
company would contact such stockholder to arrange for him or her to deliver his or her certificate to verify ownership. As a result,
the stockholder then had an "option window" after the completion of the initial business combination during which he or she
could monitor the price of the company's stock in the market. If the price rose above the redemption price, he or she could sell
his or her shares in the open market before actually delivering his or her shares to the company for cancellation. As a result, the redemption
rights, to which stockholders were aware they needed to commit before the stockholder meeting, would become "option" rights
surviving past the completion of the initial business combination until the redeeming holder delivered its certificate. The requirement
for physical or electronic delivery prior to the meeting ensures that a redeeming holder's election to redeem is irrevocable once
the initial business combination is approved.

 Any
request to redeem such shares, once made, may be withdrawn at any time up to the date set forth in the tender offer materials or the
date of the stockholder meeting set forth in our proxy materials, as applicable. Furthermore, if a holder of a public share delivered
its certificate in connection with an election of redemption rights and subsequently decides prior to the applicable date not to elect
to exercise such rights, such holder may simply request that the transfer agent return the certificate (physically or electronically).
It is anticipated that the funds to be distributed to holders of our public shares electing to redeem their shares will be distributed
promptly after the completion of our initial business combination.

 If
our initial business combination is not approved or completed for any reason, then our public stockholders who elected to exercise their
redemption rights would not be entitled to redeem their shares for the applicable pro rata share of the trust account. In such case,
we will promptly return any certificates delivered by public holders who elected to redeem their shares.

 If
our proposed initial business combination is not completed, we may continue to try to complete another initial business combination with
a different target until 18 months from the closing of our initial public offering.

 Redemption
of Public Shares and Liquidation if no Initial Business Combination

 Prior
to our proxy extension voted on in May and September, we had only 18 months from the closing of our initial public offering to complete
our initial business combination. If we are unable to complete our initial business combination within such 18-month period, we will:
(i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten
business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit
in the trust account including interest earned on the funds held in the trust account and not previously released to us to pay our franchise
and income taxes (less up to $100,000 of interest to pay dissolution expenses which interest shall be net of taxes payable), divided
by the number of then outstanding public shares, which redemption will completely extinguish public stockholders' rights as stockholders
(including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as
reasonably possible following such redemption, subject to the approval of our remaining stockholders and our board of directors, dissolve
and liquidate, subject in each case to our obligations under Delaware law to provide for claims of creditors and the requirements of
other applicable law. There will be no redemption rights or liquidating distributions with respect to our rights or warrants, which will
expire worthless if we fail to complete our initial business combination within the 18-month time period.

 Our
sponsor, officers and directors have entered into a letter agreement with us, pursuant to which they have waived their rights to liquidating
distributions from the trust account with respect to any founder shares held by them if we fail to complete our initial business combination
within 18 months from the closing of our initial public offering. However, if our sponsor, officers or directors acquire public shares
in or after our initial public offering, they will be entitled to liquidating distributions from the trust account with respect to such
public shares if we fail to complete our initial business combination within the allotted 18-month time period.

 Our
sponsor, officers and directors have agreed, pursuant to a written agreement with us, that they will not propose any amendment to our
amended and restated certificate of incorporation (i) to modify the substance or timing of our obligation to redeem 100% of our
public shares if we do not complete our initial business combination within 18 months from the closing of our initial public offering
or (ii) with respect to any other provision relating to stockholders' rights or pre-initial business combination activity,
unless we provide our public stockholders with the opportunity to redeem their shares of common stock upon approval of any such amendment
at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account including interest earned on
the funds held in the trust account and not previously released to us to pay our franchise and income taxes divided by the number of
then outstanding public shares. However, we may not redeem our public shares in an amount that would cause our net tangible assets to
be less than $5,000,001 upon consummation of our initial business combination and after payment of underwriters' fees and commissions
(so that we are not subject to the SEC's "penny stock" rules). If this optional redemption right is exercised with
respect to an excessive number of public shares such that we cannot satisfy the net tangible asset requirement (described above), we
would not proceed with the amendment or the related redemption of our public shares at such time.

 We
expect that all costs and expenses associated with implementing our plan of dissolution, as well as payments to any creditors, will be
funded from amounts remaining out of the $14,129 of proceeds held outside the trust account (as of December 31, 2022), and amounts
raised after December 31, 2022, if any, although we cannot assure you that there will be sufficient funds for such purpose. We will depend
on sufficient interest being earned on the proceeds held in the trust account to pay any tax obligations we may owe. However, if those
funds are not sufficient to cover the costs and expenses associated with implementing our plan of dissolution, to the extent that there
is any interest accrued in the trust account not required to pay taxes on interest income earned on the trust account balance, we may
request the trustee to release to us an additional amount of up to $100,000 of such accrued interest to pay those costs and expenses.

 If
we were to expend all of the net proceeds of our initial public offering and the sale of the private placement warrants, other than the
proceeds deposited in the trust account, and without taking into account interest, if any, earned on the trust account, the per-share
redemption amount received by stockholders upon our dissolution as of March 26, 2023, would be approximately $10.595. The proceeds deposited
in the trust account could, however, become subject to the claims of our creditors, which would have higher priority than the claims
of our public stockholders. We cannot assure you that the actual per-share redemption amount received by stockholders will not be substantially
less than $10.595. Under Section 281(b) of the General Corporation Law of Delaware, as amended (the "DGCL"), our plan
of dissolution must provide for all claims against us to be paid in full or make provision for payments to be made in full, as applicable,
if there are sufficient assets. These claims must be paid or provided for before we make any distribution of our remaining assets to
our stockholders. While we intend to pay such amounts, if any, we cannot assure you that we will have funds sufficient to pay or provide
for all creditors' claims.

we will seek to have all vendors, service providers, prospective target businesses or other entities with which we do business
execute agreements with us waiving any right, title, interest or claim of any kind in or to any monies held in the trust account for
the benefit of our public stockholders, there is no guarantee that they will execute such agreements or even if they execute such
agreements that they would be prevented from bringing claims against the trust account including but not limited to fraudulent
inducement, breach of fiduciary responsibility or other similar claims, as well as claims challenging the enforceability of the
waiver, in each case in order to gain an advantage with respect to a claim against our assets, including the funds held in the trust
account. If any third-party refuses to execute an agreement waiving such claims to the monies held in the trust account, our
management will perform an analysis of the alternatives available to it and will only enter into an agreement with a third party
that has not executed a waiver if management believes that such third party's engagement would be significantly more
beneficial to us than any alternative. Examples of possible instances where we may engage a third party that refuses to execute a
waiver include the engagement of a third-party consultant whose particular expertise or skills are believed by management to be
significantly superior to those of other consultants that would agree to execute a waiver or in cases where management is unable to
find a service provider willing to execute a waiver. Marcum LLP, our independent registered public accounting firm, and the
underwriters of our initial public offering will not execute agreements with us waiving such claims to the monies held in the trust
account.

 In
addition, there is no guarantee that such entities will agree to waive any claims they may have in the future as a result of, or arising
out of, any negotiations, contracts or agreements with us and will not seek recourse against the trust account for any reason. Our sponsor
has agreed that it will be liable to us if and to the extent any claims by a third party for services rendered or products sold to us,
or a prospective target business with which we have entered into a written letter of intent, confidentiality or similar agreement or
business combination agreement, reduce the amount of funds in the trust account to below the lesser of (i) $10.595 per public share
and (ii) such lesser amount per public share held in the trust account as of the date of the liquidation of the trust account, due
to reductions in value of the trust assets, in each case net of the amount of interest which may be withdrawn to pay taxes, except as
to any claims by a third party who executed a waiver of any and all rights to seek access to the trust account and except as to any claims
under our indemnity of the underwriters of our initial public offering against certain liabilities, including liabilities under the Securities
Act. In the event that an executed waiver is deemed to be unenforceable against a third party, then our sponsor will not be responsible
to the extent of any liability for such third-party claims. We have not asked our sponsor to reserve for such indemnification obligations,
and our sponsor's only assets are securities of our company. Therefore, we cannot assure you that our sponsor would be able to
satisfy those obligations. We believe the likelihood of our sponsor having to indemnify the trust account is limited because we will
endeavor to have all vendors and prospective target businesses as well as other entities execute agreements with us waiving any right,
title, interest or claim of any kind in or to monies held in the trust account.

 In
the event that the proceeds in the trust account are reduced below (i) $10.595 per public share or (ii) such lesser amount
per public share held in the trust account as of the date of the liquidation of the trust account, due to reductions in value of the
trust assets, in each case net of the amount of interest which may be withdrawn to pay taxes, and our sponsor asserts that it is unable
to satisfy its indemnification obligations or that it has no indemnification obligations related to a particular claim, our independent
directors would determine whether to take legal action against our sponsor to enforce its indemnification obligations. While we currently
expect that our independent directors would take legal action on our behalf against our sponsor to enforce its indemnification obligations
to us, it is possible that our independent directors in exercising their business judgment may choose not to do so if, for example, the
cost of such legal action is deemed by the independent directors to be too high relative to the amount recoverable or if the independent
directors determine that a favorable outcome is not likely. We have not asked our sponsor to reserve for such indemnification obligations
and we cannot assure you that our sponsor would be able to satisfy those obligations. Accordingly, we cannot assure you that due to claims
of creditors the actual value of the per-share redemption price will not be less than $10.595 per public share.

 We
will seek to reduce the possibility that our sponsor will have to indemnify the trust account due to claims of creditors by endeavoring
to have all vendors, service providers, prospective target businesses or other entities with which we do business execute agreements
with us waiving any right, title, interest or claim of any kind in or to monies held in the trust account. Our sponsor will also not
be liable as to any claims under our indemnity of the underwriters of our initial public offering against certain liabilities, including
liabilities under the Securities Act. We will have access to up to $14,129 of proceeds held outside the trust account (as of December 31,
2022), and amounts raised after December 31, 2022, if any, with which to pay any such potential claims (including costs and expenses
incurred in connection with our liquidation, currently estimated to be no more than approximately $100,000). In the event that we liquidate
and it is subsequently determined that the reserve for claims and liabilities is insufficient, stockholders who received funds from our
trust account could be liable for claims made by creditors.

 Under
the DGCL, stockholders may be held liable for claims by third parties against a corporation to the extent of distributions received by
them in a dissolution. The pro rata portion of our trust account distributed to our public stockholders upon the redemption of our public
shares in the event we do not complete our initial business combination within 18 months from the closing of our initial public offering
may be considered a liquidating distribution under Delaware law. If the corporation complies with certain procedures set forth in Section 280
of the DGCL intended to ensure that it makes reasonable provision for all claims against it, including a 60-day notice period during
which any third-party claims can be brought against the corporation, a 90-day period during which the corporation may reject any claims
brought, and an additional 150-day waiting period before any liquidating distributions are made to stockholders, any liability of stockholders
with respect to a liquidating distribution is limited to the lesser of such stockholder's pro rata share of the claim or the amount
distributed to the stockholder, and any liability of the stockholder would be barred after the third anniversary of the dissolution.

 Furthermore,
if the pro rata portion of our trust account distributed to our public stockholders upon the redemption of our public shares in the
event we do not complete our initial business combination within 18 months from the closing of our initial public offering, is not
considered a liquidating distribution under Delaware law and such redemption distribution is deemed to be unlawful (potentially due
to the imposition of legal proceedings that a party may bring or due to other circumstances that are currently unknown), then
pursuant to Section 174 of the DGCL, the statute of limitations for claims of creditors could then be six years after the
unlawful redemption distribution, instead of three years, as in the case of a liquidating distribution. If we are unable to complete
our initial business combination within 18 months from the closing of our initial public offering, we will: (i) cease all
operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days
thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the
trust account including interest earned on the funds held in the trust account and not previously released to us to pay our
franchise and income taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding
public shares, which redemption will completely extinguish public stockholders' rights as stockholders (including the right to
receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible
following such redemption, subject to the approval of our remaining stockholders and our board of directors, dissolve and liquidate,
subject in each case to our obligations under Delaware law to provide for claims of creditors and the requirements of other
applicable law. Accordingly, it is our intention to redeem our public shares as soon as reasonably possible following our 18 th month
and, therefore, we do not intend to comply with those procedures. As such, our stockholders could potentially be liable for any
claims to the extent of distributions received by them (but no more) and any liability of our stockholders may extend well beyond
the third anniversary of such date.

we will not be complying with Section 280, Section 281(b) of the DGCL requires us to adopt a plan, based on facts known to
us at such time that will provide for our payment of all existing and pending claims or claims that may be potentially brought against
us within the subsequent 10 years. However, because we are a blank check company, rather than an operating company, and our operations
will be limited to searching for prospective target businesses to acquire, the only likely claims to arise would be from our vendors
(such as lawyers, investment bankers, etc.) or prospective target businesses. As described above, pursuant to the obligation contained
in our underwriting agreement, we will seek to have all vendors, service providers, prospective target businesses or other entities with
which we do business execute agreements with us waiving any right, title, interest or claim of any kind in or to any monies held in the
trust account. As a result of this obligation, the claims that could be made against us are significantly limited and the likelihood
that any claim that would result in any liability extending to the trust account is remote. Further, our sponsor may be liable only to
the extent necessary to ensure that the amounts in the trust account are not reduced below (i) $10.595 per public share or (ii) such
lesser amount per public share held in the trust account as of the date of the liquidation of the trust account, due to reductions in
value of the trust assets, in each case net of the amount of interest withdrawn to pay taxes and will not be liable as to any claims
under our indemnity of the underwriters of our initial public offering against certain liabilities, including liabilities under the Securities
Act. In the event that an executed waiver is deemed to be unenforceable against a third party, our sponsor will not be responsible to
the extent of any liability for such third-party claims.

 If
we file a bankruptcy petition or an involuntary bankruptcy petition is filed against us that is not dismissed, the proceeds held in the
trust account could be subject to applicable bankruptcy law, and may be included in our bankruptcy estate and subject to the claims of
third parties with priority over the claims of our stockholders. To the extent any bankruptcy claims deplete the trust account, we cannot
assure you we will be able to return $10.595 per share to our public stockholders. Additionally, if we file a bankruptcy petition or
an involuntary bankruptcy petition is filed against us that is not dismissed, any distributions received by stockholders could be viewed
under applicable debtor/creditor and/or bankruptcy laws as either a "preferential transfer" or a "fraudulent conveyance."
As a result, a bankruptcy court could seek to recover some or all amounts received by our stockholders. Furthermore, our board of directors
may be viewed as having breached its fiduciary duty to our creditors and/or may have acted in bad faith, thereby exposing itself and
our company to claims of punitive damages, by paying public stockholders from the trust account prior to addressing the claims of creditors.
We cannot assure you that claims will not be brought against us for these reasons.

 Our
public stockholders will be entitled to receive funds from the trust account only upon the earlier to occur of: (i) the completion
of our initial business combination, (ii) the redemption of any public shares properly tendered in connection with a stockholder
vote to amend any provisions of our amended and restated certificate of incorporation (A) to modify the substance or timing of our
obligation to redeem 100% of our public shares if we do not complete our initial business combination within 18 months from the closing
of our initial public offering or (B) with respect to any other provision relating to stockholders' rights or pre-initial
business combination activity, and (iii) the redemption of all of our public shares if we are unable to complete our business combination
within 18 months from the closing of our initial public offering, subject to applicable law. In no other circumstances will a stockholder
have any right or interest of any kind to or in the trust account. In the event we seek stockholder approval in connection with our initial
business combination, a stockholder's voting in connection with the initial business combination alone will not result in a stockholder's
redeeming its shares to us for an applicable pro rata share of the trust account. Such stockholder must have also exercised its redemption
rights as described above. These provisions of our amended and restated certificate of incorporation, like all provisions of our amended
and restated certificate of incorporation, may be amended with a stockholder vote.

 Competition

 In
identifying, evaluating and selecting a target business for our initial business combination, we may encounter competition from
other entities having a business objective similar to ours, including other blank check companies, private equity groups and
leveraged buyout funds, and operating businesses seeking strategic business combinations. Many of these entities are well
established and have extensive experience identifying and effecting business combinations directly or through affiliates.
Moreover, many of these competitors possess greater financial, technical, human and other resources than we do. Our ability to
acquire larger target businesses will be limited by our available financial resources. This inherent limitation gives others an
advantage in pursuing the initial business combination of a target business. Furthermore, our obligation to pay cash in connection
with our public stockholders who exercise their redemption rights may reduce the resources available to us for our initial business
combination and our outstanding warrants, and the future dilution they potentially represent, may not be viewed favorably by certain
target businesses. Either of these factors may place us at a competitive disadvantage in successfully negotiating an initial
business combination.

 Facilities

 Our
executive offices are located at 955 W. John Carpenter Fwy., Suite 100-929, Irving, TX 75039 and our telephone number is (619) 500-7747.
Our executive offices are provided to us by our sponsor. Commencing on the date our securities were first listed on NASDAQ, we have agreed
to pay an affiliate of our sponsor a total of $5,000 per month for office space, utilities and secretarial and administrative support.
We consider our current office space adequate for our current operations.

 Employees

 We
currently have four executive officers. Members of our management team are not obligated to devote any specific number of hours to our
matters but they intend to devote as much of their time as they deem necessary to our affairs until we have completed our initial business
combination. The amount of time they will devote in any time period will vary based on whether a target business has been selected for
our initial business combination and the stage of the initial business combination process we are in. We do not intend to have any full-time
employees prior to the completion of our initial business combination.

 Periodic
Reporting and Financial Information

 Our
common stock, rights and warrants are registered under the Exchange Act and have reporting obligations, including the requirement that
we file annual, quarterly and current reports with the SEC. In accordance with the requirements of the Exchange Act, our annual reports
will contain financial statements audited and reported on by our independent registered public accountants.

 We
will provide stockholders with audited financial statements of the prospective target business as part of the tender offer materials
or proxy solicitation materials sent to stockholders to assist them in assessing the target business. In all likelihood, these financial
statements will need to be prepared in accordance with, or reconciled to, GAAP, or IFRS, depending on the circumstances, and the historical
financial statements may be required to be audited in accordance with the standards of the PCAOB. These financial statement requirements
may limit the pool of potential targets we may conduct an initial business combination with because some targets may be unable to provide
such statements in time for us to disclose such statements in accordance with federal proxy rules and complete our initial business combination
within the prescribed time frame. We cannot assure you that any particular target business identified by us as a potential business combination
candidate will have financial statements prepared in accordance with GAAP or that the potential target business will be able to prepare
its financial statements in accordance with the requirements outlined above. To the extent that these requirements cannot be met, we
may not be able to acquire the proposed target business. While this may limit the pool of potential business combination candidates,
we do not believe that this limitation will be material.

 We
will be required to evaluate our internal control procedures for the fiscal year ending December 31, 2022 as required by the Sarbanes-Oxley
Act. Only in the event we are deemed to be a large accelerated filer or an accelerated filer, and no longer qualify as an emerging growth
company, will we be required to have our internal control procedures audited. A target company may not be in compliance with the provisions
of the Sarbanes-Oxley Act regarding adequacy of their internal controls. The development of the internal controls of any such entity
to achieve compliance with the Sarbanes-Oxley Act may increase the time and costs necessary to complete any such business combination.

 We
are an "emerging growth company," as defined in Section 2(a) of the Securities Act of 1933, as amended, or the Securities
Act, as modified by the Jumpstart Our Business Startups Act of 2012, or the JOBS Act. As such, we are eligible to take advantage of certain
exemptions from various reporting requirements that are applicable to other public companies that are not "emerging growth companies"
including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley
Act reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from
the requirements of holding a non-binding advisory vote on executive compensation and stockholder approval of any golden parachute payments
not previously approved. If some investors find our securities less attractive as a result, there may be a less active trading market
for our securities and the prices of our securities may be more volatile.

 In
addition, Section 107 of the JOBS Act also provides that an "emerging growth company" can take advantage of the extended
transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. In
other words, an "emerging growth company" can delay the adoption of certain accounting standards until those standards would
otherwise apply to private companies. We intend to take advantage of the benefits of this extended transition period.

 We
will remain an emerging growth company until the earlier of (1) the last day of the fiscal year (a) following the fifth anniversary
of the completion of our initial public offering, (b) in which we have total annual gross revenue of at least $1.07 billion, or
(c) in which we are deemed to be a large accelerated filer, which means the market value of our shares of common stock that are
held by non-affiliates exceeds $700 million as of the prior June 30, and (2) the date on which we have issued more than $1.0
billion in non-convertible debt during the prior three-year period.

 Additionally,
we are a "smaller reporting company" as defined in Item 10(f)(1) of Regulation S-K. Smaller reporting companies may
take advantage of certain reduced disclosure obligations, including, among other things, providing only two years of audited financial
statements. We will remain a smaller reporting company until the last day of the fiscal year in which (1) the market value of our
shares of common stock held by non-affiliates exceeds $250 million as of the prior June 30, or (2) our annual revenues exceeded
$100 million during such completed fiscal year and the market value of our shares of common stock held by non-affiliates exceeds $700
million as of the prior June 30.

 ITEM 1A. RISK FACTORS

 An
investment in our securities involves a high degree of risk. You should consider carefully all of the risks described below, together
with the other information contained in this Report, before making a decision to invest in our units. If any of the following events
occur, our business, financial condition and operating results may be materially adversely affected. In that event, the trading price
of our securities could decline, and you could lose all or part of your investment.

 Summary
of Risk Factors

 We
 may not be able to complete the Business Combination pursuant to the Combination Agreement. If we are unable to do so, we will incur
 substantial costs associated with withdrawing from the transaction and may not be able to find additional sources of financing to
 cover those costs.

 We
 are a newly formed company with no operating history and no revenues, and you have no basis on which to evaluate our ability to achieve
 our business objective.

 Our
 public stockholders may not be afforded an opportunity to vote on our proposed initial business combination, which means we may complete
 our initial business combination even though a majority of our public stockholders do not support such a combination.

 If
 we seek stockholder approval of our initial business combination, our initial stockholders have agreed to vote in favor of such initial
 business combination, regardless of how our public stockholders vote.

 The
 ability of our public stockholders to exercise redemption rights with respect to a large number of our shares may not allow us to
 complete the most desirable business combination or optimize our capital structure.

 The
 ability of our public stockholders to exercise redemption rights with respect to a large number of our shares could increase the
 probability that our initial business combination would be unsuccessful and that you would have to wait for liquidation in order
 to redeem your stock.

 The
 requirement that we complete our initial business combination within the prescribed time frame may give potential target businesses
 leverage over us in negotiating an initial business combination and may decrease our ability to conduct due diligence on potential
 business combination targets as we approach our dissolution deadline, which could undermine our ability to complete our initial business
 combination on terms that would produce value for our stockholders.

 If
 a stockholder fails to receive notice of our offer to redeem our public shares in connection with our initial business combination,
 or fails to comply with the procedures for tendering its shares, such shares may not be redeemed.

 You
 will not be entitled to protections normally afforded to investors of many other blank check companies.

 of our limited resources and the significant competition for business combination opportunities, it may be more difficult for us
 to complete our initial business combination. If we are unable to complete our initial business combination, our public stockholders
 may receive only approximately $10.595 per share on our redemption of our public shares, or less than such amount in certain circumstances,
 and our warrants will expire worthless.

 If
 third parties bring claims against us, the proceeds held in the trust account could be reduced and the per-share redemption amount
 received by stockholders may be less than $10.595 per share.

 Our
 directors may decide not to enforce the indemnification obligations of our sponsor, resulting in a reduction in the amount of funds
 in the trust account available for distribution to our public stockholders.

 We
 may not hold an annual meeting of stockholders until after the consummation of our initial business combination, which could delay
 the opportunity for our stockholders to elect directors.

 we are neither limited to evaluating a target business in a particular industry sector, you will be unable to ascertain the merits
 or risks of any particular target business's operations.

 we have identified general criteria and guidelines that we believe are important in evaluating prospective target businesses, we
 may enter into our initial business combination with a target that does not meet such criteria and guidelines, and as a result, the
 target business with which we enter into our initial business combination may not have attributes entirely consistent with our general
 criteria and guidelines.

 We
 are not required to obtain an opinion on the price we are paying for the business we are completing our initial business combination
 with from an independent investment banking firm or from an independent accounting firm, and consequently, you may have no assurance
 from an independent source that the price we are paying for the business is fair to our company or the stockholders from a financial
 point of view.

 We
 may issue additional common stock or preferred stock to complete our initial business combination or under an employee incentive
 plan after completion of our initial business combination. Any such issuances would dilute the interest of our stockholders and likely
 present other risks.

 Our
 officers and directors will allocate their time to other businesses thereby causing conflicts of interest in their determination
 as to how much time to devote to our affairs. This conflict of interest could have a negative impact on our ability to complete our
 initial business combination.

 Since
 our sponsor, officers and directors will lose their entire investment in us if our initial business combination is not completed,
 a conflict of interest may arise in determining whether a particular business combination target is appropriate for our initial business

 In
 order to effectuate an initial business combination, blank check companies have, in the recent past, amended various provisions of
 their charters and other governing instruments, including their warrant agreements. We cannot assure you that we will not seek to
 amend our amended and restated certificate of incorporation or governing instruments in a manner that will make it easier for us
 to complete our initial business combination that our stockholders may not support.

 Our
 initial stockholders may exert a substantial influence on actions requiring a stockholder vote, potentially in a manner that you
 do not support.

 each unit contains one-twentieth of one right, the units may be worth less than units of other blank check companies.

 Our
 warrant agreement and rights agreement will designate the courts of the State of New York or the United States District Court for
 the Southern District of New York as the sole and exclusive forum for certain types of actions and proceedings that may be initiated
 by holders of our warrants or rights, which could limit the ability of warrant or right holders to obtain a favorable judicial forum
 for disputes with our company.

 Risks
Related to the Business Combination

 We
may not be able to complete the Business Combination pursuant to the Combination Agreement. If we are unable to do so, we will incur
substantial costs associated with withdrawing from the transaction and may not be able to find additional sources of financing to cover
those costs.

 In
connection with the Combination Agreement, we have incurred substantial costs researching, planning and negotiating the transaction.
These costs include, but are not limited to, costs associated with securing sources of financing, costs associated with employing and
retaining third-party advisors who performed the financial, auditing and legal services required to complete the transaction, and the
expenses generated by our officers, executives, and employees in connection with the transaction. If, for whatever reason, the transactions
contemplated by the Combination Agreement fail to close, we will be responsible for these costs, but will have no source of revenue with
which to pay them. We may need to obtain additional sources of financing in order to meet our obligations, which we may not be able to
secure on the same terms as our existing financing or at all. If we are unable to secure new sources of financing and do not have sufficient
funds to meet our obligations, we will be forced to cease operations and liquidate the trust account.

 Risks
Relating to Our Search For, Consummation of, or Inability to Consummate, a Business Combination

 We
are a company with no operating history and no revenues, and you have no basis on which to evaluate our ability to achieve our business
objective.

 We
are a company with no operating results, and we will not commence operations until obtaining funding through our initial public offering.
Because we lack an operating history, you have no basis upon which to evaluate our ability to achieve our business objective of completing
our initial business combination with one or more target businesses. We have no plans, arrangements or understandings with any prospective
target business concerning an initial business combination and may be unable to complete our initial business combination. If we fail
to complete our initial business combination, we will never generate any operating revenues.

 Our
public stockholders may not be afforded an opportunity to vote on our proposed initial business combination, which means we may complete
our initial business combination even though a majority of our public stockholders do not support such a combination.

 We
may choose not to hold a stockholder vote to approve our initial business combination unless the initial business combination would
require stockholder approval under applicable law or stock exchange listing requirements or if we decide to hold a stockholder vote
for business or other legal reasons. Except as required by law, the decision as to whether we will seek stockholder approval
of a proposed initial business combination or will allow stockholders to sell their shares to us in a tender offer will be made by
us, solely in our discretion, and will be based on a variety of factors, such as the timing of the transaction and whether the terms
of the transaction would otherwise require us to seek stockholder approval. Accordingly, we may complete our initial business
combination even if holders of a majority of our public shares do not approve of the initial business combination we complete.

 If
we seek stockholder approval of our initial business combination, our initial stockholders have agreed to vote in favor of such initial
business combination, regardless of how our public stockholders vote.

to the letter agreement, our sponsor, officers and directors have agreed to vote their founder shares, as well as any public shares purchased
during or after our initial public offering (including in open market and privately negotiated transactions), in favor of our initial
business combination. As of February 15, 2023, in addition to our initial stockholders' founder shares and representative shares,
we would not require any of the 1,690,196 public shares sold in our initial public offering to be voted in favor of an initial business
combination (assuming all outstanding shares are voted) in order to have our initial business combination approved. Our initial stockholders
own shares representing 20% of our outstanding shares of common stock immediately following the completion of our initial public offering.
Accordingly, if we seek stockholder approval of our initial business combination, the agreement by our initial stockholders to vote in
favor of our initial business combination will increase the likelihood that we will receive the requisite stockholder approval for such
initial business combination.

 Your
only opportunity to affect the investment decision regarding a potential business combination will be limited to the exercise of your
right to redeem your shares from us for cash, unless we seek stockholder approval of the initial business combination.

 At
the time of your investment in us, you will not be provided with an opportunity to evaluate the specific merits or risks of our initial
business combination. Since our board of directors may complete an initial business combination without seeking stockholder approval,
public stockholders may not have the right or opportunity to vote on the initial business combination, unless we seek such stockholder
vote.

 Accordingly,
if we do not seek stockholder approval, your only opportunity to affect the investment decision regarding a potential business combination
may be limited to exercising your redemption rights within the period of time (which will be at least 20 business days) set forth in
our tender offer documents mailed to our public stockholders in which we describe our initial business combination.

 The
ability of our public stockholders to redeem their shares for cash may make our financial condition unattractive to potential business
combination targets, which may make it difficult for us to enter into an initial business combination with a target.

 We
may seek to enter into an initial business combination agreement with a prospective target that requires as a closing condition that
we have a minimum net worth or a certain amount of cash. If too many public stockholders exercise their redemption rights, we would not
be able to meet such closing condition and, as a result, would not be able to proceed with the initial business combination. Furthermore,
in no event will we redeem our public shares in an amount that would cause our net tangible assets to be less than $5,000,001 upon consummation
of our initial business combination and after payment of underwriters' fees and commissions (so that we are not subject to the
SEC's "penny stock" rules) or any greater net tangible asset or cash requirement which may be contained in the agreement
relating to our initial business combination. Consequently, if accepting all properly submitted redemption requests would cause our net
tangible assets to be less than $5,000,001 upon consummation of our initial business combination and after payment of underwriters'
fees and commissions or such greater amount necessary to satisfy a closing condition as described above, we would not proceed with such
redemption and the related business combination and may instead search for an alternate business combination. Prospective targets will
be aware of these risks and, thus, may be reluctant to enter into an initial business combination with us.

 The
ability of our public stockholders to exercise redemption rights with respect to a large number of our shares may not allow us to complete
the most desirable business combination or optimize our capital structure.

 At
the time we enter into an agreement for our initial business combination, we will not know how many stockholders may exercise their
redemption rights, and therefore will need to structure the transaction based on our expectations as to the number of shares that
will be submitted for redemption. If our initial business combination agreement requires us to use a portion of the cash in the
trust account to pay the purchase price, or requires us to have a minimum amount of cash at closing, we will need to reserve a
portion of the cash in the trust account to meet such requirements, or arrange for third party financing. In addition, if a larger
number of shares are submitted for redemption than we initially expected, we may need to restructure the transaction to reserve a
greater portion of the cash in the trust account or arrange for third party financing. Raising additional third-party financing may
involve dilutive equity issuances or the incurrence of indebtedness at higher than desirable levels. The above considerations may
limit our ability to complete the most desirable business combination available to us or optimize our capital structure. The
amount of the deferred underwriting commissions payable to the underwriters will not be adjusted for any shares that are redeemed in
connection with an initial business combination. The per-share amount we will distribute to stockholders who properly exercise their
redemption rights will not be reduced by the deferred underwriting commission and after such redemptions, the per-share value of
shares held by non- redeeming stockholders will reflect our obligation to pay the deferred underwriting commissions.

 The
ability of our public stockholders to exercise redemption rights with respect to a large number of our shares could increase the probability
that our initial business combination would be unsuccessful and that you would have to wait for liquidation in order to redeem your stock.

 If
our initial business combination agreement requires us to use a portion of the cash in the trust account to pay the purchase price, or
requires us to have a minimum amount of cash at closing, the probability that our initial business combination would be unsuccessful
is increased. If our initial business combination is unsuccessful, you would not receive your pro rata portion of the trust account until
we liquidate the trust account. If you are in need of immediate liquidity, you could attempt to sell your stock in the open market; however,
at such time our stock may trade at a discount to the pro rata amount per share in the trust account. In either situation, you may suffer
a material loss on your investment or lose the benefit of funds expected in connection with our redemption until we liquidate or you
are able to sell your stock in the open market.

 The
requirement that we complete our initial business combination within the prescribed time frame may give potential target businesses leverage
over us in negotiating an initial business combination and may decrease our ability to conduct due diligence on potential business combination
targets as we approach our dissolution deadline, which could undermine our ability to complete our initial business combination on terms
that would produce value for our stockholders.

 Any
potential target business with which we enter into negotiations concerning an initial business combination will be aware that we must
complete our initial business combination within 18 months from the closing of our initial public offering. Consequently, such target
business may obtain leverage over us in negotiating an initial business combination, knowing that if we do not complete our initial business
combination with that particular target business, we may be unable to complete our initial business combination with any target business.
This risk will increase as we get closer to the timeframe described above. In addition, we may have limited time to conduct due diligence
and may enter into our initial business combination on terms that we would have rejected upon a more comprehensive investigation.

 We
may not be able to complete our initial business combination within the prescribed time frame, in which case we would cease all operations
except for the purpose of winding up and we would redeem our public shares and liquidate, in which case our public stockholders may only
receive $10.595 per share, or less than such amount in certain circumstances, and our warrants will expire worthless.

 We
must complete our initial business combination within 18 months from the closing of our initial public offering. We may not be able to
find a suitable target business and complete our initial business combination within such time period. If we have not completed our initial
business combination within such time period, we will: (i) cease all operations except for the purpose of winding up, (ii) as
promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable
in cash, equal to the aggregate amount then on deposit in the trust account including interest earned on the funds held in the trust
account and not previously released to us to pay our franchise and income taxes (less up to $100,000 of interest to pay dissolution expenses),
divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders' rights
as stockholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as
promptly as reasonably possible following such redemption, subject to the approval of our remaining stockholders and our board of directors,
dissolve and liquidate, subject in each case to our obligations under Delaware law to provide for claims of creditors and the requirements
of other applicable law. In such case, our public stockholders may only receive $10.595 per share, and our warrants will expire worthless.
In certain circumstances, our public stockholders may receive less than $10.595 per share on the redemption of their shares. See "—
If third parties bring claims against us, the proceeds held in the trust account could be reduced and the per-share redemption amount
received by stockholders may be less than $10.595 per share" and other risk factors below.

 If
we seek stockholder approval of our initial business combination, our sponsor, directors, officers, advisors and their affiliates may
elect to purchase shares or warrants from public stockholders, which may influence a vote on a proposed initial business combination
and reduce the public "float" of our common stock.

 If
we seek stockholder approval of our initial business combination and we do not conduct redemptions in connection with our initial business
combination pursuant to the tender offer rules, our sponsor, directors, officers, advisors or their affiliates may purchase shares or
public warrants or a combination thereof in privately negotiated transactions or in the open market either prior to or following the
completion of our initial business combination, although they are under no obligation to do so. However, they have no current commitments,
plans or intentions to engage in such transactions and have not formulated any terms or conditions for any such transactions. None of
the funds in the trust account will be used to purchase shares or public warrants in such transactions.

 Such
a purchase may include a contractual acknowledgement that such stockholder, although still the record holder of our shares is no longer
the beneficial owner thereof and therefore agrees not to exercise its redemption rights. In the event that our sponsor, directors, officers,
advisors or their affiliates purchase shares in privately negotiated transactions from public stockholders who have already elected to
exercise their redemption rights, such selling stockholders would be required to revoke their prior elections to redeem their shares.
The purpose of such purchases could be to vote such shares in favor of the initial business combination and thereby increase the likelihood
of obtaining stockholder approval of the initial business combination, or to satisfy a closing condition in an agreement with a target
that requires us to have a minimum net worth or a certain amount of cash at the closing of our initial business combination, where it
appears that such requirement would otherwise not be met. The purpose of any such purchases of public warrants could be to reduce the
number of public warrants outstanding or to vote such warrants on any matters submitted to the warrant holders for approval in connection
with our initial business combination. Any such purchases of our securities may result in the completion of our initial business combination
that may not otherwise have been possible. Any such purchases will be reported pursuant to Section 13 and Section 16 of the
Exchange Act to the extent such purchasers are subject to such reporting requirements.

 In
addition, if such purchases are made, the public "float" of our common stock or public warrants and the number of beneficial
holders of our securities may be reduced, possibly making it difficult to obtain or maintain the quotation, listing or trading of our
securities on a national securities exchange.

 If
a stockholder fails to receive notice of our offer to redeem our public shares in connection with our initial business combination, or
fails to comply with the procedures for tendering its shares, such shares may not be redeemed.

 We
will comply with the tender offer rules or proxy rules, as applicable, when conducting redemptions in connection with our initial business
combination. Despite our compliance with these rules, if a stockholder fails to receive our tender offer or proxy materials, as applicable,
such stockholder may not become aware of the opportunity to redeem its shares. In addition, proxy materials or tender offer documents,
as applicable, that we will furnish to holders of our public shares in connection with our initial business combination will describe
the various procedures that must be complied with in order to validly tender or redeem public shares, which will include the requirement
that a beneficial holder must identify itself. For example, we may require our public stockholders seeking to exercise their redemption
rights, whether they are record holders or hold their shares in "street name," to either tender their certificates to our
transfer agent prior to the date set forth in the tender offer documents mailed to such holders, or up to two business days prior to
the initial vote on the proposal to approve the initial business combination in the event we distribute proxy materials, or to deliver
their shares to the transfer agent electronically. In the event that a stockholder fails to comply with these or any other procedures,
its shares may not be redeemed. See the section of this Report entitled "Item 1. Business — Redemption Rights for Public
Stockholders upon Completion of our Initial Business Combination — Tendering Stock Certificates in Connection with a Tender Offer
or Redemption Rights."

 You
will not have any rights or interests in funds from the trust account, except under certain limited circumstances. To liquidate your
investment, therefore, you may be forced to sell your public shares or warrants, potentially at a loss.

 Our
public stockholders will be entitled to receive funds from the trust account only upon the earliest to occur of: (i) our completion
of an initial business combination, (ii) the redemption of any public shares properly submitted in connection with a stockholder
vote to amend our amended and restated certificate of incorporation (A) to modify the substance or timing of our obligation to redeem
100% of our public shares if we do not complete our initial business combination within 18 months from the closing of our initial public
offering or (B) with respect to any other provision relating to stockholders' rights or pre-initial business combination activity
and (iii) the redemption of our public shares if we are unable to complete an initial business combination within 18 months from
the closing of our initial public offering, subject to applicable law and as further described herein. In no other circumstances will
a public stockholder have any right or interest of any kind in the trust account. Holders of warrants will not have any right to the
proceeds held in the trust account with respect to the warrants. Accordingly, to liquidate your investment, you may be forced to sell
your public shares or warrants, potentially at a loss.

we are not limited to evaluating a target business in a particular industry sector, you will be unable to ascertain the merits or risks
of any particular target business's operations.

 We
may seek to complete a business combination with an operating company in any industry or sector. However, we will not, under our amended
and restated certificate of incorporation, be permitted to effectuate our business combination with another blank check company or similar
company with nominal operations. To the extent we complete our initial business combination, we may be affected by numerous risks inherent
in the business operations with which we combine. For example, if we combine with a financially unstable business or an entity lacking
an established record of sales or earnings, we may be affected by the risks inherent in the business and operations of a financially
unstable or a development stage entity. Although our officers and directors will endeavor to evaluate the risks inherent in a particular
target business, we cannot assure you that we will properly ascertain or assess all of the significant risk factors or that we will have
adequate time to complete due diligence. Furthermore, some of these risks may be outside of
our control and leave us with no ability to control or reduce the chances that those risks will adversely impact a target business. We
also cannot assure you that an investment in our securities will ultimately prove to be more favorable to investors than a direct investment,
if such opportunity were available, in a business combination target. Accordingly, any stockholders who choose to remain stockholders
following our initial business combination could suffer a reduction in the value of their securities. Such stockholders are unlikely
to have a remedy for such reduction in value unless they are able to successfully claim that the reduction was due to the breach by our
officers or directors of a duty of care or other fiduciary duty owed to them, or if they are able to successfully bring a private claim
under securities laws that the proxy solicitation or tender offer materials, as applicable, relating to the business combination contained
an actionable material misstatement or material omission.

 Past
performance by our management team, may not be indicative of future performance of an investment in the Company.

 Information
regarding performance by, or businesses associated with our management team and their affiliates is presented for informational purposes
only. Past performance by our management team is not a guarantee either (i) of success with respect to any business combination
we may consummate or (ii) that we will be able to locate a suitable candidate for our initial business combination. You should not
rely on the historical record of our management team's or their affiliates' performance as indicative of the future performance
of an investment in the company or the returns the company will, or is likely to, generate going forward. Our officers and directors
have not had experience with blank check companies or special purpose acquisition companies in the past.

 We
may seek business combination opportunities in industries or sectors which may or may not be outside of our management's area of
expertise.

 We
will consider an initial business combination outside of our management's area of expertise if an initial business combination
candidate is presented to us and we determine that such candidate offers an attractive business combination opportunity for our company
or we are unable to identify a suitable candidate in this sector after having expanded a reasonable amount of time and effort in an attempt
to do so. Although our management will endeavor to evaluate the risks inherent in any particular business combination candidate, we cannot
assure you that we will adequately ascertain or assess all of the significant risk factors. We also cannot assure you that an investment
in our securities will not ultimately prove to be less favorable to investors in our initial public offering than a direct investment,
if an opportunity were available, in an initial business combination candidate. In the event we elect to pursue a business combination
outside of the areas of our management's expertise, our management's expertise may not be directly applicable to its evaluation
or operation, and the information contained in this Report regarding the areas of our management's expertise would not be relevant
to an understanding of the business that we elect to acquire. As a result, our management may not be able to adequately ascertain or
assess all of the significant risk factors. Accordingly, any stockholders who choose to remain stockholders following our initial business
combination could suffer a reduction in the value of their shares. Such stockholders are unlikely to have a remedy for such reduction
in value.

we have identified general criteria and guidelines that we believe are important in evaluating prospective target businesses, we may
enter into our initial business combination with a target that does not meet such criteria and guidelines, and as a result, the target
business with which we enter into our initial business combination may not have attributes entirely consistent with our general criteria
and guidelines.

we have identified general criteria and guidelines for evaluating prospective target businesses, it is possible that a target business
with which we enter into our initial business combination will not have all of these positive attributes. If we complete our initial
business combination with a target that does not meet some or all of these guidelines, such combination may not be as successful as a
combination with a business that does meet all of our general criteria and guidelines. In addition, if we announce a prospective business
combination with a target that does not meet our general criteria and guidelines, a greater number of stockholders may exercise their
redemption rights, which may make it difficult for us to meet any closing condition with a target business that requires us to have a
minimum net worth or a certain amount of cash. In addition, if stockholder approval of the transaction is required by law, or we decide
to obtain stockholder approval for business or other legal reasons, it may be more difficult for us to attain stockholder approval of
our initial business combination if the target business does not meet our general criteria and guidelines. If we are unable to complete
our initial business combination, our public stockholders may receive only approximately $10.595 per share on the liquidation of our
trust account and our warrants will expire worthless. In certain circumstances, our public stockholders may receive less than $10.595
per share on the redemption of their shares. See "— If third parties bring claims against us, the proceeds held in the trust
account could be reduced and the per-share redemption amount received by stockholders may be less than $10.595 per share" and other
risk factors below.

 Resources
could be wasted in researching business combinations that are not completed, which could materially adversely affect subsequent attempts
to locate and acquire or merge with another business. If we are unable to complete our initial business combination, our public stockholders
may receive only approximately $10.595 per share, or less than such amount in certain circumstances, on the liquidation of our trust
account and our warrants will expire worthless.

 We
anticipate that the investigation of each specific target business and the negotiation, drafting and execution of relevant agreements,
disclosure documents and other instruments will require substantial management time and attention and substantial costs for accountants,
attorneys, consultants and others. If we decide not to complete a specific initial business combination, the costs incurred up to that
point for the proposed transaction likely would not be recoverable. Furthermore, if we reach an agreement relating to a specific target
business, we may fail to complete our initial business combination for any number of reasons including those beyond our control. Any
such event will result in a loss to us of the related costs incurred which could materially adversely affect subsequent attempts to locate
and acquire or merge with another business. If we are unable to complete our initial business combination, our public stockholders may
receive only approximately $10.595 per share on the liquidation of our trust account and our warrants will expire worthless. In certain
circumstances, our public stockholders may receive less than $10.595 per share on the redemption of their shares. See "—
If third parties bring claims against us, the proceeds held in the trust account could be reduced and the per-share redemption amount
received by stockholders may be less than $10.595 per share" and other risk factors below.

 Our
key personnel may negotiate employment or consulting agreements as well as reimbursement of out-of-pocket expenses, if any, with a target
business in connection with a particular business combination. These agreements may provide for them to receive compensation or reimbursement
for out-of-pocket expenses, if any, following our initial business combination and as a result, may cause them to have conflicts of interest
in determining whether a particular business combination is the most advantageous.

 Our
key personnel may be able to remain with the company after the completion of our initial business combination only if they are able to
negotiate employment or consulting agreements in connection with the initial business combination. Additionally, they may negotiate reimbursement
of any out-of-pocket expenses incurred on our behalf prior to the consummation of our initial business combination, should they choose
to do so. Such negotiations would take place simultaneously with the negotiation of the initial business combination and could provide
for such individuals to receive compensation in the form of cash payments and/or our securities for services they would render to us
after the completion of the initial business combination, or as reimbursement for such out-of-pocket expenses. The personal and financial
interests of such individuals may influence their motivation in identifying and selecting a target business. However, we believe the
ability of such individuals to remain with us after the completion of our initial business combination will not be the determining factor
in our decision as to whether or not we will proceed with any potential business combination. There is no certainty, however, that any
of our key personnel will remain with us after the completion of our initial business combination. We cannot assure you that any of our
key personnel will remain in senior management or advisory positions with us. The determination as to whether any of our key personnel
will remain with us will be made at the time of our initial business combination.

 Since
our sponsor, officers and directors will lose their entire investment in us if our initial business combination is not completed, a conflict
of interest may arise in determining whether a particular business combination target is appropriate for our initial business combination.

 Our
sponsor and I-Bankers hold 2,875,000 founder shares. The founder shares will be worthless if we do not complete an initial business combination.
In addition, our sponsor and I-Bankers purchased an aggregate of 5,425,000 private placement warrants, each exercisable for one share
of our common stock at $11.50 per share, for a purchase price of $5,425,000, or $1.00 per warrant, that will also be worthless if we
do not complete a business combination.

 The
personal and financial interests of our executive officers and directors may influence their motivation in identifying and selecting
a target business combination, completing an initial business combination and influencing the operation of the business following the
initial business combination. This risk may become more acute as the 18-month anniversary of the closing of our initial public offering
nears, which is the deadline for our completion of an initial business combination.

 Since
our sponsor, executive officers and directors will not be eligible to be reimbursed for their out-of-pocket expenses if our business
combination is not completed, a conflict of interest may arise in determining whether a particular business combination target is appropriate
for our initial business combination.

 At
the closing of our initial business combination, our sponsor, executive officers and directors, or any of their respective affiliates,
will be reimbursed for any out-of-pocket expenses incurred in connection with activities on our behalf such as identifying potential
target businesses and performing due diligence on suitable business combinations. There is no cap or ceiling on the reimbursement of
out-of-pocket expenses incurred in connection with activities on our behalf. These financial interests of our sponsor, executive officers
and directors may influence their motivation in identifying and selecting a target business combination and completing an initial business

 The
excise tax included in the Inflation Reduction Act of 2022 may decrease the value of our securities following our initial Business Combination,
hinder our ability to consummate an initial Business Combination, and decrease the amount of funds available for distribution in connection
with a liquidation.

 On
August 16, 2022, the Inflation Reduction Act of 2022 (the "Inflation Reduction Act") was signed into law, which, among other
things, imposes a 1% excise tax on the fair market value of stock repurchased by a domestic corporation beginning in 2023, with certain
exceptions. Because we are a Delaware corporation and our securities trade on the Nasdaq Stock Market, we are a "covered corporation"
within the meaning of the Inflation Reduction Act, and while not free from doubt, it is possible that the excise tax will apply to any
redemptions of our common stock after December 31, 2022, including redemptions in connection with an initial Business Combination and
any amendment to our certificate of incorporation to extend the time to consummate an initial Business Combination, unless an exemption
is available. Consequently, the value of your investment in our securities may decrease as a result of the excise tax. In addition, the
excise tax may make a transaction with us less appealing to potential Business Combination targets, and thus, potentially hinder our
ability to enter into and consummate an initial Business Combination. Further, the application of the excise tax in the event of a liquidation
is uncertain absent further guidance.

 Risks
Relating to Our Securities

 NASDAQ
may delist our securities from trading on its exchange, which could limit investors' ability to make transactions in our securities
and subject us to additional trading restrictions.

 Our
securities are currently listed on NASDAQ. However, we cannot assure you that our securities will continue to be listed on NASDAQ in
the future or prior to our initial business combination. In order to continue listing our securities on NASDAQ prior to our initial business
combination, we must maintain certain financial, distribution and stock price levels. Generally, we must maintain a minimum amount in
stockholders' equity (generally $2,500,000) and a minimum number of holders of our securities (300 round-lot holders). Additionally,
in connection with our initial business combination, we will be required to demonstrate compliance with NASDAQ's initial listing
requirements, which are more rigorous than NASDAQ's continued listing requirements, in order to continue to maintain the listing
of our securities on NASDAQ. For instance, our stock price would generally be required to be at least $4.00 per share, our stockholders'
equity would generally be required to be at least $5.0 million and we would be required to have a minimum of 300 round lot holders of
our securities. We cannot assure you that we will be able to meet those initial listing requirements at that time. If NASDAQ delists
our securities from trading on its exchange and we are not able to list our securities on another national securities exchange, we expect
our securities could be quoted on an over-the-counter market. If this were to occur, we could face significant material adverse consequences,
including:

 a
 limited availability of market quotations for our securities;

 reduced
 liquidity for our securities;

 a
 determination that our common stock is a "penny stock" which will require brokers trading in our common stock to adhere
 to more stringent rules and possibly result in a reduced level of trading activity in the secondary trading market for our securities;

 a
 limited amount of news and analyst coverage; and

 a
 decreased ability to issue additional securities or obtain additional financing in the future.

 You
will not be entitled to protections normally afforded to investors of many other blank check companies.

 Since
the net proceeds of our initial public offering and the sale of the private placement warrants are intended to be used to complete an
initial business combination with a target business that has not been identified, we may be deemed to be a "blank check"
company under the United States securities laws. However, because we had net tangible assets in excess of $5,000,000 upon the successful
completion of our initial public offering and the sale of the private placement warrants and filed a Current Report on Form 8-K, including
an audited balance sheet demonstrating this fact, we are exempt from rules promulgated by the SEC to protect investors in blank check
companies, such as Rule 419. Accordingly, investors will not be afforded the benefits or protections of those rules. Among other things,
this means our units will have a longer period of time to complete our initial business combination than do companies subject to Rule
419. Moreover, if our initial public offering were subject to Rule 419, that rule would prohibit the release of any interest earned on
funds held in the trust account to us unless and until the funds in the trust account were released to us in connection with our completion
of an initial business combination.

 If
we seek stockholder approval of our initial business combination and we do not conduct redemptions pursuant to the tender offer rules,
and if you or a "group" of stockholders are deemed to hold in excess of 10% of our common stock, you will lose the ability
to redeem all such shares in excess of 10% of our common stock.

 If
we seek stockholder approval of our initial business combination and we do not conduct redemptions in connection with our initial business
combination pursuant to the tender offer rules, our amended and restated certificate of incorporation provides that a public stockholder,
together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a "group"
(as defined under Section 13 of the Exchange Act), will be restricted from seeking redemption rights with respect to more than an
aggregate of 10% of the shares sold in our initial public offering without our prior consent, which we refer to as the "Excess
Shares."

 However,
we would not be restricting our stockholders' ability to vote all of their shares (including Excess Shares) for or against our
initial business combination. Your inability to redeem the Excess Shares will reduce your influence over our ability to complete our
initial business combination and you could suffer a material loss on your investment in us if you sell Excess Shares in open market transactions.
Additionally, you will not receive redemption distributions with respect to the Excess Shares if we complete our initial business combination.
And as a result, you will continue to hold that number of shares exceeding 10% and, in order to dispose of such shares, would be required
to sell your stock in open market transactions, potentially at a loss.

of our limited resources and the significant competition for business combination opportunities, it may be more difficult for us to complete
our initial business combination. If we are unable to complete our initial business combination, our public stockholders may receive
only approximately $10.595 per share on our redemption of our public shares, or less than such amount in certain circumstances, and our
warrants will expire worthless.

 We
have encountered and continue to expect to encounter competition from other entities having a business objective similar to ours, including
private investors (which may be individuals or investment partnerships), other blank check companies and other entities competing for
the types of businesses we intend to acquire. Many of these individuals and entities are well-established and have extensive experience
in identifying and effecting, directly or indirectly, acquisitions of companies operating in or providing services to various industries.
Many of these competitors possess similar technical, human and other resources to ours, and our financial resources are relatively limited
when contrasted with those of many of these competitors. While we believe there are numerous target businesses we could potentially acquire
with the net proceeds of our initial public offering and the sale of the private placement warrants, our ability to compete with respect
to the acquisition of certain target businesses that are sizable are limited by our available financial resources. This inherent competitive
limitation gives others an advantage in pursuing the acquisition of certain target businesses. Furthermore, if we are obligated to pay
cash for the shares of common stock which our public stockholders redeem in connection with our initial business combination, target
companies will be aware that this may reduce the resources available to us for our initial business combination. This may place us at
a competitive disadvantage in successfully negotiating an initial business combination. If we are unable to complete our initial business
combination, our public stockholders may receive only approximately $10.595 per share on the liquidation of our trust account and our
warrants will expire worthless.

 If
the net proceeds of our initial public offering and the sale of the private placement warrants not being held in the trust account are
insufficient to allow us to operate for at least 18 months from the closing of our initial public offering, we may be unable to complete
our initial business combination.

 The
funds available to us outside of the trust account may not be sufficient to allow us to operate for 18 months from the closing of our
initial public offering, assuming that our initial business combination is not completed during that time. We believe that, upon the
closing of our initial public offering, the funds available to us outside of the trust account will be sufficient to allow us to operate
for 18 months from the closing of our initial public offering; however, we cannot assure you that our estimate is accurate. Of the funds
available to us, we could use a portion of the funds available to us to pay fees to consultants to assist us with our search for a target
business. We could also use a portion of the funds as a down payment or to fund a "no-shop" provision (a provision in letters
of intent or merger agreements designed to keep target businesses from "shopping" around for transactions with other companies
on terms more favorable to such target businesses) with respect to a particular proposed initial business combination, although we do
not have any current intention to do so. If we entered into a letter of intent or merger agreement where we paid for the right to receive
exclusivity from a target business and were subsequently required to forfeit such funds (whether as a result of our breach or otherwise),
we might not have sufficient funds to continue searching for, or conduct due diligence with respect to, a target business. If we are
unable to complete our initial business combination, our public stockholders may receive only approximately $10.595 per share on the
liquidation of our trust account and our warrants will expire worthless. In certain circumstances, our public stockholders may receive
less than $10.595 per share upon our liquidation. See "— If third parties bring claims against us, the proceeds held in the
trust account could be reduced and the per-share redemption amount received by stockholders may be less than $10.595 per share"
and other risk factors below.

 If
the net proceeds of our initial public offering and the sale of the private placement warrants not being held in the trust account are
insufficient, it could limit the amount available to fund our search for a target business or businesses and complete our initial business
combination and we will depend on loans from our sponsor or management team to fund our search for an initial business combination, to
pay our franchise and income taxes and to complete our initial business combination. If we are unable to obtain these loans, we may be
unable to complete our initial business combination.

 Of
the net proceeds of our initial public offering and the sale of the private placement warrants, $947,443 was available to us initially
outside the trust account to fund our working capital requirements. If we are required to seek additional capital, we would need to borrow
funds from our sponsor, management team or other third parties to operate or may be forced to liquidate. None of our sponsor, members
of our management team or any of their affiliates is under any obligation to advance funds to us in such circumstances. Any such advances
would be repaid only from funds held outside the trust account or from funds released to us upon completion of our initial business combination.
We do not expect to seek loans from parties other than our sponsor or an affiliate of our sponsor as we do not believe third parties
will be willing to loan such funds and provide a waiver against any and all rights to seek access to funds in our trust account. If we
are unable to complete our initial business combination because we do not have sufficient funds available to us, we will be forced to
cease operations and liquidate the trust account. Consequently, our public stockholders may only receive approximately $10.595 per share
on our redemption of our public shares, and our rights and warrants will expire worthless.

 If
third parties bring claims against us, the proceeds held in the trust account could be reduced and the per-share redemption amount received
by stockholders may be less than $10.595 per share.

 Our
placing of funds in the trust account may not protect those funds from third-party claims against us. Although we will seek to have all
vendors, service providers, prospective target businesses and other entities with which we do business execute agreements with us waiving
any right, title, interest or claim of any kind in or to any monies held in the trust account for the benefit of our public stockholders,
such parties may not execute such agreements, or even if they execute such agreements they may not be prevented from bringing claims
against the trust account, including, but not limited to, fraudulent inducement, breach of fiduciary responsibility or other similar
claims, as well as claims challenging the enforceability of the waiver, in each case in order to gain advantage with respect to a claim
against our assets, including the funds held in the trust account. If any third-party refuses to execute an agreement waiving such claims
to the monies held in the trust account, our management will perform an analysis of the alternatives available to it and will only enter
into an agreement with a third party that has not executed a waiver if management believes that such third party's engagement would
be significantly more beneficial to us than any alternative.

 Examples
of possible instances where we may engage a third party that refuses to execute a waiver include the engagement of a third-party consultant
whose particular expertise or skills are believed by management to be significantly superior to those of other consultants that would
agree to execute a waiver or in cases where management is unable to find a service provider willing to execute a waiver. In addition,
there is no guarantee that such entities will agree to waive any claims they may have in the future as a result of, or arising out of,
any negotiations, contracts or agreements with us and will not seek recourse against the trust account for any reason. Upon redemption
of our public shares, if we are unable to complete our initial business combination within the prescribed timeframe, or upon the exercise
of a redemption right in connection with our initial business combination, we will be required to provide for payment of claims of creditors
that were not waived that may be brought against us within the 10 years following redemption. Accordingly, the per-share redemption amount
received by public stockholders could be less than the $10.595 per share initially held in the trust account, due to claims of such creditors.
Our sponsor has agreed that it will be liable to us if and to the extent any claims by a third party for services rendered or products
sold to us, or a prospective target business with which we have entered into a written letter of intent, confidentiality or similar agreement
or business combination agreement, reduce the amount of funds in the trust account to below the lesser of (i) $10.595 per public
share and (ii) the actual amount per public share held in the trust account as of the date of the liquidation of the trust account,
if less than $10.595 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will
not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held
in the trust account (whether or not such waiver is enforceable) nor will it apply to any claims under our indemnity of the underwriters
of our initial public offering against certain liabilities, including liabilities under the Securities Act. However, we have not asked
our sponsor to reserve for such indemnification obligations, nor have we independently verified whether our sponsor has sufficient funds
to satisfy its indemnity obligations and believe that our sponsor's only assets are securities of our company. Therefore, we cannot
assure you that our sponsor would be able to satisfy those obligations. None of our officers, directors or members of our sponsor will
indemnify us for claims by third parties including, without limitation, claims by vendors and prospective target businesses.

 Our
directors may decide not to enforce the indemnification obligations of our sponsor, resulting in a reduction in the amount of funds in
the trust account available for distribution to our public stockholders.

 In
the event that the proceeds in the trust account are reduced below the lesser of (i) $10.595 per share and (ii) the actual
amount per share held in the trust account as of the date of the liquidation of the trust account if less than $10.595 per share due
to reductions in the value of the trust assets, in each case net of the interest which may be withdrawn to pay taxes, and our
sponsor asserts that it is unable to satisfy its obligations or that it has no indemnification obligations related to a particular
claim, our independent directors would determine whether to take legal action against our sponsor to enforce its indemnification
obligations.

 While
we currently expect that our independent directors would take legal action on our behalf against our sponsor to enforce its indemnification
obligations to us, it is possible that our independent directors in exercising their business judgment and subject to their fiduciary
duties may choose not to do so in any particular instance if, for example, the cost of such legal action is deemed by the independent
directors to be too high relative to the amount recoverable or if the independent directors determine that a favorable outcome is not
likely. If our independent directors choose not to enforce these indemnification obligations, the amount of funds in the trust account
available for distribution to our public stockholders may be reduced below $10.595 per share.

 We
may not have sufficient funds to satisfy indemnification claims of our directors and executive officers.

 We
have agreed to indemnify our officers and directors to the fullest extent permitted by law. However, our officers and directors have
agreed to waive (and any other persons who may become an officer or director prior to the initial business combination will also be required
to waive) any right, title, interest or claim of any kind in or to any monies in the trust account and not to seek recourse against the
trust account for any reason whatsoever. Accordingly, any indemnification provided will be able to be satisfied by us only if (i) we
have sufficient funds outside of the trust account or (ii) we consummate an initial business combination. Our obligation to indemnify
our officers and directors may discourage stockholders from bringing a lawsuit against our officers or directors for breach of their
fiduciary duty. These provisions also may have the effect of reducing the likelihood of derivative litigation against our officers and
directors, even though such an action, if successful, might otherwise benefit us and our stockholders. Furthermore, a stockholder's
investment may be adversely affected to the extent we pay the costs of settlement and damage awards against our officers and directors
pursuant to these indemnification provisions.

 If,
after we distribute the proceeds in the trust account to our public stockholders, we file a bankruptcy petition or an involuntary bankruptcy
petition is filed against us that is not dismissed, a bankruptcy court may seek to recover such proceeds, and we and our board may be
exposed to claims of punitive damages.

 If,
after we distribute the proceeds in the trust account to our public stockholders, we file a bankruptcy petition or an involuntary bankruptcy
petition is filed against us that is not dismissed, any distributions received by stockholders could be viewed under applicable debtor/creditor
and/or bankruptcy laws as either a "preferential transfer" or a "fraudulent conveyance." As a result, a bankruptcy
court could seek to recover all amounts received by our stockholders. In addition, our board of directors may be viewed as having breached
its fiduciary duty to our creditors and/or having acted in bad faith, thereby exposing itself and us to claims of punitive damages, by
paying public stockholders from the trust account prior to addressing the claims of creditors.

 If,
before distributing the proceeds in the trust account to our public stockholders, we file a bankruptcy petition or an involuntary bankruptcy
petition is filed against us that is not dismissed, the claims of creditors in such proceeding may have priority over the claims of our
stockholders and the per-share amount that would otherwise be received by our stockholders in connection with our liquidation may be
reduced.

 If,
before distributing the proceeds in the trust account to our public stockholders, we file a bankruptcy petition or an involuntary bankruptcy
petition is filed against us that is not dismissed, the proceeds held in the trust account could be subject to applicable bankruptcy
law, and may be included in our bankruptcy estate and subject to the claims of third parties with priority over the claims of our stockholders.
To the extent any bankruptcy claims deplete the trust account, the per-share amount that would otherwise be received by our stockholders
in connection with our liquidation may be reduced.

 Our
stockholders may be held liable for claims by third parties against us to the extent of distributions received by them upon redemption
of their shares.

 Under
the DGCL, stockholders may be held liable for claims by third parties against a corporation to the extent of distributions received by
them in a dissolution. The pro rata portion of our trust account distributed to our public stockholders upon the redemption of our public
shares in the event we do not complete our initial business combination within 18 months from the closing of our initial public offering
may be considered a liquidating distribution under Delaware law. If a corporation complies with certain procedures set forth in Section 280
of the DGCL intended to ensure that it makes reasonable provision for all claims against it, including a 60-day notice period during
which any third-party claims can be brought against the corporation, a 90-day period during which the corporation may reject any claims
brought, and an additional 150-day waiting period before any liquidating distributions are made to stockholders, any liability of stockholders
with respect to a liquidating distribution is limited to the lesser of such stockholder's pro rata share of the claim or the amount
distributed to the stockholder, and any liability of the stockholder would be barred after the third anniversary of the dissolution.
However, it is our intention to redeem our public shares as soon as reasonably possible following the 18 th month from the
closing of our initial public offering in the event we do not complete our initial business combination and, therefore, we do not intend
to comply with the foregoing procedures.

we will not be complying with Section 280, Section 281(b) of the DGCL requires us to adopt a plan, based on facts known to
us at such time that will provide for our payment of all existing and pending claims or claims that may be potentially brought against
us within the 10 years following our dissolution. However, because we are a blank check company, rather than an operating company, and
our operations will be limited to searching for prospective target businesses to acquire, the only likely claims to arise would be from
our vendors (such as lawyers, investment bankers, etc.) or prospective target businesses. If our plan of distribution complies with Section 281(b)
of the DGCL, any liability of stockholders with respect to a liquidating distribution is limited to the lesser of such stockholder's
pro rata share of the claim or the amount distributed to the stockholder, and any liability of the stockholder would likely be barred
after the third anniversary of the dissolution. We cannot assure you that we will properly assess all claims that may be potentially
brought against us. As such, our stockholders could potentially be liable for any claims to the extent of distributions received by them
(but no more) and any liability of our stockholders may extend beyond the third anniversary of such date. Furthermore, if the pro rata
portion of our trust account distributed to our public stockholders upon the redemption of our public shares in the event we do not complete
our initial business combination within 18 months from the closing of our initial public offering is not considered a liquidating distribution
under Delaware law and such redemption distribution is deemed to be unlawful (potentially due to the imposition of legal proceedings
that a party may bring or due to other circumstances that are currently unknown), then pursuant to Section 174 of the DGCL, the
statute of limitations for claims of creditors could then be six years after the unlawful redemption distribution, instead of three years,
as in the case of a liquidating distribution.

 We
may not hold an annual meeting of stockholders until after the consummation of our initial business combination, which could delay the
opportunity for our stockholders to elect directors.

 We
may not hold an annual meeting of stockholders until after we consummate a business combination (unless required by NASDAQ), and thus
may not be in compliance with Section 211(b) of the DGCL, which requires an annual meeting of stockholders be held for the purposes
of electing directors in accordance with a company's bylaws unless such election is made by written consent in lieu of such a meeting.
Therefore, if our stockholders want us to hold an annual meeting prior to our consummation of a business combination, they may attempt
to force us to hold one by submitting an application to the Delaware Court of Chancery in accordance with Section 211(c) of the
DGCL.

 We
have not registered the shares of common stock issuable upon exercise of the warrants under the Securities Act or any state securities
laws at this time, and such registration may not be in place when an investor desires to exercise warrants, thus precluding such investor
from being able to exercise its warrants except on a cashless basis. If the issuance of the shares upon exercise of warrants is not registered,
qualified or exempt from registration or qualification, the holder of such warrant will not be entitled to exercise such warrant and
such warrant may have no value and expire worthless.

 We
have not registered the shares of common stock issuable upon exercise of the warrants under the Securities Act or any state securities
laws at this time. However, under the terms of the warrant agreement, we have agreed that as soon as practicable, but in no event later
than 15 business days after the closing of our initial business combination, we will use our best efforts to file with the SEC a registration
statement for the registration under the Securities Act of the shares of common stock issuable upon exercise of the warrants and thereafter
will use our best efforts to cause the same to become effective within 60 business days following our initial business combination and
to maintain a current prospectus relating to the common stock issuable upon exercise of the warrants, until the expiration of the warrants
in accordance with the provisions of the warrant agreement. We cannot assure you that we will be able to do so if, for example, any facts
or events arise which represent a fundamental change in the information set forth in the registration statement or prospectus, the financial
statements contained or incorporated by reference therein are not current or correct or the SEC issues a stop order. If the shares issuable
upon exercise of the warrants are not registered under the Securities Act, we will be required to permit holders to exercise their warrants
on a cashless basis. However, no warrant will be exercisable for cash or on a cashless basis, and we will not be obligated to issue any
shares to holders seeking to exercise their warrants, unless the issuance of the shares upon such exercise is registered or qualified
under the securities laws of the state of the exercising holder, or an exemption from registration is available. If that exemption, or
another exemption, is not available, holders will not be able to exercise their warrants on a cashless basis. In no event will we be
required to net cash settle any warrant, or issue securities or other compensation in exchange for the warrants in the event that we
are unable to register or qualify the shares underlying the warrants under applicable state securities laws and there is no exemption
available. If the issuance of the shares upon exercise of the warrants is not so registered or qualified or exempt from registration
or qualification, the holder of such warrant will not be entitled to exercise such warrant and such warrant may have no value and expire
worthless. In such event, holders who acquired their warrants as part of a purchase of units will have paid the full unit purchase price
solely for the shares of common stock included in the units. If and when the warrants become redeemable by us, we may not exercise our
redemption right if the issuance of shares of common stock upon exercise of the warrants is not exempt from registration or qualification
under applicable state blue sky laws or we are unable to effect such registration or qualification. We will use our best efforts to register
or qualify such shares of common stock under the blue sky laws of the state of residence in those states in which the warrants were offered
by us in our initial public offering. However, there may be instances in which holders of our public warrants may be unable to exercise
such public warrants but holders of our private warrants may be able to exercise such private warrants.

 The
grant of registration rights to our initial stockholders and holders of our private placement warrants may make it more difficult to
complete our initial business combination, and the future exercise of such rights may adversely affect the market price of our common
stock.

to an agreement to be entered into concurrently with the issuance and sale of the securities in our initial public offering, our initial
stockholders and their permitted transferees can demand that we register their shares of our common stock at the time of our initial
business combination. In addition, holders of our private placement warrants and their permitted transferees can demand that we register
the private placement warrants and the shares of common stock issuable upon exercise of the private placement warrants, and holders of
warrants that may be issued upon conversion of working capital loans may demand that we register such warrants or the common stock issuable
upon exercise of such warrants. We will bear the cost of registering these securities. The registration and availability of such a significant
number of securities for trading in the public market may have an adverse effect on the market price of our common stock. In addition,
the existence of the registration rights may make our initial business combination more costly or difficult to conclude. This is because
the stockholders of the target business may increase the equity stake they seek in the combined entity or ask for more cash consideration
to offset the negative impact on the market price of our common stock that is expected when the common stock owned by our initial stockholders,
holders of our private placement warrants or holders of our working capital loans or their respective permitted transferees are registered.

 We
may issue additional common stock or preferred stock to complete our initial business combination or under an employee incentive plan
after completion of our initial business combination. Any such issuances would dilute the interest of our stockholders and likely present
other risks.

 Our
amended and restated certificate of incorporation authorizes the issuance of up to 100,000,000 shares of common stock, par value $0.0001
per share and 1,000,000 shares of undesignated preferred stock, par value $0.0001 per share. Immediately after our initial public offering,
there were 67,875,000 authorized but unissued shares of common stock available for issuance, which amount takes into account shares of
common stock reserved for issuance upon exercise of outstanding warrants and the conversion of the rights. There are no shares of preferred
stock issued and outstanding.

 We
may issue a substantial number of additional shares of common or preferred stock to complete our initial business combination or under
an employee incentive plan after completion of our initial business combination (although our amended and restated certificate of incorporation
provides that we may not issue securities that can vote with common stockholders on matters related to our pre-initial business combination
activity). However, our amended and restated certificate of incorporation provides, among other things, that prior to our initial business
combination, we may not issue additional shares of capital stock that would entitle the holders thereof to (i) receive funds from
the trust account or (ii) vote on any initial business combination. These provisions of our amended and restated certificate of
incorporation, like all provisions of our amended and restated certificate of incorporation, may be amended with the approval of our
stockholders. However, our executive officers and directors have agreed, pursuant to a written agreement with us, that they will not
propose any amendment to our amended and restated certificate of incorporation (A) to modify the substance or timing of our obligation
to redeem 100% of our public shares if we do not complete our initial business combination within 18 months from the closing of our initial
public offering (or up to 18 months from the closing of our initial public offering if we extend the period of time to consummate a business
combination) or (B) with respect to any other provision relating to stockholders' rights or pre-initial business combination
activity, unless we provide our public stockholders with the opportunity to redeem their shares of common stock upon approval of any
such amendment at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest
(which interest shall be net of taxes payable), divided by the number of then outstanding public shares.

 The
issuance of additional shares of common or preferred stock:

 may significantly dilute the equity interest of investors in our initial public offering;

 may
 subordinate the rights of holders of common stock if preferred stock is issued with rights senior to those afforded our common stock;

 could
 cause a change of control if a substantial number of shares of our common stock are issued, which may affect, among other things,
 our ability to use our net operating loss carry forwards, if any, and could result in the resignation or removal of our present officers
 and directors; and

 may
 adversely affect prevailing market prices for our units, common stock, rights and/or warrants.

 Our
officers and directors will allocate their time to other businesses thereby causing conflicts of interest in their determination as to
how much time to devote to our affairs. This conflict of interest could have a negative impact on our ability to complete our initial
business combination.

 Our
officers and directors are not required to, and will not, commit their full time to our affairs, which may result in a conflict of interest
in allocating their time between our operations and our search for an initial business combination and their other businesses.

 We
do not intend to have any full-time employees prior to the completion of our initial business combination. Each of our officers is engaged
in other business endeavors for which he may be entitled to substantial compensation and our officers are not obligated to contribute
any specific number of hours per week to our affairs. Our independent directors may also serve as officers or board members for other
entities. If our officers' and directors' other business affairs require them to devote substantial amounts of time to such
affairs in excess of their current commitment levels, it could limit their ability to devote time to our affairs which may have a negative
impact on our ability to complete our initial business combination. For a complete discussion of our officers' and directors'
other business affairs, please see the section of this Report entitled "Item 10. Directors, Executive Officers and Corporate Governance
— Directors and Executive Officers."

of our officers and directors are now, and all of them may in the future become, affiliated with entities engaged in business activities
similar to those intended to be conducted by us and, accordingly, may have conflicts of interest in allocating their time and determining
to which entity a particular business opportunity should be presented.

the completion of our initial public offering and until we consummate our initial business combination, we intend to engage in the business
of identifying and combining with one or more businesses. Our officers and directors are, and may in the future become, affiliated with
entities that are engaged in business activities similar to those intended to be conducted by us following our initial business combination.
.

 Our
officers and directors also may become aware of business opportunities which may be appropriate for presentation to us and the other
entities to which they owe certain fiduciary or contractual duties. Any such companies may present additional conflicts of interest in
pursuing an acquisition target.

 Accordingly,
they may have conflicts of interest in determining to which entity a particular business opportunity should be presented. These conflicts
may not be resolved in our favor and a potential target business may be presented to another entity prior to its presentation to us.
Our amended and restated certificate of incorporation provides that we renounce our interest in any corporate opportunity offered to
any director or officer unless such opportunity is expressly offered to such person solely in his or her capacity as a director or officer
of our company and such opportunity is one we are legally and contractually permitted to undertake and would otherwise be reasonable
for us to pursue, and to the extent the director or officer is permitted to refer that opportunity to us without violating another legal
obligation.

 For
a complete discussion of our officers' and directors' business affiliations and the potential conflicts of interest that
you should be aware of, please see the sections of this Report entitled "Item 10. Directors, Executive Officers and Corporate Governance—
Directors and Executive Officers," "Item 10. Directors, Executive Officers and Corporate Governance — Conflicts of
Interest" and "Item 13. Certain Relationships and Related Transactions, and Director Independence."

 Our
officers, directors, security holders and their respective affiliates may have competitive pecuniary interests that conflict with our
interests.

 We
have not adopted a policy that expressly prohibits our directors, officers, security holders or affiliates from having a direct or indirect
pecuniary or financial interest in any investment to be acquired or disposed of by us or in any transaction to which we are a party or
have an interest. In fact, we may enter into an initial business combination with a target business that is affiliated with our sponsor,
our directors or officers, although we do not intend to do so. We do not have a policy that expressly prohibits any such persons from
engaging for their own account in business activities of the types conducted by us. Accordingly, such persons or entities may have a
conflict between their interests and ours.

 In
order to effectuate an initial business combination, blank check companies have, in the recent past, amended various provisions of their
charters and other governing instruments, including their warrant agreements. We cannot assure you that we will not seek to amend our
amended and restated certificate of incorporation or governing instruments in a manner that will make it easier for us to complete our
initial business combination that our stockholders may not support.

 In
order to effectuate an initial business combination, blank check companies have, in the recent past, amended various provisions of
their charters and modified governing instruments, including their warrant agreements. For example, blank check companies have
amended the definition of business combination, increased redemption thresholds and extended the time to consummate an initial
business combination. And, with respect to their warrants, amended their warrant agreements to require the warrants to be exchanged
for cash and/or other securities. Amending our amended and restated certificate of incorporation requires the approval of holders of
65% of our common stock, and amending our warrant agreement requires a vote of holders of at least 65% of the public warrants and,
solely with respect to any amendment to the terms of the private placement warrants or any provision of the warrant agreement with
respect to the private placement warrants, 50% of the number of the then outstanding private placement warrants. In addition, our
amended and restated certificate of incorporation requires us to provide our public stockholders with the opportunity to redeem
their public shares for cash if we propose an amendment to our amended and restated certificate of incorporation (A) to modify
the substance or timing of our obligation to redeem 100% of our public shares if we do not complete our initial business
combination within 18 months or (B) with respect to any other provision relating to stockholders' rights or pre-initial
business combination activity. To the extent any such amendments would be deemed to fundamentally change the nature of any
securities offered through this registration statement, we would register, or seek an exemption from registration for, the affected
securities. We cannot assure you that we will not seek to amend our charter or governing instruments or extend the time to
consummate an initial business combination in order to effectuate our initial business combination.

agreements related to our initial public offering may be amended without stockholder approval.

agreements, including the underwriting agreement relating to our initial public offering, the investment management trust agreement between
us and Continental Stock Transfer & Trust Company, the letter agreement among us and our sponsor, executive officers and directors,
the registration rights agreement among us and our initial stockholders, the administrative services agreement between us and our sponsor,
and the business combination marketing agreement may be amended without stockholder approval. These agreements contain various provisions
that our public stockholders might deem to be material. While we do not expect our board to approve any amendment to any of these agreements
prior to our initial business combination, it may be possible that our board, in exercising its business judgment and subject to its
fiduciary duties, chooses to approve one or more amendments to any such agreement in connection with the consummation of our initial
business combination. Any such amendment may have an adverse effect on the value of an investment in our securities.

 We
may redeem your unexpired warrants prior to their exercise at a time that is disadvantageous to you, thereby making your warrants worthless.

 We
have the ability to redeem outstanding warrants at any time after they become exercisable and prior to their expiration, at a price of
$0.01 per warrant, provided that the last reported sales price of our common stock equals or exceeds $18.00 per share for any 20 trading
days within a 30 trading-day period ending on the third trading day prior to the date we send the notice of redemption to the warrant
holders. We may not redeem the warrants when a holder may not exercise such warrants. Redemption of the outstanding warrants could force
you (i) to exercise your warrants and pay the exercise price therefor at a time when it may be disadvantageous for you to do so, (ii) to
sell your warrants at the then-current market price when you might otherwise wish to hold your warrants or (iii) to accept the nominal
redemption price which, at the time the outstanding warrants are called for redemption, is likely to be substantially less than the market
value of your warrants. None of the private placement warrants will be redeemable by us so long as they are held by their initial purchasers
or their permitted transferees.

 Our
warrants and founder shares may have an adverse effect on the market price of our common stock and make it more difficult to effectuate
our initial business combination.

 We
issued warrants to purchase 11,500,000 shares of our common stock as part of the units offered in our initial public offering and, simultaneously
with the closing of our initial public offering, we issued in a private placement warrants to purchase an aggregate of 5,425,000 shares
of common stock at $11.50 per share. Our initial stockholders currently own an aggregate of 2,875,000 founder shares. The founder shares
are convertible into shares of common stock on a one-for-one basis, subject to adjustment as set forth herein. In addition, if our sponsor
makes any working capital loans, up to $1,000,000 of such loans may be converted into warrants, at the price of $1.00 per warrant at
the option of the lender. Such warrants would be identical to the private placement warrants, including as to exercise price, exercisability
and exercise period.

 To
the extent we issue shares of common stock to effectuate an initial business combination, the potential for the issuance of a substantial
number of additional shares of common stock upon exercise of these warrants and conversion rights could make us a less attractive business
combination vehicle to a target business. Any such issuance will increase the number of issued and outstanding shares of our common stock
and reduce the value of the shares of common stock issued to complete the initial business combination. Therefore, our warrants and founder
shares may make it more difficult to effectuate an initial business combination or increase the cost of acquiring the target business.

 The
private placement warrants are identical to the warrants sold as part of the units in our initial public offering except that, so long
as they are held by our sponsor or its permitted transferees, (i) they will not be redeemable by us, (ii) they (including the
common stock issuable upon exercise of these warrants) may not, subject to certain limited exceptions, be transferred, assigned or sold
by our sponsor until 30 days after the completion of our initial business combination and (iii) they may be exercised by the holders
on a cashless basis.

each unit contains one-twentieth of one right, the units may be worth less than units of other blank check companies.

 Each
unit contains one-twentieth of one right. Pursuant to the rights agreement, the rights may only be exercised for a whole number of shares,
which means you must hold 20 rights in order to receive one share of common stock. We have established the components of the units in
this way in order to reduce the dilutive effect of the rights upon completion of our initial business combination. While we believe this
makes us a more attractive merger partner for target businesses, this unit structure may nevertheless cause our units to be worth less
than if they included a right to purchase one whole share.

 General
Risks

 Our
search for a business combination, and any target business with which we ultimately consummate a business combination, may be materially
adversely affected by the recent coronavirus (COVID-19) outbreak.

 In
December 2019, a novel strain of coronavirus was reported to have surfaced in Wuhan, China, which has and is continuing to spread throughout
China and other parts of the world, including the United States. On January 30, 2020, the World Health Organization declared the
outbreak of the coronavirus disease (COVID-19) a "Public Health Emergency of International Concern." On January 31,
2020, U.S. Health and Human Services Secretary Alex M. Azar II declared a public health emergency for the United States to aid the U.S.
healthcare community in responding to COVID-19, and on March 11, 2020 the World Health Organization characterized the outbreak as
a "pandemic". A significant outbreak of COVID-19 and other infectious diseases could result in a widespread health crisis
that could adversely affect the economies and financial markets worldwide, and the business of any potential target business with which
we consummate a business combination could be materially and adversely affected. Furthermore, we may be unable to complete a business
combination if continued concerns relating to COVID-19 restrict travel, limit the ability to have meetings with potential investors or
the target company's personnel, vendors and services providers are unavailable to negotiate and consummate a transaction in a timely
manner. The extent to which COVID-19 impacts our search for a business combination will depend on future developments, which are highly
uncertain and cannot be predicted, including new information which may emerge concerning the severity of COVID-19 and the actions to
contain COVID-19 or treat its impact, among others. If the disruptions posed by COVID-19 or other matters of global concern continue
for an extensive period of time, our ability to consummate a business combination, or the operations of a target business with which
we ultimately consummate a business combination, may be adversely affected in a material way.

 The
target business with which we ultimately consummate a business combination may be materially adversely affected by geopolitical conflicts
and wars.

 With
rising tensions around the world based on the current conflict between Ukraine and Russia, we may be unable to complete a business combination
if concerns related to this and other potential conflicts impact global capital markets, the ability to transfer money, currency exchange
rates, cyber attacks and infrastructure including power generation and transmission, communications, and travel. The outcome of these
conflicts or their impact cannot be predicted and may have an adverse impact in a material way on our ability to consummate a business
combination, or to operate a target business with which we ultimately consummate a business combination.

 If
we are deemed to be an investment company under the Investment Company Act, we may be required to institute burdensome compliance requirements
and our activities may be restricted, which may make it difficult for us to complete our initial business combination.

 If
we are deemed to be an investment company under the Investment Company Act, our activities may be restricted, including:

 restrictions
 on the nature of our investments; and

 restrictions
 on the issuance of securities, each of which may make it difficult for us to complete our initial business combination.

 In
 addition, we may have imposed upon us burdensome requirements, including:

 registration
 as an investment company;

 adoption
 of a specific form of corporate structure; and

 reporting,
 record keeping, voting, proxy and disclosure requirements and other rules and regulations.

 In
order not to be regulated as an investment company under the Investment Company Act, unless we can qualify for an exclusion, we must
ensure that we are engaged primarily in a business other than investing, reinvesting or trading in securities and that our activities
do not include investing, reinvesting, owning, holding or trading "investment securities" constituting more than 40% of our
total assets (exclusive of U.S. government securities and cash items) on an unconsolidated basis. Our business is to identify and complete
an initial business combination and thereafter to operate the post-transaction business or assets for the long term. We do not plan to
buy businesses or assets with a view to resale or profit from their resale. We do not plan to buy unrelated businesses or assets or to
be a passive investor.

 We
do not believe that our anticipated principal activities will subject us to the Investment Company Act. To this end, the proceeds
held in the trust account may only be invested in United States "government securities" within the meaning of
Section 2(a)(16) of the Investment Company Act having a maturity of 185 days or less or in money market funds meeting certain
conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury
obligations. Pursuant to the trust agreement, the trustee is not permitted to invest in other securities or assets. By restricting
the investment of the proceeds to these instruments, and by having a business plan targeted at acquiring and growing businesses for
the long term (rather than on buying and selling businesses in the manner of a merchant bank or private equity fund), we intend to
avoid being deemed an "investment company" within the meaning of the Investment Company Act. Our securities are not
intended for persons who are seeking a return on investments in government securities or investment securities. The trust
account is intended as a holding place for funds pending the earliest to occur of: (i) the completion of our initial business
combination; (ii) the redemption of any public shares properly submitted in connection with a stockholder vote to amend our
amended and restated certificate of incorporation (A) to modify the substance or timing of our obligation to redeem 100% of our
public shares if we do not complete our initial business combination within 18 months from the closing of our initial public
offering or (B) with respect to any other provision relating to stockholders' rights or pre-initial business combination
activity; or (iii) absent an initial business combination within 18 months from the closing of our initial public offering, our
return of the funds held in the trust account to our public stockholders as part of our redemption of the public shares. If we do
not invest the proceeds as discussed above, we may be deemed to be subject to the Investment Company Act. If we were deemed to be
subject to the Investment Company Act, compliance with these additional regulatory burdens would require additional expenses for
which we have not allotted funds and may hinder our ability to complete an initial business combination or may result in our
liquidation. If we are unable to complete our initial business combination, our public stockholders may receive only approximately
$10.595 per share on the liquidation of our trust account and our rights and warrants will expire worthless.

 We
are dependent upon our executive officers and directors and their departure could adversely affect our ability to operate.

 Our
operations are dependent upon a relatively small group of individuals and, in particular, our executive officers and directors. We believe
that our success depends on the continued service of our executive officers and directors, at least until we have completed our initial
business combination. We do not have an employment agreement with, or key-man insurance on the life of, any of our directors or executive
officers. The unexpected loss of the services of one or more of our directors or executive officers could have a detrimental effect on
us.

 The
requirements of being a public company may strain our resources and divert management's attention.

 As
a public company, we are subject to the reporting requirements of the Exchange Act, the Sarbanes Oxley Act, the Dodd-Frank Wall Street
Reform and Consumer Protection Act, the listing requirements of NASDAQ and other applicable securities rules and regulations. Compliance
with these rules and regulations increase our legal and financial compliance costs, make some activities more difficult, time-consuming
or costly and increase demand on our systems and resources, particularly after we are no longer an "emerging growth company."
The Sarbanes-Oxley Act requires, among other things, that we maintain effective disclosure controls and procedures and internal control
over financial reporting. In order to maintain and, if required, improve our disclosure controls and procedures and internal control
over financial reporting to meet this standard, significant resources and management oversight may be required. As a result, management's
attention may be diverted from other business concerns, which could adversely affect our business and operating results. We may need
to hire more employees in the future or engage outside consultants to comply with these requirements, which will increase our costs and
expenses.

 We
are an emerging growth company within the meaning of the Securities Act, and if we take advantage of certain exemptions from disclosure
requirements available to emerging growth companies, this could make our securities less attractive to investors and may make it more
difficult to compare our performance with other public companies.

 We
are an "emerging growth company" within the meaning of the Securities Act, as modified by the JOBS Act, and we may take advantage
of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth
companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of
the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements,
and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any
golden parachute payments not previously approved. As a result, our stockholders may not have access to certain information they may
deem important. We could be an emerging growth company for up to five years, although circumstances could cause us to lose that status
earlier, including if the market value of our common stock held by non-affiliates exceeds $700 million as of any June 30 before
that time, in which case we would no longer be an emerging growth company as of the following December 31. We cannot predict whether
investors will find our securities less attractive because we will rely on these exemptions. If some investors find our securities less
attractive as a result of our reliance on these exemptions, the trading prices of our securities may be lower than they otherwise would
be, there may be a less active trading market for our securities and the trading prices of our securities may be more volatile.

 Further,
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial
accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective
or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting
standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements
that apply to non-emerging growth companies but any such an election to opt out is irrevocable. We have elected not to opt out of such
extended transition period, which means that when a standard is issued or revised and it has different application dates for public or
private companies, we, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new
or revised standard. This may make comparison of our financial statements with another public company which is neither an emerging growth
company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of
the potential differences in accounting standards used.

 Compliance
obligations under the Sarbanes-Oxley Act may make it more difficult for us to effectuate our initial business combination, require substantial
financial and management resources, and increase the time and costs of completing an initial business combination.

 Section 404
of the Sarbanes-Oxley Act requires that we evaluate and report on our system of internal controls beginning with our Annual Report on
Form 10-K for the year ending December 31, 2022. Only in the event we are deemed to be a large accelerated filer or an accelerated
filer will we be required to comply with the independent registered public accounting firm attestation requirement on our internal control
over financial reporting. Further, for as long as we remain an emerging growth company, we will not be required to comply with the independent
registered public accounting firm attestation requirement on our internal control over financial reporting. The fact that we are a blank
check company makes compliance with the requirements of the Sarbanes-Oxley Act particularly burdensome on us as compared to other public
companies because a target company with which we seek to complete our initial business combination may not be in compliance with the
provisions of the Sarbanes-Oxley Act regarding adequacy of its internal controls. The development of the internal control of any such
entity to achieve compliance with the Sarbanes-Oxley Act may increase the time and costs necessary to complete any such business combination.

 Provisions
in our amended and restated certificate of incorporation and Delaware law may inhibit a takeover of us, which could limit the price investors
might be willing to pay in the future for our common stock and could entrench management.

 Our
amended and restated certificate of incorporation contains provisions that may discourage unsolicited takeover proposals that stockholders
may consider to be in their best interests. These provisions include a staggered board of directors and the ability of the board of directors
to designate the terms of and issue new series of preferred shares, which may make the removal of management more difficult and may discourage
transactions that otherwise could involve payment of a premium over prevailing market prices for our securities.

 We
are also subject to anti-takeover provisions under Delaware law, which could delay or prevent a change of control. Together these provisions
may make the removal of management more difficult and may discourage transactions that otherwise could involve payment of a premium over
prevailing market prices for our securities.

 Our
amended and restated certificate of incorporation requires, to the fullest extent permitted by law, that derivative actions brought in
our name, actions against our directors, officers, other employees or stockholders for breach of fiduciary duty and other similar actions
may be brought only in the Court of Chancery in the State of Delaware and, if brought outside of Delaware, the stockholder bringing the
suit will be deemed to have consented to service of process on such stockholder's counsel, which may have the effect of discouraging
lawsuits against our directors, officers, other employees or stockholders.

 Our
amended and restated certificate of incorporation requires, to the fullest extent permitted by law, that derivative actions brought in
our name, actions against our directors, officers, other employees or stockholders for breach of fiduciary duty and other similar actions
may be brought only in the Court of Chancery in the State of Delaware and, if brought outside of Delaware, the stockholder bringing the
suit will be deemed to have consented to service of process on such stockholder's counsel except any action (A) as to which
the Court of Chancery in the State of Delaware determines that there is an indispensable party not subject to the jurisdiction of the
Court of Chancery (and the indispensable party does not consent to the personal jurisdiction of the Court of Chancery within ten days
following such determination), (B) which is vested in the exclusive jurisdiction of a court or forum other than the Court of Chancery,
(C) for which the Court of Chancery does not have subject matter jurisdiction, or (D) any action arising under the Securities
Act, as to which the Court of Chancery and the federal district court for the District of Delaware shall have concurrent jurisdiction.
Any person or entity purchasing or otherwise acquiring any interest in shares of our capital stock shall be deemed to have notice of
and consented to the forum provisions in our amended and restated certificate of incorporation. This choice of forum provision may limit
a stockholder's ability to bring a claim in a judicial forum that it finds favorable for disputes with us or any of our directors,
officers, other employees or stockholders, which may discourage lawsuits with respect to such claims, although our stockholders will
not be deemed to have waived our compliance with federal securities laws and the rules and regulations thereunder. Alternatively, if
a court were to find the choice of forum provision contained in our amended and restated certificate of incorporation to be inapplicable
or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions, which could
harm our business, operating results and financial condition.

 Our
amended and restated certificate of incorporation provides that the exclusive forum provision will be applicable to the fullest extent
permitted by applicable law. Section 27 of the Exchange Act creates exclusive federal jurisdiction over all suits brought to enforce
any duty or liability created by the Exchange Act or the rules and regulations thereunder. As a result, the exclusive forum provision
will not apply to suits brought to enforce any duty or liability created by the Exchange Act or any other claim for which the federal
courts have exclusive jurisdiction.

 The
determination of the offering price of our units and the size of our initial public offering was more arbitrary than the pricing of securities
and size of an offering of an operating company in a particular industry. You may have less assurance, therefore, that the offering price
of our units properly reflects the value of such units than you would have in a typical offering of an operating company.

 Prior
to our public offering there has been no public market for any of our securities. The public offering price of the units and the terms
of the rights and warrants were negotiated between us and the underwriters. In determining the size of our initial public offering, management
held customary organizational meetings with representatives of the underwriters, both prior to our inception and thereafter, with respect
to the state of capital markets, generally, and the amount the underwriters believed they reasonably could raise on our behalf. Factors
considered in determining the size of our initial public offering, prices and terms of the units, including the common stock, rights
and warrants underlying the units, included:

 the
 history and prospects of companies whose principal business is the acquisition of other companies;

 prior
 offerings of those companies;

 our
 prospects for acquiring an operating business at attractive values;

 a
 review of debt-to-equity ratios in leveraged transactions;

 our
 capital structure;

 an
 assessment of our management and their experience in identifying operating companies;

 general
 conditions of the securities markets at the time of our initial public offering; and

 other
 factors as were deemed relevant.

these factors were considered, the determination of our offering price was more arbitrary than the pricing of securities of an operating
company in a particular industry since we have no historical operations or financial results.

 Our
warrant agreement and rights agreement will designate the courts of the State of New York or the United States District Court for the
Southern District of New York as the sole and exclusive forum for certain types of actions and proceedings that may be initiated by holders
of our warrants or rights, which could limit the ability of warrant or right holders to obtain a favorable judicial forum for disputes
with our company.

 Our
warrant agreement and right agreement will provide that, subject to applicable law, (i) any action, proceeding or claim against
us arising out of or relating in any way to the warrant agreement, including under the Securities Act, will be brought and enforced in
the courts of the State of New York or the United States District Court for the Southern District of New York, and (ii) that we
irrevocably submit to such jurisdiction, which jurisdiction shall be the exclusive forum for any such action, proceeding or claim. We
will waive any objection to such exclusive jurisdiction and that such courts represent an inconvenient forum.

 Notwithstanding
the foregoing, these provisions of the warrant agreement and rights agreement will not apply to suits brought to enforce any liability
or duty created by the Exchange Act or any other claim for which the federal district courts of the United States of America are the
sole and exclusive forum. Any person or entity purchasing or otherwise acquiring any interest in any of our warrants or rights shall
be deemed to have notice of and to have consented to the forum provisions in our warrant agreement or rights agreement, as applicable.
If any action, the subject matter of which is within the scope the forum provisions of the warrant agreement or rights agreement, is
filed in a court other than a court of the State of New York or the United States District Court for the Southern District of New York
(a "foreign action") in the name of any holder of our warrants or rights, such holder shall be deemed to have consented to:
(x) the personal jurisdiction of the state and federal courts located in the State of New York in connection with any action brought
in any such court to enforce the forum provisions (an "enforcement action"), and (y) having service of process made
upon such warrant holder or right holder in any such enforcement action by service upon such warrant or right holder's counsel
in the foreign action as agent for such warrant or right holder.

 This
choice-of-forum provision may limit a warrant or right holder's ability to bring a claim in a judicial forum that it finds favorable
for disputes with our company, which may discourage such lawsuits. Alternatively, if a court were to find this provision of our warrant
agreement or rights agreement inapplicable or unenforceable with respect to one or more of the specified types of actions or proceedings,
we may incur additional costs associated with resolving such matters in other jurisdictions, which could materially and adversely affect
our business, financial condition and results of operations and result in a diversion of the time and resources of our management and
board of directors.

 Risks
Relating to Restatement of Our Previously Issued Financial Statements

 Our
warrants are accounted for as liabilities and changes in the value of our warrants could have a material effect on our financial results.

 On
April 12, 2021, the SEC Staff expressed its view that certain terms and conditions common to SPAC warrants may require the warrants to
be classified as liabilities instead of equity on the SPAC's balance sheet. As a result of the SEC Staff Statement, we reevaluated
the accounting treatment of our public warrants and private placement warrants, and determined to classify the warrants as derivative
liabilities measured at fair value, with changes in fair value reported in our statement of operations for each reporting period.

 As
a result, included on our balance sheets as of December 31, 2022 and 2021, contained elsewhere in this Report are derivative liabilities
related to embedded features contained within our warrants. Accounting Standards Codification ("ASC") 815-40 provides for
the remeasurement of the fair value of such derivatives at each balance sheet date, with a resulting non-cash gain or loss related to
the change in the fair value being recognized in earnings in the statement of operations. As a result of the recurring fair value measurement,
our financial statements and results of operations may fluctuate quarterly based on factors which are outside of our control. Due to
the recurring fair value measurement, we expect that we will recognize non-cash gains or losses on our warrants each reporting period
and that the amount of such gains or losses could be material.

 We
identified a material weakness in our internal control over financial reporting. This material weakness could continue to adversely affect
our ability to report our results of operations and financial condition accurately and in a timely manner.

 Our
management is responsible for establishing and maintaining adequate internal control over financial reporting designed to provide reasonable
assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance
with GAAP. Our management also evaluates the effectiveness of our internal controls and we will disclose any changes and material weaknesses
in those internal controls identified through such evaluation. A material weakness is a deficiency, or a combination of deficiencies,
in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual
or interim financial statements will not be prevented or detected on a timely basis.

 In
our 2020 Form 10-K/A Amendment No. 1, we identified a material weakness in our internal control over financial reporting related to the
previous classification of our warrants as equity instead of liabilities. Management concluded that a deficiency in internal control
over financial reporting existed relating to the accounting treatment for complex financial instruments and that the failure to properly
account for such instruments constituted a material weakness as defined in the SEC regulations. On June 10, 2021, our audit committee
authorized management to restate our audited financial statements for the year ended December 31, 2020, and, accordingly, management
concluded that the control deficiency that resulted in the incorrect classification of our warrants constituted a material weakness as
of December 31, 2020. This material weakness resulted in a material misstatement of our warrant liabilities, change in fair value of
warrant liabilities, additional paid-in capital, accumulated deficit and related financial disclosures for our previously filed audited
balance sheet related to our initial public offering dated November 25, 2020 and our audited financial statements for the year ended
December 31, 2020.

 In
our 2020 Form 10-K/A Amendment No. 2 ("Amendment No. 2"), we identified a material weakness in our internal control over
financial reporting related to the Company's accounting treatment of all of the Public Shares as temporary equity as described
in the Explanatory Note to Amendment No. 2. The Company also recorded additional offering costs related to the excess fair value over
purchase price for the sale of indirect interests in the Representative Shares by the Company to the Company's Underwriter and
Consultant as compensation for underwriting and consulting services in connection with the Initial Public Offering, as well as recording
additional paid-in capital related to the relative fair value of the Rights, which are part of the Units issued in the Initial Public
Offering, that were not previously recorded as described in the Explanatory Note to Amendment No. 2. However, the non-cash adjustments
to the financial statements did not impact the amounts previously reported for our cash and cash equivalents, total assets, revenue or
net cash flows.

 In
our 2021 Form 10-Q/A Amendment No. 1 for the quarter ended September 30, 2021, we identified a material weakness in our internal control
over financial reporting related to the Company's accounting treatment of founder shares purchased by independent directors as
described in the Explanatory Note to 10-Q/A Amendment No. 1. Management concluded that a deficiency in internal control over financial
reporting existed relating to the accounting treatment for complex financial instruments and that the failure to properly account for
such instruments constituted a material weakness as defined in the SEC regulations. On March 9, 2022, our audit committee authorized
management to restate our unaudited financial statements for the quarter ended September 30, 2021, and, accordingly, management concluded
that the control deficiency that resulted in our not booking compensation expense for the founder shares purchased by our independent
directors constituted a material weakness as of September 30, 2021. This material weakness resulted in a material misstatement of our
compensation expense, additional paid-in capital, accumulated deficit and related financial disclosures for our previously filed unaudited
financial statements for the quarter ended September 30, 2021. However, the non-cash adjustments to the financial statements did not
impact the amounts previously reported for our cash and cash equivalents, total assets, revenue or net cash flows.

 We
have implemented a remediation plan, described under Item 9A, Evaluation of Disclosure Controls and Procedures, which remedied the material
weakness surrounding our historical presentation of our warrants, redeemable shares, representative shares, rights, and director shares
but can give no assurance that the measures we have taken will prevent any future material weaknesses or deficiencies in internal control
over financial reporting. Even though we have strengthened our controls and procedures, in the future those controls and procedures may
not be adequate to prevent or identify irregularities or errors or to facilitate the fair presentation of our financial statements.

 We
may face litigation and other risks and uncertainties as a result of the material weakness in our internal control over financial reporting
and the restatement of our financial statements.

the issuance of an SEC statement entitled "Staff Statement on Accounting and Reporting considerations for Warrants Issued by Special
Purpose Acquisition Companies" on April 12, 2021, management and our Audit Committee concluded that it was appropriate to restate
(i) certain items on the Company's previously issued audited balance sheet dated as of November 25, 2020, which was related to
our IPO, and (ii) the Company's previously issued audited financial statements as of December 31, 2020. See " —Our
warrants are accounted for as liabilities and the changes in value of our warrants could have a material effect on our financial results."
As part of such process, we identified a material weakness in our internal controls over financial reporting.

 The
Company has also re-evaluated its application of ASC 480-10-S99-SA to its accounting classification of the redeemable common stock, par
value $0.0001 per share, issued as part of the units sold in the Company's initial public offering on November 23, 2020. Management
and our Audit Committee have determined that all of the Public Shares be classified as temporary equity. In addition, the Company also
recorded additional offering costs related to the sale of common stock to the Company's Underwriters and Consultant as compensation
in connection with the IPO. Therefore, the Company restated (i) certain items on the Company's previously issued audited financial
statements as of December 31, 2021, and (ii) the unaudited interim financial statements for the quarterly periods ended June 30, 2021
and March 31, 2021.

 In
addition, the Company has re-evaluated its application of ASC 718, Compensation – Stock Compensation (Topic 718) to the
treatment of the purchase of founder shares, par value $0.0001 per share, by our independent directors from our sponsor on July 6, 2021.
Therefore, the Company's management has determined that compensation expense should have been recorded for the stock purchase at
the time of the transaction. As a result, the Company restated certain items on the Company's previously issued unaudited interim
financial statements for the quarter ended September 30, 2021.

 As
a result of such material weaknesses, the restatement of previously issued financials of the Company, the change in accounting for the
warrants and redeemable shares, and the recording of additional offering costs, and other matters raised or that may in the future be
raised by the SEC, we face potential for litigation, inquiries from the SEC and other regulatory bodies, other disputes or proceedings
which may include, among other things, monetary judgments, penalties or other sanctions, claims invoking the federal and state securities
laws and contractual claims. As of the date of this report, we have no knowledge of any such litigation, inquires, disputes or proceedings.
However, we can provide no assurance that such litigation, inquiries, disputes or proceedings will not arise in the future. Any such
litigation, inquiries, disputes or proceedings, whether successful or not, could have a material adverse effect on our business, results
of operations and financial condition or our ability to complete our initial business combination.

 ITEM 1B.
UNRESOLVED STAFF COMMENTS

 None.

 ITEM 2.
PROPERTIES

 We
maintain our principal executive offices at 955 W. John Carpenter Fwy., Suite 100-929, Irving, TX 75039. The cost of our use of this
space is included in the $5,000 per month fee we currently pay to an affiliate of our sponsor for office space, administrative and support
services. We consider our current office space adequate for our current operations.

 ITEM 3.
LEGAL PROCEEDINGS

 To
the knowledge of our management, there is no litigation currently pending or contemplated against us, any of our officers or directors
in their capacity as such or against any of our property.

 ITEM 4.
MINE SAFETY DISCLOSURES

 Not
applicable.

 PART
II

 ITEM 5.
MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

 (a)
Market Information

 Our
units commenced public trading on November 23, 2020, on the NASDAQ under the symbol "BREZU" until December 23,
2020, at which time our common stock, rights and warrants began separate trading, and units ceased trading. Our common stock, rights
and redeemable warrants are each traded on the NASDAQ under the symbol "BREZ", "BREZR" and "BREZW",
respectively.

 (b)
Holders

 On
February 15, 2023, there were 10 holders of record for our shares of common stock, 1 holder of our rights and 3 holders of our warrants.
The number of record holders was determined from the records of our transfer agent and does not include beneficial owners of our shares
of common stock whose shares are held in the names of various security brokers, dealers and registered clearing agencies.

 (c)
Dividends

 We
have not paid any cash dividends on our common stock to date and do not intend to pay cash dividends prior to the completion of an initial
business combination. The payment of cash dividends in the future will be dependent upon our revenues and earnings, if any, capital requirements
and general financial conditions subsequent to completion of an initial business combination. The payment of any cash dividends subsequent
to an initial business combination will be within the discretion of our board of directors at such time. In addition, our board of directors
is not currently contemplating and does not anticipate declaring any stock dividends in the foreseeable future. Further, if we incur
any indebtedness, our ability to declare dividends may be limited by restrictive covenants we may agree to in connection therewith.

 (d)
Securities Authorized for Issuance Under Equity Compensation Plans

 None.

 (e)
Performance Graph

 Not
applicable.

 (f)
Recent Sales of Unregistered Securities; Use of Proceeds from Registered Offerings

 Unregistered
Sales

 On
June 11, 2020, our sponsor, purchased an aggregate of 2,875,000 founder shares, for an aggregate offering price of $25,000 at an
average purchase price of approximately $0.0001 per share. Such securities were issued in connection with our organization pursuant to
the exemption from registration contained in Section 4(a)(2) of the Securities Act. Our sponsor is an accredited investor for purposes
of Rule 501 of Regulation D.

 In
addition, our sponsor and I-Bankers purchased an aggregate of 5,425,000 warrants at a price of $1.00 per warrant ($5,425,000 in the aggregate).
This purchase took place on a private placement basis simultaneously with the completion of our initial public offering. This issuance
was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act.

 Use
of Proceeds

 In
connection with the initial public offering, we incurred offering costs of $4,099,907 (including underwriting commissions of approximately
$2.3 million). Other incurred offering costs consisted principally of preparation fees related to the initial public offering. After
deducting the underwriting discounts and commissions and the initial public offering expenses, $116,725,000 of the net proceeds from
our initial public offering and certain of the proceeds from the private placement of the private placement warrants (or $10.15 per Unit
sold in the initial public offering) was placed in the trust account. The net proceeds of the initial public offering and certain proceeds
from the sale of the private placement warrants are held in the trust account and invested as described elsewhere in this Report.

 There
has been no material change in the planned use of the proceeds from our initial public offering and the sale of the private placement
warrants as is described in our final prospectus related to our initial public offering. Other than as described above, no payments were
made by us to directors, officers or persons owning ten percent or more of our common stock or to their associates, or to our affiliates.

 (g)
Purchases of Equity Securities by the Issuer and Affiliated Purchasers

 None.

 ITEM 6.
[RESERVED]

 ITEM 7.
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 References
in this report (the "Annual Report") to "we," "us" or the "Company" refer to Breeze Holdings
Acquisition Corp. References to our "management" or our "management team" refer to our officers and directors,
and references to the "Sponsor" refer to Breeze Sponsor, LLC.

 Special
Note Regarding Forward-Looking Statements

 This
Annual Report includes "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section
21E of the Exchange Act that are not historical facts and involve risks and uncertainties that could cause actual results to differ materially
from those expected and projected. All statements, other than statements of historical fact included in this Form 10-K including, without
limitation, statements in this "Management's Discussion and Analysis of Financial Condition and Results of Operations"
regarding the Company's financial position, business strategy and the plans and objectives of management for future operations,
are forward-looking statements. Words such as "expect," "believe," "anticipate," "intend,"
"estimate," "seek" and variations and similar words and expressions are intended to identify such forward-looking
statements. Such forward-looking statements relate to future events or future performance, but reflect management's current beliefs,
based on information currently available. A number of factors could cause actual events, performance or results to differ materially
from the events, performance and results discussed in the forward-looking statements.

 The
following discussion and analysis of our financial condition and results of operations should be read in conjunction with the financial
statements and the notes thereto contained elsewhere in this Annual Report. Certain information contained in the discussion and analysis
set forth below includes forward-looking statements that involve risks and uncertainties. For information identifying important factors
that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the Risk
Factors section of the Annual Report.

 Overview

 We
are a blank check company formed under the laws of the State of Delaware on June 11, 2020 for the purpose of effecting a merger,
capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination with one or more businesses.
We intend to effectuate our business combination using cash from the proceeds of the Initial Public Offering and the sale of the private
placement warrants, our capital stock, debt or a combination of cash, stock and debt.

 As
indicated in the accompanying financial statements, at December 31, 2022 and December 31, 2021, we had $14,129 and $5,403 in cash,
respectively, and working capital deficits of $5,345,736 and $1,667,202, respectively (excluding franchise tax payable and common stock
payable). We expect to continue to incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans
to complete our initial business combination will be successful.

 Results
of Operations

 We
have neither engaged in any operations nor generated any revenues to date. Our only activities from June 11, 2020 (inception) through
December 31, 2022 were organizational activities, those necessary to prepare for the Initial Public Offering, described below, and,
after our Initial Public Offering, identifying a target company for a business combination. We do not expect to generate any operating
revenues until after the completion of our business combination. We generate non-operating income in the form of interest income on marketable
securities held in the trust account, and changes in the fair value of warrant liabilities. We incur expenses as a result of being a
public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses.

 For
the year ended December 31, 2022, we had net income of $3,788,224, which consisted of a change of $5,923,750 in the fair value of
warrant liabilities, interest income from our money market account of $813, and an unrealized gain on marketable securities held in our
trust account of $188,903, offset by operating costs of $2,323,153.

 For
the year ended December 31, 2021, we had net income of $8,703,976, which consisted of a change of $10,378,500 in the fair value
of warrant liabilities, interest income from our money market account of $764, and an unrealized gain on marketable securities held in
our trust account of $47,076, offset by operating and formation costs of $1,722,364.

 Liquidity
and Capital Resources

 On
November 25, 2020, we consummated the Initial Public Offering of 11,500,000 units at a price of $10.00 per unit (including 1,500,000
units from the full exercise of the underwriters' over-allotment option), generating gross proceeds of $115,000,000. Simultaneously
with the closing of the Initial Public Offering, we consummated the sale of 5,425,000 private placement warrants to the Sponsor at a
price of $1.00 per warrant, generating gross proceeds of $5,425,000.

the Initial Public Offering, the exercise of the over-allotment option and the sale of the private placement warrants, a total of $116,725,000
was placed in the trust account. We incurred $4,099,907 in transaction costs, including $2,300,000 of underwriting fees, $1,322,350 of
representative share offering costs, and $477,557 of other offering costs.

 As
of December 31, 2022, we had cash held in the non-interest bearing trust account of $17,730,969. On May 5, 2022, the Company held
a stockholders' meeting at which a proposal to approve the extension of time to consummate the closing of a Business Combination
Agreement to September 26, 2022 was approved. The Company provided its stockholders with the opportunity to redeem all or a portion of
their Public Shares at the time of this stockholders' meeting. The stockholders who elected to redeem their shares did so for a
pro rata portion of the amount then in the Trust Account ($10.35 per share), plus any pro rata interest earned on the funds held in the
Trust Account and not previously released to the Company to pay its tax obligations. In connection with the extension proposal, 6,732,987
shares of the Company's common stock were redeemed for $69,700,628, (the "Redemption"). On May 10, 2022, $109,000 was
withdrawn from the Trust Account for payment of franchise and income taxes.

 On
September 13, 2022, the Company held its annual stockholders' meeting at which a proposal to approve the extension of time to consummate
the closing of a Business Combination Agreement to March 26, 2023 was approved. The Company provided its stockholders with the opportunity
to redeem all or a portion of their Public Shares at the time of this stockholders' meeting. The stockholders who elected to redeem
their shares did so for a pro rata portion of the amount then in the Trust Account ($10.35 per share), plus any pro rata interest earned
on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations. In connection with the
extension proposal, 3,076,817 shares of the Company's common stock were redeemed for $31,845,056 with 1,690,196 shares remaining.
On September 8, 2022, $122,247 was withdrawn from the Trust Account for payment of franchise and income taxes.

 At
the annual meeting of the Company held on September 13, 2022, the Company's stockholders approved (i) a proposal to amend
the Company's Amended and Restated Certificate of Incorporation (the "A&R COI") to authorize the Company to extend
the date of September 26, 2022, up to six (6) times for an additional one (1) month each time (ultimately until as late
as March 26, 2023) by which the Company must (a) consummate a merger, capital stock exchange, asset, stock purchase, reorganization
or other similar business combination, which we refer to as our initial business combination, or (b) cease its operations except
for the purpose of winding up if it fails to complete such initial business combination, and redeem all of the shares of common stock
of the Company included as part of the units sold in the Company's initial public offering that was consummated on November 25,
2020, and (ii) a proposal to amend the Trust Agreement to authorize the Extension and its implementation by the Company. The amended
Trust Agreement authorizes the Company's Board of Directors to extend the time to complete the Business Combination
up to six (6) times for an additional one (1) month each time (for a maximum of six one-month extensions), upon the deposit into the
Trust Account of $0.035 for each outstanding public share by the Sponsor or its designees on or prior to September 26, 2022 or such other
date as may be extended. Breeze executed its first one month extension of September 26, 2022 depositing $59,157 in the Trust
Account. On October 21, November 23, and December 20, 2022 Breeze executed the second, third and fourth one month extensions through
January 26, 2023.

 As
of December 31, 2021, we had cash and marketable securities held in the trust account of $117,931,556 (including $56,556 of unrealized
gains) consisting of U.S. Treasury Bills with a maturity of 180 days or less. Interest income on the balance in the trust account may
be used by us to pay taxes. Through December 31, 2021, we did not withdraw any interest earned on the trust account.

 For
the year ended December 31, 2022, cash used in operating activities was $3,022,729 which was due to a change in fair value of warrant
liabilities of $5,923,750, and an unrealized gain on marketable securities held in Trust Account of $189,716, offset in part by our net
income of $3,788,224, and a reduction in working capital of $697,487.

 For
the year ended December 31, 2021, cash used in operating activities was $688,415 which was due to an increase in fair value of warrant
liabilities of $10,378,500, and an unrealized gain on marketable securities held in Trust Account of $47,076, offset in part by our net
income of $8,703,976, compensation expense for common stock purchased by Directors from Sponsor of $401,000, and changes in working capital
of $632,185.

 We
intend to use substantially all of the funds held in the trust account, including any amounts representing interest earned on the trust
account (less deferred underwriting commissions and income taxes payable), to complete our business combination. To the extent that our
capital stock or debt is used, in whole or in part, as consideration to complete our business combination, the remaining proceeds held
in the trust account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions
and pursue our growth strategies.

 As
of December 31, 2022 and 2021, the Company had $14,129 and $5,403, respectively, in cash held outside of the Trust Account and working
capital deficits of $5,345,736 and $1,667,202, respectively, (excluding franchise tax payable).

 In
order to fund working capital deficiencies or finance transaction costs in connection with a business combination, the initial stockholders
or their affiliates may, but are not obligated to, loan us funds as may be required. If we complete a business combination, we would
repay such loaned amounts. In the event that a business combination does not close, we may use a portion of the working capital held
outside the trust account to repay such loaned amounts but no proceeds from our trust account would be used for such repayment. Up to
$1,000,000 of such loans may be convertible into warrants identical to the private placement warrants, at a price of $1.00 per warrant
at the option of the lender. The warrants would be identical to the private placement warrants issued to our sponsor, including as to
exercise price, exercisability and exercise period. The terms of such loans by our officers and directors, if any, have not been determined
and no written agreements exist with respect to such loans. We do not expect to seek loans from parties other than our sponsor or an
affiliate of our sponsor as we do not believe third parties will be willing to loan such funds and provide a waiver against any and all
rights to seek access to funds in our trust account.

 On
November 19, 2021, the Sponsor loaned the Company an aggregate of $1,150,000 pursuant to an unsecured promissory note to extend the date
by which the Company has to consummate a business combination from November 25, 2021 to February 25, 2022. This unsecured promissory
note is non-interest bearing and payable on the earlier of (i) the consummation of an initial Business Combination, or (ii) March

 On
February 1, 2022, the Company signed a Promissory Note with Sponsor, with a Maturity Date of March 26, 2023, for a total of up to $1,500,000.
On October 1, 2022, the Company signed an Amended Promissory Note with Sponsor, with a Maturity Date of September 26, 2023 for a total
of up to $4,000,000. As of December 31, 2022, the amount outstanding under this Promissory Note was $2,800,209 for direct working capital,
and $236,628 for monthly SPAC extension funds for the months of September, 2022 through December, 2022 for a total of $3,036,837 from
Sponsor. The Promissory Note is non-interest bearing and payable on the earlier of (i) the consummation of an initial Business
Combination, or (ii) September 26, 2023.

 On
February 18, 2022, the Sponsor loaned the Company an aggregate of $1,150,000 pursuant to an unsecured promissory note to extend the date
by which the Company has to consummate a business combination from February 25, 2022 to May 25, 2022. This unsecured promissory note
is non-interest bearing and payable on the earlier of (i) the consummation of an initial Business Combination, or (ii) March

 We
believe we will need to raise additional funds in order to meet the expenditures required for operating our business. If our estimate
of the costs of identifying a target business, undertaking in-depth due diligence and negotiating a business combination are less than
the actual amount necessary to do so, we may have insufficient funds available to operate our business prior to our business combination.
Moreover, we may need to obtain additional financing either to complete our business combination or because we become obligated to redeem
a significant number of our public shares upon consummation of our business combination, in which case we may issue additional securities
or incur debt in connection with such business combination. Subject to compliance with applicable securities laws, we would only complete
such financing simultaneously with the completion of our business combination. If we are unable to complete our business combination
because we do not have sufficient funds available to us, we will be forced to cease operations and liquidate the trust account. In addition,
following our business combination, if cash on hand is insufficient, we may need to obtain additional financing in order to meet our
obligations.

 Going
Concern

 Based
upon the above narrative, Management determined that the above conditions and/or events indicate that it may be probable that the Company
would be unable to meet its obligations as they become due within one year after the date that the financial statements as of December
31, 2022 are available to be issued. Although Management plans to address this uncertainty through a Business Combination
or through obtaining Working Capital Loans, there is no assurance that the Company's plans to consummate the Business Combination
or obtain the Working Capital Loans will be successful.

 The
accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As more fully described
in Note 1 to the financial statements, the Company's business plan is dependent on the completion of a business combination and
the Company's cash and working capital as of December 31, 2022 are not sufficient to complete its planned activities. These conditions
raise substantial doubt about the Company's ability to continue as a going concern. Management's plans in regard to these matters
are also described in Note 1. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 Off-balance
sheet financing arrangements

 We
did not have any off-balance sheet arrangements as of December 31, 2022 and 2021.

 Contractual
obligations

 On
November 19, 2021, the Sponsor loaned the Company an aggregate of $1,150,000 pursuant to an unsecured promissory note to extend the date
by which the Company has to consummate a business combination from November 25, 2021 to February 25, 2022. This unsecured promissory
note is non-interest bearing and payable on the earlier of (i) the consummation of an initial Business Combination, or (ii) March

 On
February 1, 2022, the Company signed a Promissory Note with Sponsor, with a Maturity Date of March 26, 2023, for a total of up to $1,500,000.
On October 1, 2022, the Company signed an Amended Promissory Note with Sponsor, with a Maturity Date of September 26, 2023 for a total
of up to $4,000,000. As of December 31, 2022, the amount outstanding under this Promissory Note was $2,800,209 for direct working capital,
and $236,628 for monthly SPAC extension funds for the month of September, 2022 through December, 2022 for a total of $3,036,837 from
Sponsor. The Promissory Note is non-interest bearing and payable on the earlier of (i) the consummation of an initial Business
Combination, or (ii) September 26, 2023.

 On
February 18, 2022, the Sponsor loaned the Company an aggregate of $1,150,000 pursuant to an unsecured promissory note to extend the date
by which the Company has to consummate a business combination from February 25, 2022 to May 25, 2022. This unsecured promissory note
is non-interest bearing and payable on the earlier of (i) the consummation of an initial Business Combination, or (ii) March

 We
do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities, other than an agreement
to pay Breeze Financial, Inc. a monthly fee of $5,000 for office space, administrative and support services to the Company.

 The
underwriters are entitled to a deferred fee of $0.275 per share, or $3,162,500 in the aggregate. The deferred fee will become payable
to the underwriters from the amounts held in the trust account solely in the event that we complete a business combination, subject to
the terms of the underwriting agreement.

 On
December 2, 2022, the Company signed a Merger Proxy/Business Combination Rate Agreement with Edgar Agents LLC, for SEC document preparation,
printing and filing for the merger with TV Ammo. The agreement includes an obligation to pay a Transaction Success Fee of $50,000 upon
successful completion and filing of the documents with the SEC.

 Critical
Accounting Policies

 The
preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United
States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure
of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Actual
results could materially differ from those estimates. We have identified the following critical accounting policies:

 Warrant
Liabilities

 We
account for the warrants issued in connection with our initial public offering in accordance with ASC 815-40, Derivatives and Hedging—Contracts
in Entity's Own Equity ("ASC 815"), under which the warrants do not meet the criteria for equity classification and
must be recorded as liabilities. As the warrants meet the definition of a derivative as contemplated in ASC 815, the Warrants are measured
at fair value at inception and at each reporting date in accordance with ASC 820, Fair Value Measurement, with changes in fair value
recognized in the Statement of Operations in the period of change.

 Representative
and Consultant Shares

to the underwriting agreement (the "Underwriting Agreement") between the Company and I-Bankers Securities (the "Representative"),
on November 23, 2020, the Company issued to the Representative and its designee 250,000 shares of common stock and separately agreed
to issue the Company's Consultant 15,000 shares of common stock for nominal consideration in a private placement intended to be
exempt from registration under Section 4(a)(2) of the Act. The Company accounts for the Representative Shares and Consultant Shares as
a deferred offering cost of the Initial Public Offering. Accordingly, the offering cost will be allocated to the separable financial
instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering
costs allocated to the Warrants will be expensed immediately in the Statement of Operations, while offering costs allocated to the redeemable
Public Shares will be deferred and subsequently charged to temporary stockholders' equity upon the completion of the Initial Public
Offering.

stock subject to possible redemption

 We
account for common stock subject to possible redemption in accordance with the guidance in ASC Topic 480, "Distinguishing Liabilities
from Equity". Common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair
value. Conditionally redeemable common stock (including common stock that features redemption rights that are either within the control
of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company's control) is classified
as temporary equity. At all other times, common stock is classified as stockholders' equity. Our common stock features certain
redemption rights that are considered to be outside of our control and subject to occurrence of uncertain future events. Accordingly,
common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders'
deficit section of our balance sheet.

 Net
Income (Loss) Per Share

 Net
income (loss) per share of common stock is computed by dividing net income (loss) by the weighted-average number of common shares outstanding
during the period. As the Public Shares are considered to be redeemable at fair value, and a redemption at fair value does not amount
to a distribution different than other stockholders, redeemable and non-redeemable shares of common stock are presented as one class
of shares in calculating net income (loss) per share of common stock. As a result, the calculated net income (loss) per share is the
same for redeemable and non-redeemable shares of common stock.

 Recent
Accounting Standards

 In
August 2020, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2020-06,
Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity's
Own Equity (Subtopic 815-40) ("ASU 2020-06") to simplify accounting for certain financial instruments. ASU 2020-06 eliminates
the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies
the derivative scope exception guidance pertaining to equity classification of contracts in an entity's own equity. The new standard
also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity's
own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for
all convertible instruments. ASU 2020-06 is effective January 1, 2022 and should be applied on a full or modified retrospective basis,
with early adoption permitted beginning on January 1, 2021. The Company is currently assessing the impact, if any, that ASU 2020-06 would
have on its financial position, results of operations or cash flows.

 ITEM 7A.
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 We
are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise
required under this item.

 ITEM 8.
FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

 This
information appears following Item 16 of this Amendment and is included herein by reference.

 ITEM 9.
CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

 None.

 ITEM 9A.
CONTROLS AND PROCEDURES

 Evaluation
of Disclosure Controls and Procedures

 Disclosure
controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our
reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in
the SEC's rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to
ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated
to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding
required disclosure.

 As
required by Rules 13a-15 and 15d-15 under the Exchange Act, our Chief Executive Officer and Chief Financial Officer carried out an evaluation
of the effectiveness of the design and operation of our disclosure controls and procedures as of December 31, 2022. Based upon his evaluation,
our Chief Executive Officer and Chief Financial Officer concluded that, our disclosure controls and procedures were effective.

 Management's
Report on Internal Controls Over Financial Reporting

 As
required by SEC rules and regulations implementing Section 404 of the Sarbanes-Oxley Act, our management is responsible for establishing
and maintaining adequate internal control over financial reporting. Our internal control over financial reporting is designed to provide
reasonable assurance regarding the reliability of financial reporting and the preparation of our consolidated financial statements for
external reporting purposes in accordance with GAAP. Our internal control over financial reporting includes those policies and procedures
that: (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions
of the assets of our company, (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial
statements in accordance with GAAP, and that our receipts and expenditures are being made only in accordance with authorizations of our
management and directors, and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition,
use or disposition of our assets that could have a material effect on the consolidated financial statements.

 Management
assessed the effectiveness of our internal control over financial reporting at December 31, 2022. In making these assessments, management
used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control - Integrated
Framework (2013). Based on our assessments and those criteria, management determined that we maintain effective internal control over
financial reporting as of December 31, 2022.

 This
Annual Report on Form 10-K does not include an attestation report on internal control over financial reporting from our independent registered
public accounting firm due to our status as an emerging growth company under the JOBS Act.

 Remediation
of a Prior Material Weakness

 We
previously identified and disclosed in our Form 10-K filed for the year ended December 31, 2021, as well as in our subsequent quarterly
reports, a deficiency in internal control over financial reporting that existed relating to the accounting treatment for complex financial
instruments and the failure to properly account for such instruments, which constituted a material weakness as defined in the SEC regulations.
Our management implemented additional controls which addressed complex financial instruments and their proper accounting during the year
ended December 31, 2022. These controls included risk identification and assessment, the use of third party technical accountants to
supplement management's review of complex financial instruments and new accounting pronouncements, and the enhanced use of accounting
memos, position papers, and policies regarding accounting for significant, non-routine transactions.

 During
2022, our management utilized the services of an independent accounting consulting firm, to assist with the documentation and testing
of internal controls and to review the operating effectiveness of these internal controls performed by management. These actions resulted
in an improved internal control environment that was in place for a period of time to allow for our management to conclude that we have
fully remediated this material weakness as of December 31, 2022.

 Changes
in Internal Control over Financial Reporting

 Except
as set forth above, during the most recently completed fiscal quarter, there has been no change in our internal control over financial
reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that has materially affected, or is reasonably likely
to materially affect, our internal control over financial reporting.

 ITEM 9B.
OTHER INFORMATION.

 None.

 ITEM
9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS.

 Not
applicable.

 PART
III

 ITEM
10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

 Directors
and Executive Officers

 As
of the date of this Report our directors and officers are as follows:

 Name

 Age

 Title

 J.
 Douglas Ramsey, Ph. D.

 Chairman,
 Chief Executive Officer and Chief Financial Officer

 Russell
 D. Griffin

 President
 and Director

 Charles
 C. Ross, P.E.

 Chief
 Operating Officer

 James
 L. Williams

 Independent

 Albert
 McLelland

 Independent

 Robert
 Lee Thomas

 Independent

 Bill
 Stark

 Independent

 J.
Douglas Ramsey, Ph. D. has served as our Chairman, Chief Executive Officer and Chief Financial Officer since June 2020. Dr. Ramsey
was the President and Chief Financial Officer of Saddle Operating and served in that role from May 2014 until February 2019. Prior to
joining Saddle Operating, Dr. Ramsey served as the Director of Strategic Planning and Special Projects of EXCO from June 2013 until
April 2014, Vice President – Finance and Special Assistant to the Chairman of EXCO Resources from August 2009 until May 2013 and
as Treasurer of EXCO Resources from December 1997 until May 2013. From December 1997 until July 2009, Dr. Ramsey served as EXCO
Resources' Chief Financial Officer during which time EXCO Resources completed over 160 transactions and its assets grew from $3
million to over $6 billion with over 15,000 wells and more than 1,400 employees and contractors. Dr. Ramsey also played a key role
in EXCO Resources' $698 million IPO in February 2006 after EXCO Resources had gone private in July 2003. Other key financing transactions
in which Dr. Ramsey was involved included a $2 billion mandatory convertible preferred stock offering, a $2.4 billion line of credit
with 34 banks in the syndicate, and two bond offerings totaling $750 million. Dr. Ramsey also served as a director of EXCO Resources
from March 1998 until July 2003. From March 1992 until December 1997, Dr. Ramsey worked for Coda Energy as the Financial Analyst
and Assistant to the President and then as the Financial Planning Manager. Dr. Ramsey also taught finance at various universities
including Southern Methodist University in its undergraduate and professional MBA programs and Baylor University in its Executive MBA
program. Dr. Ramsey was named the 1996 Distinguished Alumnus of the College of Business Administration at Cal Poly Pomona. Dr. Ramsey
earned his BS in Finance from Cal Poly Pomona, an MBA from the University of Chicago Booth School of Business and an MA and Ph. D. in
Business and Financial Economics from the Claremont Graduate University. Dr. Ramsey is National Association of Corporate Directors
(NACD) Directorship Certified. Dr. Ramsey is well qualified to serve as a director because of his strong financial background, including
his 29 years of experience as a financial executive.

 Russell
D. Griffin has served as our President and as a director since June 2020. Mr. Griffin was the Chief Operating Officer of Saddle
Operating and served in that role from November 2015 until June 2019. Prior to joining Saddle Operating, Mr. Griffin served as the
Vice President of Environmental, Health and Safety of EXCO Resources from June 2010 until November 2015, and as the Vice President of
Environmental, Health and Safety of TGGT Holdings, an independent midstream oil and gas company, from 2012 until 2013. Prior to joining
EXCO Resources, Mr. Griffin was the Senior Regulatory Representative for Hunt Oil Company, an independent international oil and
natural gas company, from August 2005 until January 2008 and held positions in exploration and production operations from August 1984
until August 2005. His areas of expertise include onshore U.S conventional and non-conventional, offshore Gulf of Mexico Outer Continental
Shelf (OCS) as well as State waters of both Louisiana and Texas. Mr. Griffin has also led or participated in multiple acquisitions
and divestitures, both domestic and international. He is a member of the American Association of Drilling Engineers, Society of Petroleum
Engineers and American Association of Safety Professionals. Mr. Griffin received his BS degree in Petroleum Engineering Technology
and an AS degree in Safety Management from Nicholls State University. Mr. Griffin is National Association of Corporate Directors
(NACD) Directorship Certified. Mr. Griffin is well qualified to serve as a director because of his more than 35 years of diverse
experience in management, operations, drilling, regulatory compliance and EHS in the oil and gas industry with an in-depth knowledge
of federal, state and local compliance requirements with governmental regulations and standards.

 Charles
C. Ross, P.E. has served as our Chief Operating Officer since June 2020. Mr. Ross was the Vice President of Regulatory
Affairs and EHS of Saddle Operating and served in that role from December 2015 until June 2019. In January 2010 until December 2013,
Mr. Ross was the Director of Regulatory Affairs of TGGT Midstream. In August 2012, Mr. Ross was named Director of
Regulatory Affairs for EXCO Resources, as well, until November 2015. Mr. Ross began his career in 1982 working for the Railroad
Commission of Texas Oil and Gas Division as a New Field Discovery Examiner. Mr. Ross continued working for the RRC for 27 more
years in various positions including Engineering Supervisor of the Underground Injection Control Section, District Engineer,
Assistant District Director, and Director of Field Operations. As Director of Field Operations, Mr. Ross oversaw nine district
offices and 247 employees. Mr. Ross is an expert witness at Railroad Commission hearings, civil trials, legislative committee
meetings, and legislative hearings on various issues related to oil and gas regulatory and technical matters. Mr. Ross has been
a registered Professional Engineer (Petroleum) since 1988, and currently serves as the Chair of the TIPRO (Texas Independent
Producers and Royalty Association) Regulatory Committee. Mr. Ross received his BS in Architectural Engineering and a BS in
Petroleum Engineering both from the University of Texas at Austin.

 On
August 10, 2022, Dan Hunt resigned from the Board of Directors (the "Board") of Breeze Holdings Acquisition Corp. (the "Company"),
including his roles as a member of the audit committee, and the chairman of the nominating and corporate governance committee. Mr. Hunt
informed the Company that his decision to resign as a director and committee member was due to personal reasons and that there was no
disagreement with the Company on any matter relating to the Company's operations, policies or practices.

 On
August 12, 2022, the Board, upon recommendation of the nominating and corporate governance committee, appointed James L. Williams to
fill the vacancies created by Mr. Hunt's resignation from the Board, including the roles as a member of the audit committee and
the chairman of the nominating and corporate governance committee. Mr. Williams serves as a Class I director of the Board.

 James
L. Williams began serving as a director in August 2022. General Williams served in the United States Marine Corps
for over 35 years, most recently as a Major General, 4th Marine Division, where he commanded Marines at every level in combat operations
and readiness until he retired from military service in 2010. During the Global War on Terrorism, General Williams held positions as
Assistant Division Commander, 2nd Marine Division, in combat operations at Camp Blue Diamond, Al-Ramadi, Iraq and as Deputy Commanding
General, 1st Marine Expeditionary Force in Fallujah, Iraq. General Williams also served on the Secretary of Defense's Reserve Force
Policy Board, and included in his military decorations are the Defense Meritorious Service Medal, Legion of Merit, Bronze Star Medal,
Meritorious Service Medal, and the National Defense Medal, to name a few. General Williams currently serves as Chief Executive Officer
and Chairman of Zenneck Power LLC. General Williams received a Bachelor of Science Degree from Slippery Rock University, PA and
reported to Officer Candidate School, receiving his commission in 1976. His education includes Master's Degrees from Georgetown
University in Government and National Affairs, and Yale University in Hospital Management and Public Health. He has completed program
studies at Harvard's JFK School of Government in the National and International Studies Program. General Williams has completed
the LOGTECH Program, Center of Excellence in Logistics and Technology, University of North Carolina, Kenan-Flagler Business School, Chapel
Hill, North Carolina and a Master of Science in Strategic Studies, U.S. Army War College, Carlisle Barracks, Carlisle, Pennsylvania.
General Williams has served on boards of directors and/or boards of advisors of for-profit companies, including Zenneck Power, LLC, Rewards.com/RewardToken. IO,
PayFor All, LLC, Mobile Equity Corporation (d.b.a. Qruz), and DCG International. In the non-profit sector, General Williams served with
the Board of International Learning of Texas Public Charter School District, the Tower Center at Southern Methodist University, Cybercrime
Committee of the North Texas Crime Commission, the Tarleton State Criminal Justice Program, the Admiral Nimitz Foundation and National
Museum of the Pacific War, the American Board of Physician Specialties and Disaster Medicine Committee, the Veterans Coalition of North
Central Texas, the VA Medical Center of North Texas, the World Craniofacial Foundation, and the Bridge-Homeless Program. General Williams
also spends time helping Veterans and surviving spouses fight for the benefits and services they so rightfully deserve. General Williams
is well qualified to serve as a director based on his demonstrated leadership during his outstanding military career, and as a result
of his experience with both for-profit and non-profit organizations.

 Albert
McLelland has served as a director since November 2020. Mr. McLelland is the Interim CEO of Spout Analytics, Inc., a digital transformation
company, since 2020. From 2014 until 2019, Mr. McLelland served as the Managing Director Asia and Chief Executive Officer of Hover Energy
LLC and its related companies. From 1998 until 2002, Mr. McLelland was the Director of the Chairman's Asian Cross-Border Transactions
Initiative for PricewaterhouseCoopers. Prior to PricewaterhouseCoopers, between 1993 and 1998, Mr. McLelland founded and sold Pearl Delta
Capital Corp. in Taiwan. From 1991 until 1993, Mr. McLelland was Senior Manager for Corporate Finance at CEF Taiwan Limited. In
1990, Mr. McLelland assisted in the formation of Riddell*Tseng where he worked until 1993. Mr. McLelland started his career
at Shearson Lehman as an Associate in Public Finance in 1987 until 1990. Mr. McLelland has served as a Director, Audit Committee
Chairman and Special Committee Chairman for a number of public and private companies. Mr. McLelland has also been an Adjunct Professor
at Southern Methodist University's Caruth Institute for Entrepreneurship in the Cox School of Business. Mr. McLelland received
his BA in Political Science and History from the University of South Florida, an MBA from the University of Chicago Booth School of Business
and an MA in International Affairs from Columbia University. Mr. McLelland is National Association of Corporate Directors (NACD)
Directorship Certified. Mr. McLelland is well qualified to serve as a director because of his extensive operating, capital markets
and corporate governance experience including multiple director roles on behalf of Carlyle Group and other prominent financial services
firms.

 Robert
Lee Thomas has served as a director since November 2020. Mr. Thomas was Vice President and Chief Information Officer at
Kosmos Energy from 2015 until May 2020. In this role, Mr. Thomas had corporate information systems oversight, as well as
geotechnical systems strategy responsibility. Prior to Kosmos, Mr. Thomas was a corporate officer and Chief Information Officer
at EXCO Resources from 2008 until 2015. In addition to corporate information systems oversight, Mr. Thomas had responsibility
for the geoscience personnel and technology. From 1994 until 2006, Mr. Thomas held a series of roles, from geotechnical systems
leadership to international business management to Chief Information Officer at Burlington Resources Canada with Burlington
Resources Oil and Gas. Following the acquisition of Burlington Resources by ConocoPhillips in 2006, Mr. Thomas co-led the
integration of systems into ConocoPhillips, earning a President's Award, and was Director of IT Strategy and Architecture at
ConocoPhillips until 2008. From 1981 until 1994, Mr. Thomas held a series of roles from geophysical seismic acquisition and
processing to exploration system development in the exploration technology groups with Sun Oil Company and the Oryx Energy spinoff.
Mr. Thomas earned his BS in Economics and Finance from The University of Texas at Dallas. Mr. Thomas was elected and
served on the City Council in Murphy, Texas, was a former member of the Advisory Board at the University of North Texas school of
Information Technology Decision Sciences and has been an active member of the Society of Exploration Geophysicists for over 25
years. Mr. Thomas is National Association of Corporate Directors (NACD) Directorship Certified. Mr. Thomas is well qualified to
serve as director, having been involved with many aspects of international oil and gas company management, including many
multibillion-dollar corporate acquisitions and integrations.

 Bill
Stark has served as a director since November 2020. Mr. Stark currently serves as Senior Vice President of the Americas, and
previous served as the Vice President—Western U.S. Operations of Ulterra from August 2017 to March 2021. Mr. Stark has operated
in different executive positions over the Permian since joining Ulterra. In December 2009, Mr. Stark became the District Manager
over the Permian. In January 2012, Mr. Stark was promoted to Area Manager for Ulterra—Permian. Prior to this, he was an agent
for Halliburton—Security DBS, as well as President/Owner of Permian Bit Service Inc. and Permian Equipment Rentals Inc. Mr. Stark
was one of the first to successfully introduce and continually market PDC bits in the Spraberry Trend. He has over 40 years of experience
in the oil industry, all of which were with Halliburton before joining Ulterra. Mr. Stark led a team in the Permian that became
one of the largest revenue districts in the U.S. for Halliburton-Security DBS. From 2012 to 2017, Mr. Stark operated as the Director
of National Sales which grew Ulterra into becoming number one in market share in the U.S. In addition to his success with Ulterra, in
2012, Mr. Stark also became President and CEO of Cactus Fuel, LLC while continuously maintaining his role at Ulterra. Mr. Stark
lives in Midland, Texas. Mr. Stark is well qualified to serve as a director because of his extensive energy services experience,
ability to grow profitable companies, vast network with oil and gas producers and leadership skills.

 Number
and Terms of Office of Officers and Directors

 Our
board of directors is divided into two classes with only one class of directors being elected in each year and each class (except for
those directors appointed prior to our first annual meeting of stockholders) serving a two-year term. The class I directors will consist
of Messrs. Griffin, Stark and Williams. The class II directors will consist of Messrs. Ramsey, McLelland and Thomas.

 Our
officers are elected by the board of directors and serve at the discretion of the board of directors, rather than for specific terms
of office. Our board of directors is authorized to appoint persons to the offices set forth in our bylaws as it deems appropriate. Our
bylaws provide that our officers may consist of a Chief Executive Officer, President, Chief Financial Officer, Vice Presidents, Secretary,
Assistant Secretaries, Treasurer and such other offices as may be determined by the board of directors.

 Involvement
in Certain Legal Proceedings

 There
is no material litigation, arbitration or governmental proceeding currently pending against us or any members of our management team
in their capacity as such.

Independence

 NASDAQ
listing standards require that a majority of our board of directors be independent. An "independent director" is defined
generally as a person other than an officer or employee of the company or its subsidiaries or any other individual having a relationship
which in the opinion of the company's board of directors, would interfere with the director's exercise of independent judgment
in carrying out the responsibilities of a director. Our board of directors has determined that each of Mr. Hunt, Mr. McLelland,
Mr. Thomas and Mr. Stark are "independent directors" as defined in NASDAQ listing standards and applicable SEC
rules. Our independent directors have regularly scheduled meetings at which only independent directors are present.

 Committees
of the Board of Directors

 Our
board of directors has three standing committees: an audit committee, a compensation committee, and a nominating and corporate governance
committee. Each committee operates under a charter that has been approved by our board and has the composition and responsibilities described
below. Our audit committee, compensation committee and nominating and corporate governance committee are composed solely of independent
directors.

 Audit
Committee

 Messrs.
McLelland, Thomas and Williams serve as members of our audit committee, and Mr. McLelland serves as its chairman. Under the NASDAQ
listing standards and applicable SEC rules, we are required to have at least three members on the audit committee. The rules of NASDAQ
and Rule 10A-3 of the Exchange Act require that the audit committee of a listed company be comprised solely of independent directors.
Messrs. McLelland, Thomas and Willaims qualify as independent directors under applicable rules. Each member of the audit committee is
financially literate and our board of directors has determined that Mr. McLelland qualifies as an "audit committee financial
expert" as defined in applicable SEC rules.

 We
adopted an audit committee charter, which details the principal functions of the audit committee, including:

 the
 appointment, compensation, retention, replacement, and oversight of the work of the independent registered accounting firm and any
 other independent registered public accounting firm engaged by us;

 pre-approving
 all audit and non-audit services to be provided by the independent registered accounting firm or any other registered public accounting
 firm engaged by us, and establishing pre-approval policies and procedures;

 and discussing with the independent registered accounting firm all relationships the auditors have with us in order to evaluate their
 continued independence;

 setting
 clear hiring policies for employees or former employees of the independent registered accounting firm;

 setting
 clear policies for audit partner rotation in compliance with applicable laws and regulations; (i) obtaining and reviewing a report,
 at least annually, from the independent registered accounting firm describing (ii) the independent registered accounting firm's
 internal quality-control procedures and (ii) any material issues raised by the most recent internal quality-control review,
 or peer review, of the audit firm, or by any inquiry or investigation by governmental or professional authorities, within, the preceding
 five years respecting one or more independent audits carried out by the firm and any steps taken to deal with such issues;

 and approving any related party transaction required to be disclosed pursuant to Item 404 of Regulation S-K promulgated by the
 SEC prior to us entering into such transaction; and

 with management, the independent registered accounting firm, and our legal advisors, as appropriate, any legal, regulatory or compliance
 matters, including any correspondence with regulators or government agencies and any employee complaints or published reports that
 raise material issues regarding our financial statements or accounting policies and any significant changes in accounting standards
 or rules promulgated by the Financial Accounting Standards Board, the SEC or other regulatory authorities.

 Compensation
Committee

 Messrs.
McLelland, Thomas and Stark serve as members of our compensation committee, and Mr. Thomas serves as its chairman. Under the NASDAQ
listing standards and applicable SEC rules, we are required to have at least two members on the compensation committee, all of whom must
be independent.

 We
adopted a compensation committee charter, which details the principal functions of the compensation committee, including:

 and approving on an annual basis the corporate goals and objectives relevant to our Chief Executive Officer's compensation,
 evaluating our Chief Executive Officer's performance in light of such goals and objectives and determining and approving the
 remuneration (if any) of our Chief Executive Officer's based on such evaluation;

 and approving the compensation of all of our other executive officers;

 our executive compensation policies and plans;

 implementing
 and administering our incentive compensation equity-based remuneration plans;

 assisting
 management in complying with our proxy statement and annual report disclosure requirements;

 approving
 all special perquisites, special cash payments and other special compensation and benefit arrangements for our executive officers
 and employees;

 producing
 a report on executive compensation to be included in our annual proxy statement; and

 reviewing,
 evaluating and recommending changes, if appropriate, to the remuneration for directors.

 The
charter also provides that the compensation committee may, in its sole discretion, retain or obtain the advice of a compensation consultant,
legal counsel or other adviser and will be directly responsible for the appointment, compensation and oversight of the work of any such
adviser. However, before engaging or receiving advice from a compensation consultant, external legal counsel or any other adviser, the
compensation committee will consider the independence of each such adviser, including the factors required by NASDAQ and the SEC.

 Nominating
and Corporate Governance Committee

 Messrs.
Williams, Thomas and Stark serve as members of our nominating and corporate governance committee, and Mr. Williams serves as its
chairman.

 The
primary purposes of our nominating and corporate governance committee is to assist the board in:

 identifying,
 screening and reviewing individuals qualified to serve as directors and recommending to the board of directors candidates for nomination
 for election at the annual meeting of stockholders or to fill vacancies on the board of directors;

 developing,
 recommending to the board of directors and overseeing implementation of our corporate governance guidelines;

 coordinating
 and overseeing the annual self-evaluation of the board of directors, its committees, individual directors and management in the governance
 of the company; and

 on a regular basis our overall corporate governance and recommending improvements as and when necessary.

 The
nominating and corporate governance committee is governed by a charter that complies with the rules of the NASDAQ.

 Code
of Ethics

 We
have adopted a code of ethics that applies to our officers and directors. We have filed copies of our code of ethics, our audit committee
charter, our compensation committee charter, and our nominating and corporate governance committee as exhibits to our registration statement
in connection with our initial public offering. You may review these documents by accessing our public filings at the Commission's
website at www.sec.gov. In addition, a copy of the code of ethics will be provided without charge upon request to us.

 Conflicts
of Interest

 I-Bankers
and its affiliates engage in a broad spectrum of activities including principal investing, specialized investment vehicle management,
asset management, financial advisory, securities underwriting, sales and trading, investment research, lending and other activities.
In the ordinary course of business, they engage in activities where their interests or the interests of their clients may conflict with
our interests. Accordingly, there may be situations in which I-Bankers or an affiliate has an obligation or an interest that actually
or potentially conflicts with our interests. You should assume that these conflicts will not be resolved in our favor and, as a result,
we may be denied certain acquisition opportunities or otherwise disadvantaged in certain situations by our relationship with I-Bankers.

 I-Bankers,
its affiliates and their clients make investments in a variety of different businesses and may directly compete with us for acquisition
opportunities provided or created by I-Bankers or its affiliates that meet our initial business combination objectives. Neither I-Bankers
nor any of its affiliates has an obligation to offer potential acquisition opportunities to us and may allocate them at its discretion
to us or other parties. We will not have any priority in respect of acquisition opportunities provided or created by I-Bankers or its
affiliates. You should assume that I-Bankers and its affiliates and clients will have priority over us in terms of access to acquisition
opportunities and, as a result, we may be denied certain acquisition opportunities or otherwise disadvantaged in certain situations by
our relationship with I-Bankers.

 Clients
of I-Bankers and its affiliates may also compete with us for investment opportunities meeting our initial business combination objectives.
If I-Bankers or any of its affiliates is engaged to act for any such clients, we may be precluded from pursuing opportunities that would
conflict with I-Bankers' or its affiliates' obligations to such client. In addition, investment ideas generated within I-Bankers
or its affiliates may be suitable for our company or a client of I-Bankers or its affiliates, and may be directed to any of such persons
or entities rather than to us. I-Bankers or its affiliates may also be engaged to advise the seller of a company, business or assets
that would qualify as an acquisition opportunity for us. In such cases, we may be precluded from participating in the sale process or
from purchasing the company, business or assets. If, however, we are permitted to pursue the opportunity, the interests of I-Bankers
or its affiliates, or their obligations to the seller, may diverge from our interests.

 Each
of our officers and directors presently has, and any of them in the future may have additional, fiduciary or contractual obligations
to another entity pursuant to which such officer or director is or will be required to present a business combination opportunity to
such entity. Accordingly, if any of our officers or directors becomes aware of a business combination opportunity which is suitable
for an entity to which he or she has then- current fiduciary or contractual obligations, he or she will honor these fiduciary
obligations under applicable law. We do not believe, however, that the fiduciary duties or contractual obligations of our officers
or directors will materially affect our ability to complete our business combination. Our amended and restated certificate of
incorporation provides that we renounce our interest in any corporate opportunity offered to any director or officer unless such
opportunity is expressly offered to such person solely in his or her capacity as a director or officer of our company and such
opportunity is one we are legally and contractually permitted to undertake and would otherwise be reasonable for us to
pursue.

 Our
sponsor and executive officers have agreed, pursuant to a written letter agreement, not to participate in the formation of, or become
an officer of, any other blank check company until we have entered into a definitive agreement regarding our initial business combination
or we have failed to complete our initial business combination within 18 months after the closing of our initial public offering; provided
that this agreement would not prevent our executive officers from serving as directors in other blank check companies. Neither Bankers
nor any of its affiliates has entered into such an agreement, and, accordingly, are not precluded from participating in any other blank
check company or from underwriting an offering by any other blank check company. Potential investors should also be aware of the following
other potential conflicts of interest:

 None
 of our officers or directors is required to commit his or her full time to our affairs and, accordingly, may have conflicts of interest
 in allocating his or her time among various business activities.

 In
 the course of their other business activities, our officers and directors may become aware of investment and business opportunities
 which may be appropriate for presentation to us as well as the other entities with which they are affiliated. Our management may
 have conflicts of interest in determining to which entity a particular business opportunity should be presented. For a complete description
 of our management's other affiliations, see "— Directors and Executive Officers."

 Our
 initial stockholders have agreed to waive their redemption rights with respect to their founder shares and public shares in connection
 with the consummation of our initial business combination. Additionally, our initial stockholders have agreed to waive their redemption
 rights with respect to their founder shares if we fail to consummate our initial business combination within 18 months after the
 closing of our initial public offering. If we do not complete our initial business combination within such applicable time period,
 the proceeds of the sale of the private placement warrants will be used to fund the redemption of our public shares, and the private
 placement warrants will expire worthless. With certain limited exceptions, the founder shares will not be transferable, assignable
 or salable by the holder of such shares until the earlier of (1) one year after the completion of our initial business combination
 and (2) the date on which we consummate a liquidation, merger, capital stock exchange, reorganization, or other similar transaction
 after our initial business combination that results in all of our stockholders having the right to exchange their shares of common
 stock for cash, securities or other property. Notwithstanding the foregoing, if the last sale price of our common stock equals or
 exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any
 20 trading days within any 30-trading day period commencing at least 90 days after our initial business combination, the founder
 shares will be released from the lock-up. With certain limited exceptions, the private placement warrants and the common stock underlying
 such warrants, will not be transferable, assignable or salable by our sponsor until 30 days after the completion of our initial business
 combination. Since our sponsor and officers and directors directly or indirectly own common stock and warrants following our initial
 public offering, our officers and directors may have a conflict of interest in determining whether a particular target business is
 an appropriate business with which to effectuate our initial business combination.

 Our
 officers and directors may have a conflict of interest with respect to evaluating a particular business combination if the retention
 or resignation of any such officers and directors was included by a target business as a condition to any agreement with respect
 to our initial business combination.

 Our
 sponsor, officers or directors may have a conflict of interest with respect to evaluating a business combination and financing arrangements
 as we may obtain loans from our sponsor or an affiliate of our sponsor or any of our officers or directors to finance transaction
 costs in connection with an intended initial business combination. Up to $1,000,000 of such loans may be convertible into warrants
 at a price of $1.00 per warrant at the option of the lender. Such warrants would be identical to the private placement warrants,
 including as to exercise price, exercisability and exercise period.

 We
 have engaged certain I-Bankers as advisors in connection with our business combination to assist us in holding meetings with our
 stockholders to discuss the potential business combination and the target business's attributes, introduce us to potential
 investors that are interested in purchasing our securities in connection with the potential business combination, assist us in obtaining
 stockholder approval for the business combination and assist us with our press releases and public filings in connection with the
 business combination. We will pay the I-Bankers a cash fee for such services upon the consummation of our initial business combination
 in an amount equal to, in the aggregate, 2.75% of the gross proceeds of our initial public offering, including any proceeds from
 the full or partial exercise of the over- allotment option.

 The
conflicts described above may not be resolved in our favor.

 In
general, officers and directors of a corporation incorporated under the laws of the State of Delaware are required to present business
opportunities to a corporation if:

 the
 corporation could financially undertake the opportunity;

 the
 opportunity is within the corporation's line of business; and

 it
 would not be fair to the corporation and its stockholders for the opportunity not to be brought to the attention of the corporation.

 Accordingly,
as a result of multiple business affiliations, our officers and directors may have similar legal obligations relating to presenting business
opportunities meeting the above-listed criteria to multiple entities. Furthermore, our amended and restated certificate of incorporation
provides that the doctrine of corporate opportunity will not apply with respect to any of our officers or directors in circumstances
where the application of the doctrine would conflict with any fiduciary duties or contractual obligations they may have. We do not believe
that these contractual obligations will materially affect our ability to complete our business combination. Our amended and restated
certificate of incorporation provides that we renounce our interest in any corporate opportunity offered to any director or officer unless
such opportunity is expressly offered to such person solely in his or her capacity as a director or officer of our company and such opportunity
is one we are legally and contractually permitted to undertake and would otherwise be reasonable for us to pursue.

 We
are not prohibited from pursuing an initial business combination with a company that is affiliated with our sponsor, officers or directors.
In the event we seek to complete our initial business combination with such a company, we, or a committee of independent directors, would
obtain an opinion from an independent investment banking firm which is a member of FINRA, or from an independent accounting firm other
than our registered independent public accounting firm, that such an initial business combination is fair to our company from a financial
point of view.

 In
the event that we submit our initial business combination to our public stockholders for a vote, our initial stockholders have agreed
to vote their founder shares and any public shares purchased during or after our initial public offering in favor of our initial business
combination and our officers and directors have also agreed to vote any public shares purchased during or after our initial public offering
in favor of our initial business combination.

 Limitation
on Liability and Indemnification of Officers and Directors

 Our
amended and restated certificate of incorporation provides that our officers and directors will be indemnified by us to the fullest extent
authorized by Delaware law, as it now exists or may in the future be amended. In addition, our amended and restated certificate of incorporation
provides that our directors will not be personally liable for monetary damages to us or our stockholders for breaches of their fiduciary
duty as directors, unless they violated their duty of loyalty to us or our stockholders, acted in bad faith, knowingly or intentionally
violated the law, authorized unlawful payments of dividends, unlawful stock purchases or unlawful redemptions, or derived an improper
personal benefit from their actions as directors.

 We
entered into agreements with our officers and directors to provide contractual indemnification in addition to the indemnification provided
for in our amended and restated certificate of incorporation. Our bylaws also will permit us to secure insurance on behalf of any officer,
director or employee for any liability arising out of his or her actions, regardless of whether Delaware law would permit such indemnification.
We will purchase a policy of directors' and officers' liability insurance that insures our officers and directors against
the cost of defense, settlement or payment of a judgment in some circumstances and insures us against our obligations to indemnify our
officers and directors. Except with respect to any public shares they may acquire after our initial public offering (in the event we
do not consummate an initial business combination), our officers and directors have agreed to waive (and any other persons who may become
an officer or director prior to the initial business combination will also be required to waive) any right, title, interest or claim
of any kind in or to any monies in the trust account, and not to seek recourse against the trust account for any reason whatsoever, including
with respect to such indemnification.

 These
provisions may discourage stockholders from bringing a lawsuit against our directors for breach of their fiduciary duty. These provisions
also may have the effect of reducing the likelihood of derivative litigation against officers and directors, even though such an action,
if successful, might otherwise benefit us and our stockholders. Furthermore, a stockholder's investment may be adversely affected
to the extent we pay the costs of settlement and damage awards against officers and directors pursuant to these indemnification provisions.

 We
believe that these provisions, the directors' and officers' liability insurance and the indemnity agreements are necessary
to attract and retain talented and experienced officers and directors.

 ITEM
11. EXECUTIVE COMPENSATION

 Officer
and Director Compensation

 None
of our executive officers or directors have received any cash compensation for services rendered to us. Until the earlier of consummation
of our initial business combination and our liquidation, beginning on the effective date of this registration statement, we will pay
Breeze Financial, an affiliate of our sponsor, a total of $5,000 per month for office space, utilities, secretarial support and other
administrative and consulting services. Our sponsor, executive officers and directors, or any of their respective affiliates, will be
reimbursed for any out-of-pocket expenses incurred in connection with activities on our behalf such as identifying potential target businesses
and performing due diligence on suitable business combinations. Our audit committee will review on a quarterly basis all payments that
were made to our sponsor, officers, directors or our or their affiliates.

 After
the completion of our initial business combination, directors or members of our management team who remain with us may be paid consulting,
management or other fees from the combined company. All of these fees will be fully disclosed to stockholders, to the extent then known,
in the tender offer materials or proxy solicitation materials furnished to our stockholders in connection with a proposed business combination.
It is unlikely the amount of such compensation will be known at the time, because the directors of the post-combination business will
be responsible for determining executive officer and director compensation. Any compensation to be paid to our executive officers will
be determined by a compensation committee constituted solely by independent directors.

 We
do not intend to take any action to ensure that members of our management team maintain their positions with us after the consummation
of our initial business combination, although it is possible that some or all of our executive officers and directors may negotiate employment
or consulting arrangements to remain with us after the initial business combination. The existence or terms of any such employment or
consulting arrangements to retain their positions with us may influence our management's motivation in identifying or selecting
a target business but we do not believe that the ability of our management to remain with us after the consummation of our initial business
combination will be a determining factor in our decision to proceed with any potential business combination. We are not party to any
agreements with our executive officers and directors that provide for benefits upon termination of employment.

 ITEM
12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

 The
following table sets forth information regarding the beneficial ownership of our common stock as of February 15, 2022 based on information
obtained from the persons named below, with respect to the beneficial ownership of our shares of common stock, by:

 each
 person known by us to be the beneficial owner of more than 5% of our outstanding shares of common stock;

 each
 of our executive officers and directors that beneficially owns shares of our common stock; and

 all
 our executive officers and directors as a group.

 Unless
otherwise indicated, we believe that all persons named in the table have sole voting and investment power with respect to all shares
of common stock beneficially owned by them.

 The
beneficial ownership of our shares of common stock is based on 4,830,196 shares of common stock issued and outstanding as of February
28, 2023.

 Common Stock

 Approximate

 Percentage of

 Number of Shares

 Outstanding

 Name of Beneficial Owner (1)

 Beneficially Owned

 Common Stock

 Breeze Sponsor, LLC

 2,475,000

 51.2
 %

 J. Douglas Ramsey, Ph. D. (2)

 2,475,000

 51.2
 %

 Russell D. Griffin (3)

 —

 *

 Charles C. Ross (3)

 —

 *

 Albert McLelland

 25,000

 *

 Bill Stark

 25,000

 *

 Robert Lee Thomas

 25,000

 *

 James L. Williams

 —

 *

 All directors and executive officers as a group (7 individuals)

 2,550,000

 52.8
 %

 Harraden Circle Investors, LP (4)

 534,698

 11.1
 %

 Feis Equities LLC (5)

 533,108

 11.0
 %

 I-Bankers Securities, Inc.

 512,500

 10.6
 %

 Meteora Capital, LLC (6)

 268,038

 5.5
 %

 Difesa Master Fund, LP (7)

 250,003

 5.2
 %

 Cowen Financial Products LLC (8)

 250,000

 5.2
 %

 Karpus Management, Inc. (9)

 133,460

 2.8
 %

 *
 Less
than one percent.

 (1)

 Unless
 otherwise noted, the business address of each of the following entities or individuals is c/o Breeze Holdings Acquisition Corp.,
 955 W. John Carpenter Fwy., Suite 100-929, Irving, TX 75039.

 (2)

 Represents
 shares of common stock owned by our sponsor, Breeze Sponsor, LLC. Dr. Ramsey is the manager of the Sponsor and has voting and dispositive
 control over all such shares. Dr. Ramsey disclaims beneficial ownership of the reported securities, except to the extent of his pecuniary
 interest therein.

 (3)

 Does
 not include any securities held by our sponsor, Breeze Sponsor, LLC, of which each person is a direct or indirect member.

 (4)

 Based
 solely on the Schedule 13G filed with the SEC on May 6, 2022 by Harraden Circle Investors, LP ("Harraden Circle Investors")
 with respect to shares of common stock held by Harraden Circle Investors. Harraden GP is the general partner to Harraden Circle Investors,
 and Harraden LLC is the general partner of Harraden GP. Harraden Adviser serves as investment manager to Harraden Circle Investors.
 Mr. Fortmiller is the managing member of each of Harraden LLC and Harraden Adviser. In such capacities, each of Harraden GP, Harraden
 LLC, Harraden Adviser and Mr. Fortmiller may be deemed to indirectly beneficially own the Shares reported herein directly beneficially
 owned by Harraden Circle Investors. The business address of the reporting persons is 299 Park Avenue. 21 st Floor,
 New York, NY 10171.

 (5)

 Based
 solely on the amendment to Schedule 13G filed with the SEC on May 3, 2022 by Feis Equities LLC ("Feis Equities") and
 Lawrence M. Feis (Mr. Feis") with respect to shares of common stock held by Feis Equities and Mr. Feis. Mr. Feis is the Managing
 Member of Feis Equities. The business address of the reporting persons is 20 North Wacker Drive, Suite 2115, Chicago, IL 60606.

 (6)

 Based
 solely on the amendment to Schedule 13G filed with the SEC on February 16, 2023 by Meteora Capital, LLC, ("Meteora Capital")
 with respect to the common stock held by certain funds and managed accounts to which Meteora Capital serves as investment manager
 (collectively, the "Meteora Funds"); and (ii) Vik Mittal, who serves as the Managing Member of Meteora Capital, with
 respect to the common stock held by the Meteora Funds. The business address of reporting persons is 840 Park Drive East, Boca Raton,
 FL 33444.

 (7)

 Based
 solely on the Schedule 13G filed with the SEC on November 30, 2022 by Difesa Master Fund, LP (the "Master Fund") for
 which Difesa Capital Management, LP (the "Adviser") serves as the investment manager. Difesa Capital Partners, LLC (the
 "General Partner") is the general partner of the Adviser and Peter Cohen is the managing member of the General Partner.
 By virtue of these relationships, the reporting persons may be deemed to have shared voting and dispositive power with respect to
 the shares owned directly by the Master Fund. The business address of the reporting persons is 40 West 57th Street, Suite 2020, New
 York, NY 10019.

 (8)

 Based
 solely on the amendment to Schedule 13G filed with the SEC on January 23, 2023 by Cowen Financial Products LLC. The business address
 of the reporting persons is 599 Lexington Ave., New York, NY 10022.

 (9)

 Based
 solely on the amendment to Schedule 13G filed with the SEC on May 10, 2022 by Karpus Management, Inc., d/b/a Karpus Investment Management
 ("Karpus"). Karpus is a registered investment adviser under Section 203 of the Investment Advisers Act of 1940. Karpus
 is controlled by City of London Investment Group plc ("CLIG"), which is listed on the London Stock Exchange. However,
 in accordance with SEC Release No. 34-39538 (January 12, 1998), effective informational barriers have been established between Karpus
 and CLIG such that voting and investment power over the subject securities is exercised by Karpus independently of CLIG, and, accordingly,
 attribution of beneficial ownership is not required between Karpus and CLIG. The shares of common stock are owned directly by the
 accounts managed by Karpus. The business address of reporting persons is 183 Sully's Trail, Pittsford, NY 14534.

 Our
sponsor, officers and directors are deemed to be our "promoter" as such term is defined under the federal securities laws.

 Changes
in Control

 None.

 ITEM
13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

 On
June 11, 2020, our initial shareholders purchased 100 founder shares for an aggregate purchase price of $25,000. On July 15,
2020, we effected a 28,750-for-1 forward stock split and, as a result, our initial shareholders held 2,875,000 founder shares as of the
date of our initial public offering. The number of founder shares issued was determined based on the expectation that such founder shares
would represent 20% of the outstanding shares upon completion of our initial public offering. The founder shares may not, subject to
certain limited exceptions, be transferred, assigned or sold by the holder.

 Our
sponsor and I-Bankers purchased an aggregate of 5,425,000 warrants at a price of $1.00 per warrant in a private placement that occurred
simultaneously with the closing of our initial public offering. Of such amount, 4,325,000 warrants were purchased by our sponsor, and
1,100,000 warrants were purchased by I-Bankers. The private placement warrants (including the common stock issuable upon exercise of
the private placement warrants) may not, subject to certain limited exceptions, be transferred, assigned or sold by the holder until
30 days after the completion of our initial business combination.

 If
any of our officers or directors becomes aware of a business combination opportunity that falls within the line of business of any entity
to which he or she has then-current fiduciary or contractual obligations, he or she may be required to present such business combination
opportunity to such entity prior to presenting such business combination opportunity to us. Our executive officers and directors currently
have certain relevant fiduciary duties or contractual obligations that may take priority over their duties to us.

 Commencing
on the date our securities were first listed on NASDAQ, we have agreed to pay an affiliate of our sponsor a total of $5,000 per month
for office space, utilities and secretarial and administrative support. Upon completion of our initial business combination or our liquidation,
we will cease paying these monthly fees.

 Our
sponsor, executive officers and directors, or any of their respective affiliates, will be reimbursed for any out-of-pocket expenses incurred
in connection with activities on our behalf such as identifying potential target businesses and performing due diligence on suitable
business combinations. Our audit committee will review on a quarterly basis all payments that were made to our sponsor, officers, directors
or our or their affiliates and will determine which expenses and the amount of expenses that will be reimbursed. There is no cap or ceiling
on the reimbursement of out-of-pocket expenses incurred by such persons in connection with activities on our behalf.

 Our
sponsor agreed to loan us up to $300,000 to be used for a portion of the expenses of our initial public offering. On November 25,
2020, the outstanding balance under the promissory note in the aggregate amount of $145,617 was repaid.

 On
November 19, 2021, the sponsor loaned the Company an aggregate of $1,150,000 pursuant to an unsecured promissory note (the "Note")
to extend the date by which the Company has to consummate a business combination from November 25, 2021 to February 25, 2022. The Note
is non-interest bearing and payable on the earlier of (i) the consummation of an initial Business Combination, or (ii) March

 On
February 18, 2022, the Sponsor loaned the Company an aggregate of $1,150,000 pursuant to an unsecured promissory note to extend the date
by which the Company has to consummate a business combination from February 25, 2022 to May 25, 2022. This unsecured promissory note
is non-interest bearing and payable on the earlier of (i) the consummation of an initial Business Combination, or (ii) March

 The
amended Trust Agreement, approved on September 13, 2022, authorizes the Company's Board of Directors to extend the time to complete
the Business Combination up to six (6) times for an additional one (1) month each time (for a maximum of six one-month extensions), upon
the deposit into the Trust Account of $0.035 for each outstanding public share by the Sponsor or its designees on or prior to September
26, 2022 or such other date as may be extended. Breeze executed its first one month extension of September 26, 2022 depositing
$59,157 in the Trust Account. On October 21, November 23, and December 20, 2022 Breeze executed the second, third and fourth one month
extensions depositing $59,157 in the Trust Account for each monthly extension through January 26, 2023.

 In
addition, in order to finance transaction costs in connection with an intended initial business combination, our sponsor or an affiliate
of our sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete
an initial business combination, we would repay such loaned amounts. In the event that the initial business combination does not close,
we may use a portion of the working capital held outside the trust account to repay such loaned amounts but no proceeds from our trust
account would be used for such repayment. Up to $1,000,000 of such loans may be convertible into warrants of the post business combination
entity at a price of $1.00 per warrant at the option of the lender. The warrants would be identical to the private placement warrants
issued to our sponsor, including as to exercise price, exercisability and exercise period. The terms of such loans by our officers and
directors, if any, have not been determined and no written agreements exist with respect to such loans. We do not expect to seek loans
from parties other than our sponsor or an affiliate of our sponsor as we do not believe third parties will be willing to loan such funds
and provide a waiver against any and all rights to seek access to funds in our trust account.

 After
our initial business combination, members of our management team who remain with us may be paid consulting, management or other fees
from the combined company with any and all amounts being fully disclosed to our stockholders, to the extent then known, in the tender
offer or proxy solicitation materials, as applicable, furnished to our stockholders. It is unlikely the amount of such compensation will
be known at the time of distribution of such tender offer materials or at the time of a stockholder meeting held to consider our initial
business combination, as applicable, as it will be up to the directors of the post-combination business to determine executive officer
and director compensation.

 We
entered into a registration rights agreement with respect to the founder shares, the private placement warrants and warrants issued upon
conversion of working capital loans (if any).

 Policy
for Approval of Related Party Transactions

 Our
audit committee must review and approve any related person transaction we propose to enter into. Our audit committee charter details
the policies and procedures relating to transactions that may present actual, potential or perceived conflicts of interest and may raise
questions as to whether such transactions are consistent with the best interest of our company and our stockholders. A summary of such
policies and procedures is set forth below.

 Any
potential related party transaction that is brought to the audit committee's attention will be analyzed by the audit committee,
in consultation with outside counsel or members of management, as appropriate, to determine whether the transaction or relationship does,
in fact, constitute a related party transaction. At its meetings, the audit committee will be provided with the details of each new,
existing or proposed related party transaction, including the terms of the transaction, the business purpose of the transaction and the
benefits to us and to the relevant related party.

 In
determining whether to approve a related party transaction, the audit committee must consider, among other factors, the following factors
to the extent relevant:

 whether
 the terms of the transaction are fair to us and on the same basis as would apply if the transaction did not involve a related party;

 whether
 there are business reasons for us to enter into the transaction;

 whether
 the transaction would impair the independence of an outside director;

 whether
 the transaction would present an improper conflict of interest for any director or executive officer; and

 any pre-existing contractual obligations.

 Any
member of the audit committee who has an interest in the transaction under discussion must abstain from any voting regarding the transaction,
but may, if so requested by the chairman of the audit committee, participate in some or all of the audit committee's discussions
of the transaction. Upon completion of its review of the transaction, the audit committee may determine to permit or to prohibit the
transaction.

 Our
sponsor, officers and directors are deemed to be our "promoter" as such term is defined under the federal securities laws.

 To
further minimize conflicts of interest, we have agreed not to consummate an initial business combination with an entity that is affiliated
with any of our sponsor, officers or directors unless we, or a committee of independent directors, have obtained an opinion from an independent
investment banking firm or another independent entity that commonly renders valuation opinions that our initial business combination
is fair to our company and our stockholders from a financial point of view. No finder's fees, reimbursements, consulting fee, monies
in respect of any payment of a loan or other compensation will be paid by us to our sponsor, officers or directors, or any affiliate
of our sponsor or officers, for services rendered to us prior to, or in connection with any services rendered in order to effectuate,
the consummation of our initial business combination (regardless of the type of transaction that it is). However, the following payments
have been or will be made to our sponsor, officers or directors, or our or their affiliates, none of which will be made from the proceeds
of our initial public offering held in the trust account prior to the completion of our initial business combination:

 Repayment
 of up to an aggregate of $145,617 in loans made to us by our sponsor to cover offering related and organizational expenses;

 Payment
 to an affiliate of our sponsor of $5,000 per month, for up to 18 months, for office space, utilities and secretarial and administrative
 support;

 Reimbursement
 for any out-of-pocket expenses related to identifying, investigating and completing an initial business combination; and

 Repayment
 of loans which may be made by our sponsor or an affiliate of our sponsor or certain of our officers and directors to finance transaction
 costs in connection with an intended initial business combination, the terms of which have not been determined nor have any written
 agreements been executed with respect thereto. Up to $1,000,000 of such loans may be convertible into warrants, at a price of $1.00
 per warrant at the option of the lender.

 Our
audit committee reviews on a quarterly basis all payments that were made to our sponsor, officers or directors, or our or their affiliates.

 ITEM 14.
PRINCIPAL ACCOUNTANT FEES AND SERVICES

 The
following is a summary of fees paid or to be paid to Marcum LLP, or Marcum, for services rendered.

 Audit
Fees. Audit fees consist of fees billed for professional services rendered for the audit of our year-end financial statements and services
that are normally provided by Marcum in connection with regulatory filings. The aggregate fees billed by Marcum for professional services
rendered for the audit of our annual financial statements, review of the financial information for the respective periods and other required
filings with the SEC for the year ended December 31, 2022 and December 31, 2021 totaled $284,442 and $84,975, respectively. The above
amounts include interim procedures and audit fees.

 Audit-Related
Fees. Audit-related services consist of fees billed for assurance and related services that are reasonably related to performance of
the audit or review of our financial statements and are not reported under "Audit Fees." These services include attest services
that are not required by statute or regulation and consultations concerning financial accounting and reporting standards. We did not
pay Marcum for consultations concerning financial accounting and reporting standards for the years ended December 31, 2022 and December
31, 2021, respectively.

 Tax
Fees. We paid Marcum $8,755 and $8,755 for tax planning and tax advice for the years ended December 31, 2022 and December 31, 2021, respectively.

 All
Other Fees. We did not pay Marcum for other services for the years ended December 31, 2022 and December 31, 2021, respectively.

 Pre-Approval
Policy

 Our
audit committee was formed upon the consummation of our Initial Public Offering. As a result, the audit committee did not pre-approve
all of the foregoing services, although any services rendered prior to the formation of our audit committee were approved by our board
of directors. Since the formation of our audit committee, and on a going-forward basis, the audit committee has and will pre-approve
all auditing services and permitted non-audit services to be performed for us by our auditors, including the fees and terms thereof (subject
to the de minimis exceptions for non-audit services described in the Exchange Act which are approved by the audit committee prior to
the completion of the audit).

 PART
IV

 ITEM 15. EXHIBITS, FINANCIAL STATEMENTS SCHEDULES

 (a)

 The
 following documents are filed as part of this Report:

 (1)

 Statements:

 Page

 Report of Independent Registered Public Accounting Firm ( Marcum LLP; New York, NY; PCAOB ID# 688)

 Balance Sheets

 Statements of Operations

 Statements of Changes in Stockholders' Deficit

 Statements of Cash Flows

 Notes to Financial Statements

 (2)

 Statement Schedules:

 None.

 (3)

 Exhibits

 We
hereby file as part of this Report the exhibits listed in the attached Exhibit Index. Exhibits which are incorporated herein by reference
can be inspected and copied at the public reference facilities maintained by the SEC, 100 F Street, N.E., Room 1580, Washington, D.C.
20549. Copies of such material can also be obtained from the Public Reference Section of the SEC, 100 F Street, N.E., Washington, D.C.
20549, at prescribed rates or on the SEC website at www.sec.gov.

 Exhibit No.

 Description

 2.1

 Business Combination Agreement, dated as of January 26, 2022, by and among Breeze Holdings Acquisition Corp., D-Orbit S.p. A., D-Orbit S.A., Lift-Off Merger Sub, Inc. and Seraphim Space (Manager) LLP (filed as exhibit 2.1 to the Form 8-K filed January 27, 2022).

 2.2

 Form of Contribution and Exchange Agreement to be entered into prior to the Closing among D-Orbit S.p. A., D-Orbit S.A. and the Contributors party thereto (incorporated by reference to Exhibit A-1 to the Business Combination Agreement filed as Exhibit 2.1 hereto).

 2.3

 Form of Converted Company Shareholder Contribution and Exchange Agreement to be entered into prior to the Closing among D-Orbit S.p. A., D-Orbit S.A. and the Converted Company Shareholders party thereto (incorporated by reference to Exhibit A-2 to the Business Combination Agreement filed as Exhibit 2.1 hereto).

 2.4

 Merger Agreement and Plan of Reorganization, dated as of October 31, 2022, by and among Breeze, BH Velocity Merger Sub, Inc. and TV Ammo, Inc. (filed as exhibit 2.1 to the form 8-K filed November 1, 2022).

 3.1

 Amended and Restated Certificate of Incorporation (incorporated by reference to exhibit 3.3 of the registrant's Form S-1 (file no. 333-249677).

 3.2

 Amendment to Amended and Restated Certificate of Incorporation of Breeze Holdings Acquisition Corp., dated May 9, 2022 (filed as exhibit 3.1 to the Form 8-K filed May 9, 2022).

 3.3

 Amendment to Amended and Restated Certificate of Incorporation of Breeze Holdings Acquisition Corp., dated September 13, 2022 (filed as exhibit 3.1 to the Form 8-K filed September 15, 2022).

 3.4

 Bylaws (incorporated by reference to exhibit 3.4 of the registrant's Form S-1 (file no. 333-249677).

 4.1

 Warrant Agreement, dated November 23, 2020, by and between the Company and Continental Stock Transfer & Trust Company, as warrant agent. (1)

 4.2

 Rights Agreement, dated November 23, 2020, by and between the Company and Continental Stock Transfer & Trust Company, as rights agent. (1)

 4.3

 Description of Registrant's Securities (filed as exhibit 4.3 to the Form 10-K filed March 31, 2021).

 4.4

 Form of Original Issue Discount Convertible Debenture of D-Orbit S.A. (incorporated by reference to Exhibit A to the Securities Purchase Agreement filed as Exhibit 10.8 hereto).

 4.5

 Form of Ordinary Shares Purchase Warrant of D-Orbit S.A. (incorporated by reference to Exhibit C to the Securities Purchase Agreement filed as Exhibit 10.8 hereto).

 4.6

 Form of Callable Ordinary Shares Purchase Warrant of D-Orbit S.A. (incorporated by reference to Exhibit E to the Securities Purchase Agreement filed as Exhibit 10.8 hereto).

 4.7

 Amended and Restated Rights Agreement, dated as of January 26, 2022, between Breeze Holdings Acquisition Corp. and Continental Stock Transfer & Trust Company.

 10.1

 Letter Agreement, dated November 23, 2020, by and among the Company, Breeze Sponsor, LLC and each of the officers and directors of the Company. (1)

 10.2

 Investment Management Trust Agreement between Continental Stock Transfer & Trust Company and the Registrant. (1)

 10.3

 Registration Rights Agreement, dated November 23, 2020, by and among the Company and certain holders party thereto. (1)

 10.4

 Administrative Services Agreement, dated November 23, 2020, by and between the Company and Breeze Sponsor, LLC. (1)

 10.5

 Securities Escrow Agreement, by and among the Company, Breeze Sponsor, LLC and each of the officers and directors of the Company. (incorporated by reference to exhibit 10.9 of the registrant's Form S-1 (file no. 333-249677).

 10.6

 SPAC Stockholder Support Agreement, dated as of January 26, 2022, among D-Orbit S.p. A., D-Orbit S.A., Breeze Sponsor, LLC, Breeze Holdings Acquisition Corp. and the investors party thereto (filed as exhibit 10.1 to the Form 8-K filed January 27, 2022).

 10.7

 Form of Existing Company & SPAC Shareholders Registration Rights and Lock-Up Agreement among D-Orbit S.A., Breeze Holdings Acquisition Corp. and the holders party thereto (incorporated by reference to Exhibit B-1 to the Business Combination Agreement filed as Exhibit 2.1 hereto).

 10.8

 Securities Purchase Agreement, dated as of January 26, 2022, among Breeze Holdings Acquisition Corp., D-Orbit S.p. A., D-Orbit S.A. and the purchasers party thereto (filed as exhibit 10.3 to the Form 8-K filed January 27, 2022).

 10.9

 Form of Registration Rights Agreement between D-Orbit S.A. and the holders party thereto (incorporated by reference to Exhibit B-2 to the Business Combination Agreement filed as Exhibit 2.1 hereto).

 Exhibit No.

 Description

 10.10

 Form of Subscription Agreement dated as of January 26, 2022, among Breeze Holdings Acquisition Corp., D-Orbit S.A. and the investors party thereto (filed as exhibit 10.5 to the Form 8-K filed January 27, 2022).

 10.11

 Termination of Securities Purchase Agreement, dated July 28, 2022 (filed as exhibit 10.1 to the Form 8-K filed August 1, 2022).

 10.12

 Termination Agreement, dated August 12, 2022, by and among Breeze Holdings Acquisition Corp., D-Orbit S.p. A., D-Orbit S.A., Lift-Off Merger Sub, Inc., Seraphim Space (Manager) LLP and Breeze Sponsor, LLC (filed as exhibit 10.1 to the Form 8-K filed August 15, 2022).

 10.13

 Sponsor Support Agreement (filed as exhibit 10.1 to the Form 8-K filed November 1, 2022).

 10.14

 Form of Stockholder Support Agreement (filed as exhibit 10.2 to the Form 8-K filed November 1, 2022).

 10.15

 Form of Lock-Up Agreement (filed as exhibit 10.3 to the Form 8-K filed November 1, 2022).

 10.16

 Form of Amended and Restated Registration Rights Agreement (filed as exhibit 10.4 to the Form 8-K filed November 1, 2022).

 Code of Ethics (incorporated by reference to exhibit 14 of the registrant's Form S-1 (file no. 333-249677).

 31.1

 Certification of Principal Executive Officer and Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*

 32.1

 Certification of Principal Executive Officer and Principal Financial Officer Pursuant to Section 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.**

 101.INS

 101.CAL

 101.SCH

 101.DEF

 101.LAB

 101.PRE

 *

 Filed
 herewith.

 **

 Furnished
 herewith.

 (1)

 Incorporated
 by reference to the registrant's Current Report on Form 8-K, filed with the SEC on November 27, 2020.

 of the exhibits and schedules to this exhibit have been omitted in accordance with Regulation S-K Item 601(b)(2). The Registrant
 agrees to furnish supplementally a copy of all omitted exhibits and schedules to the SEC upon its request.

 ITEM 16. FORM 10-K SUMMARY

 Not
applicable.

 SIGNATURES

to the requirements of Section 13 or 15(d) of the Securities Act of 1934, the registrant has duly caused this Form 10-K to be signed
on its behalf by the undersigned, thereunto duly authorized.

 March
21, 2024

 /s/
 J. Douglas Ramsey

 Name:
 J. Douglas Ramsey

 Title:
 Chief Executive Officer

TO FINANCIAL STATEMENTS

 Report
 of Independent Registered Public Accounting Firm (Marcum LLP; New York, NY; PCAOB ID#688)

 Statements:

 Balance
 Sheets

 Statements
 of Operations

 Statements
 of Changes in Stockholders' Deficit

 Statements
 of Cash Flows

 Notes
 to Financial Statements

 F- 1

 REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 To
the Stockholders and the Board of Directors of

 Breeze
Holdings Acquisition Corp.

 Opinion
on the Financial Statements

 We
have audited the accompanying balance sheet s of Breeze Holdings Acquisition Corp. (the "Company") as of December 31,
2022 and 2021, the related statements of operations, changes in stockholders' deficit and cash flows for each of the two
years in the period ended December 31, 2022, and the related notes (collectively referred to as the "financial statements").
In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December
31, 2022 and 2021, and the results of its operations and its cash flows for each of the two years in the period ended December 31, 2022,
in conformity with accounting principles generally accepted in the United States of America.

 Explanatory
Paragraph – Going Concern

 The
accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As more fully described
in Note 1, the Company's business plan is dependent on the completion of a business combination, it has a significant working capital
deficiency, has incurred significant losses and needs to raise additional funds to meet its obligations and sustain its operations. These
conditions raise substantial doubt about the Company's ability to continue as a going concern. Management's plans in regard
to these matters are also described in Note 1. The financial statements do not include any adjustments that might result from the outcome
of this uncertainty.

 Basis
for Opinion

 These
financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's
financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board
(United States) ("PCAOB") and are required to be independent with respect to the Company in accordance with the U.S. federal
securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 We
conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain
reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company
is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits,
we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion
on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion.

 Our
audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error
or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding
the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant
estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits
provide a reasonable basis for our opinion.

 /s/
Marcum LLP

 Marcum
LLP

 We
have served as the Company's auditor since 2020.

 New
York, NY

 March
30, 2023

 F- 2

 BALANCE
SHEETS

 2022

 2021

 ASSETS

 Current assets

 Cash

 $
 14,129

 $
 5,403

 Due from Sponsor

 18,073

 Prepaid expenses

 160,503

 123,292

 Prepayment - Franchise Taxes

 10,000

 —

 Total Current Assets

 202,705

 129,560

 Cash and marketable securities held in Trust Account

 17,730,969

 117,931,556

 Total Assets

 $
 17,933,674

 $
 118,061,116

 LIABILITIES AND STOCKHOLDERS' DEFICIT

 Current liabilities

 Accounts payable and accrued expenses

 $
 67,500

 $
 598,447

 Franchise tax payable

 —

 200,000

 Income tax payable

 2,089

 —

 Due to Sponsor

 5,480,941

 1,198,315

 Total Current Liabilities

 5,550,530

 1,996,762

 Warrant liabilities

 1,184,750

 7,108,500

 Other long-term liabilities

 —

 —

 Total Liabilities

 6,735,280

 9,105,262

 Commitments

 Common stock subject to possible redemption, 1,690,196 and 11,500,000 shares at redemption value as of December 31, 2022 and 2021, respectively

 17,730,156

 117,875,000

 Stockholders' Deficit

 Preferred stock, $0.0001 par value; 1,000,000 authorized; none issued and outstanding

 —

 —

 Common stock, $0.0001 par value; 100,000,000 shares authorized; 3,140,000 shares and 3,140,000 shares issued and outstanding as of December 31, 2022 and 2021, respectively (excluding 1,690,196 and 11,500,000 shares subject to possible redemption, respectively)

 Additional paid-in capital

 —

 —

 Accumulated deficit

 (6,532,077
)

 (8,919,461
)

 Total Stockholders' Deficit

 (6,531,762
)

 (8,919,146
)

 TOTAL LIABILITIES, COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION AND STOCKHOLDERS' DEFICIT

 $
 17,933,674

 $
 118,061,116

 The
accompanying notes are an integral part of the financial statements.

 F- 3

 STATEMENTS
OF OPERATIONS

 December 31, 2022

 December 31, 2021

 Operating and formation costs

 $
 2,323,153

 $
 1,722,364

 Loss from operations

 (2,323,153
)

 (1,722,364
)

 Other income (expense):

 Interest income

 Unrealized gain on marketable securities held in Trust Account

 188,903

 47,076

 Change in fair value of warrant liabilities

 5,923,750

 10,378,500

 Total other income (expenses), net

 6,113,466

 10,426,340

 Income before income taxes

 3,790,313

 Income tax expense

 (2,089
)

 —

 Net income

 $

 $

 Basic and diluted weighted average shares outstanding

 9,294,000

 14,631,082

 Basic and diluted net income per share of Common Stock

 $
 0.41

 $
 0.59

 The
accompanying notes are an integral part of the financial statements.

 F- 4

 STATEMENTS
OF CHANGES IN STOCKHOLDERS' DEFICIT

 FOR
THE YEARS ENDED DECEMBER 31, 2022 AND 2021

 Additional

 Total

 Stock

 Paid-in

 Accumulated

 Stockholders'

 Shares

 Amount

 Capital

 Deficit

 Deficit

 Balance
 – December 31, 2020

 3,125,000

 $

 $
 —

 $
 (16,949,285
)

 $
 (16,948,972
)

 Stock issued to Consultant

 15,000

 —

 74,848

 74,850

 Stock purchased by Directors from Sponsor

 —

 —

 —

 401,000

 401,000

 Accretion
 of Common Stock to redemption value

 —

 —

 —

 (1,150,000
)

 (1,150,000
)

 Net
 income

 —

 —

 —

 Balance
 – December 31, 2021

 3,140,000

 $

 $
 —

 $
 (8,919,461
)

 $
 (8,919,146
)

 Accretion
 of Common Stock to redemption value

 —

 —

 —

 (1,400,840
)

 (1,400,840
)

 Net
 income

 —

 —

 —

 Balance
 – December 31, 2022

 3,140,000

 $

 $
 —

 $
 (6,532,077
)

 $
 (6,531,762
)

 The
accompanying notes are an integral part of the financial statements.

 F- 5

 STATEMENTS
OF CASH FLOWS

 December 31, 2022

 December 31, 2021

 Cash Flows from Operating Activities:

 Net income

 $

 $

 Adjustments to reconcile net income to net cash used in operating activities:

 Interest and unrealized gain on marketable securities held in Trust Account

 (189,716
)

 (47,076
)

 Change in fair value of warrant liabilities

 (5,923,750
)

 (10,378,500
)

 Compensation expense for common stock purchased by Directors from Sponsor

 —

 401,000

 Changes in operating assets and liabilities:

 Prepaid expense

 (54,419
)

 36,084

 Long-term liabilities

 95,790

 (111,926
)

 Accounts payable and accrued expenses

 (530,947
)

 531,183

 Franchise tax payable

 (210,000
)

 176,844

 Income tax payable

 2,089

 —

 Net cash provided by (used in) operating activities

 (3,022,729
)

 (688,415
)

 Cash Flows from Investing Activities:

 Investment of cash in Trust Account

 (1,400,840
)

 (1,150,000
)

 Cash withdrawn from Trust Account to redeeming shareholders

 101,545,684

 —

 Cash withdrawn from Trust Account to pay franchise and income taxes

 231,246

 —

 Net cash used in investing activities

 100,376,090

 (1,150,000
)

 Cash Flows from Financing Activities:

 Proceeds from short-term working capital loan - related party

 2,800,209

 —

 Proceeds from promissory note – related party

 1,400,840

 Redemptions of common stock

 (101,545,684
)

 —

 Net cash provided by (used in) financing activities

 (97,344,635
)

 Net Change in Cash

 8,726

 (688,415
)

 Cash – Beginning of period

 5,403

 693,818

 Cash – End of period

 $
 14,129

 $
 5,403

 Supplemental disclosure of non-cash financing activities:

 Compensation expense for common stock purchased by Directors from Sponsor

 $
 —

 $
 401,000

 Common stock issued to Consultant

 $
 —

 $
 74,850

 Accretion of common stock subject to redemption value

 $
 1,400,840

 $

 The
accompanying notes are an integral part of the financial statements.

 F- 6

HOLDINGS ACQUISITON CORP.

 NOTES
TO FINANCIAL STATEMENTS

 DECEMBER
31, 2022 and 2021

 Note
1 — Description of Organization and Business Operations

 Breeze
Holdings Acquisition Corp. (the "Company") is a blank check company incorporated in Delaware on June 11, 2020. The Company
was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar
business combination with one or more businesses (the "Business Combination").

 The
Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early
stage and emerging growth companies.

 As
of December 31, 2022, the Company had not commenced any operations. All activity for the period from June 11, 2020 (inception)
through December 31, 2020, and the years ended December 31, 2021 and 2022, relate to the Company's formation, the Initial
Public Offering ("Initial Public Offering"), which is described below, and, after the Initial Public Offering, identifying
a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of its initial
Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds
derived from the Initial Public Offering and from changes in the fair value of its warrant liability.

 The
registration statement for the Company's Initial Public Offering was declared effective on November 23, 2020. On November 25,
2020, the Company consummated the Initial Public Offering of 11,500,000 units (the "Units" and, with respect to the shares
of common stock included in the Units sold, the "Public Shares"), generating gross proceeds of $115,000,000, which is described
in Note 3.

 Simultaneously
with the closing of the Initial Public Offering, the Company consummated the sale of 5,425,000 warrants (the "Private Placement
Warrants") at a price of $1.00 per Private Placement Warrant in a private placement to Breeze Sponsor, LLC, a Delaware limited
liability company (the "Sponsor") and I-Bankers Securities, Inc., generating gross proceeds of $5,425,000, which is described
in Note 4.

the closing of the Initial Public Offering on November 25, 2020, an amount of $116,725,000 ($10.15 per Unit) from the net proceeds
of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Warrants was placed in a trust account
(the "Trust Account") and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of
the Investment Company Act, with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money
market fund selected by the Company meeting the conditions of Rule 2a-7 of the Investment Company Act of 1940, as amended (the "Investment
Company Act"), as determined by the Company, until the earlier of: (i) the completion of a Business Combination or (ii) the
distribution of the Trust Account to the Company's stockholders, as described below.

 Transaction
costs incurred in connection with the Initial Public Offering amounted to $4,099,907, consisting of $2,300,000 of underwriting fees,
$1,322,350 of representative share offering costs, and $477,557 of other offering costs. As of December 31, 2022, cash of $14,129
was held outside of the Trust Account and was available for working capital purposes.

 The
Company's management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering
and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward
consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully.
The Company must complete an initial Business Combination having an aggregate fair market value of at least 80% of the assets held in
the Trust Account (excluding the deferred underwriting commissions and taxes payable) at the time of the agreement to enter into the
initial Business Combination. The Company will only complete a Business Combination if the post-transaction company owns or acquires
50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient
for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the "Investment
Company Act").

 The
Company will provide its stockholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of a
Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by
means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a
tender offer will be made by the Company, solely in its discretion. The stockholders will be entitled to redeem their shares for a pro
rata portion of the amount then in the Trust Account (initially $10.15 per share), plus any pro rata interest earned on the funds held
in the Trust Account and not previously released to the Company to pay its tax obligations. The per-share amount to be distributed to
stockholders who redeem their shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters
(as discussed in Note 6). There will be no redemption rights upon the completion of a Business Combination with respect to the Company's
warrants.

 F- 7

 The
Company will proceed with a Business Combination only if the Company has net tangible assets of at least $5,000,001 upon such consummation
of a Business Combination and, if the Company seeks stockholder approval, a majority of the outstanding shares voted are voted in favor
of the Business Combination. If a stockholder vote is not required and the Company does not decide to hold a stockholder vote for business
or other legal reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation, conduct the redemptions
pursuant to the tender offer rules of the Securities and Exchange Commission ("SEC") and file tender offer documents containing
substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination.
If the Company seeks stockholder approval in connection with a Business Combination, the Company's Sponsor has agreed to vote its
Founder Shares (as defined in Note 5) and any Public Shares purchased by it during or after the Initial Public Offering in favor of approving
a Business Combination. Additionally, each public stockholder may elect to redeem their Public Shares, regardless of whether they vote
for or against a Business Combination.

 If
the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules,
the Company's Amended and Restated Certificate of Incorporation provides that a public stockholder, together with any affiliate
of such stockholder or any other person with whom such stockholder is acting in concert or as a "group" (as defined under
Section 13 of the Securities Exchange Act of 1934, as amended (the "Exchange Act")), will be restricted from seeking
redemption rights with respect to 10% or more of the Public Shares, without the Company's prior written consent.

 The
Sponsor has agreed (a) to waive its redemption rights with respect to any Founder Shares and Public Shares held by it in connection
with the completion of a Business Combination, (b) to waive its liquidation rights with respect to the Founder Shares if the Company
fails to complete a Business Combination by November 25, 2021 (which can be extended up to 6 months) and (c) not to propose
an amendment to the Amended and Restated Certificate of Incorporation (i) to modify the substance or timing of the Company's
obligation to allow redemption in connection with the Company's initial Business Combination or to redeem 100% of its Public Shares
if the Company does not complete a Business Combination or (ii) with respect to any other provision relating to stockholders'
rights or pre-initial business combination activity, unless the Company provides the public stockholders with the opportunity to redeem
their Public Shares in conjunction with any such amendment. However, if the Sponsor acquires Public Shares in or after the Initial Public
Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a
Business Combination within the Combination Period.

 On
November 22, 2021, the Company announced that its sponsor, Breeze Sponsor, LLC, timely deposited an aggregate of $1,150,000 (the "Extension
Payment"), representing $0.10 per public share, into the Trust Account to extend the date by which the Company has to consummate
a business combination from November 25, 2021 to February 25, 2022. The Sponsor loaned the Extension Payment to the Company in exchange
for a promissory note in the amount of the Extension Payment. The loan under the promissory note is non-interest bearing and will be
repaid upon the consummation of a business combination. The Company's stockholders are not entitled to vote on or redeem their
shares in connection with such extension.

 On
February 22, 2022, the Company announced that its sponsor, Breeze Sponsor, LLC, timely deposited an aggregate of $1,150,000 (the "Second
Extension Payment"), representing $0.10 per public share, into the Trust Account to extend the date by which the Company has to
consummate a business combination from February 25, 2022 to May 25, 2022. The Sponsor loaned the Second Extension Payment to the Company
in exchange for a promissory note in the amount of the Second Extension Payment. The loan under the promissory note is non-interest bearing
and will be repaid upon the consummation of a business combination. The Company's stockholders are not entitled to vote on or redeem
their shares in connection with such extension.

 On
May 5, 2022, the Company held a stockholders' meeting at which a proposal to approve the extension of time to consummate the closing
of a Business Combination Agreement to September 26, 2022 was approved. The Company provided its stockholders with the opportunity to
redeem all or a portion of their Public Shares at the time of this stockholders' meeting. The stockholders who elected to redeem
their shares did so for a pro rata portion of the amount then in the Trust Account ($10.35 per share), plus any pro rata interest earned
on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations. In connection with the
extension proposal, 6,732,987 shares of the Company's common stock were redeemed for $69,700,628, (the "Redemption").
On May 10, 2022, $109,000 was withdrawn from the Trust Account for payment of franchise and income taxes.

 On
September 13, 2022, the Company held its annual stockholders' meeting at which a proposal to approve the extension of time to consummate
the closing of a Business Combination Agreement to March 26, 2023 was approved. The Company provided its stockholders with the opportunity
to redeem all or a portion of their Public Shares at the time of this stockholders' meeting. The stockholders who elected to redeem
their shares did so for a pro rata portion of the amount then in the Trust Account ($10.35 per share), plus any pro rata interest earned
on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations. In connection with the
extension proposal, 3,076,817 shares of the Company's common stock were redeemed for $31,845,056 and on September 8, 2022, $122,247
was withdrawn from the Trust Account for payment of franchise and income taxes.

 F- 8

 At
the annual meeting of the Company held on September 13, 2022, the Company's stockholders approved (i) a proposal to amend
the Company's Amended and Restated Certificate of Incorporation (the "A&R COI") to authorize the Company to extend
the date of September 26, 2022, up to six (6) times for an additional one (1) month each time (ultimately until as late
as March 26, 2023) by which the Company must (a) consummate a merger, capital stock exchange, asset, stock purchase, reorganization
or other similar business combination, which we refer to as our initial business combination, or (b) cease its operations except
for the purpose of winding up if it fails to complete such initial business combination, and redeem all of the shares of common stock
of the Company included as part of the units sold in the Company's initial public offering that was consummated on November 25,
2020, and (ii) a proposal to amend the Trust Agreement to authorize the Extension and its implementation by the Company. The amended
Trust Agreement authorizes the Company's Board of Directors to extend the time to complete the Business Combination up to
six (6) times for an additional one (1) month each time (for a maximum of six one-month extensions), upon the deposit into the Trust
Account of $0.035 for each outstanding public share by the Sponsor or its designees on or prior to September 26, 2022 or such other date
as may be extended. Breeze executed its first one-month extension of September 26, 2022 depositing $59,157 in the Trust Account.
On October 21, November 23, and December 20, 2022 Breeze executed the second, third and fourth one-month extensions through January 26,
2023. On January 25, 2023 and February 23, 2023, Breeze executed the fifth and sixth one-month extensions depositing $59,157 in the Trust
Account for each monthly extension through March 26, 2023. The Company held a meeting of its stockholders on March 22, 2023 where
the Company's stockholders approved (i) a proposal to amend the Company's A&R COI to authorize the Company to extend
the date of March 26, 2023, up to six (6) times for an additional one (1) month each time (ultimately until as late as
September 26, 2023), and (ii) a proposal to amend the Trust Agreement to authorize the Extension and its implementation by the Company.

 The
Company will have until September 26, 2023 (unless the Company's shareholders approve a proposal to amend the A&R COI to permit
an extension of up to six additional one month periods) to complete a Business Combination (the "Combination Period"). If
the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations
except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem
the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including
interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations (less up
to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will
completely extinguish public stockholders' rights as stockholders (including the right to receive further liquidating distributions,
if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company's
remaining stockholders and the Company's board of directors, dissolve and liquidate, subject in each case to the Company's
obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption
rights or liquidating distributions with respect to the Company's warrants, which will expire worthless if the Company fails to
complete a Business Combination within the Combination Period.

 In
order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims
by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed
entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (1) $10.35 per Public Share or (2) the
actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in
the value of the trust assets, in each case net of the interest which may be withdrawn to pay our taxes. This liability will not apply
with respect to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and will
not apply to any claims under the Company's indemnity of the underwriters of the Initial Public Offering against certain liabilities,
including liabilities under the Securities Act of 1933, as amended (the "Securities Act"). Moreover, in the event that an
executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability
for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account
due to claims of creditors by endeavoring to have all vendors, service providers (except the Company's independent registered public
accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company
waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. In order to protect the amounts held
in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party for services
rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction
agreement, reduce the amount of funds in the Trust Account to below (1) $10.35 per Public Share or (2) the actual amount per
Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust
assets, in each case net of the interest which may be withdrawn to pay our taxes. This liability will not apply with respect to any claims
by a third party who executed a waiver of any and all rights to seek access to the Trust Account and will not apply to any claims under
the Company's indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under
the Securities Act of 1933, as amended (the "Securities Act"). Moreover, in the event that an executed waiver is deemed to
be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims.
The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors
by endeavoring to have all vendors, service providers (except the Company's independent registered public accounting firm), prospective
target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title,
interest or claim of any kind in or to monies held in the Trust Account.

 F- 9

 On
October 31, 2022, Breeze Holdings Acquisition Corp., a Delaware corporation ("Breeze"), entered into a Merger Agreement and
Plan of Reorganization (the "Merger Agreement"), by and among Breeze, BH Velocity Merger Sub Inc., a Texas corporation and
a direct, wholly-owned subsidiary of Breeze ("Merger Sub"), and TV Ammo, Inc., a Texas corporation ("TV Ammo").

 The
Merger Agreement and the transactions contemplated thereby were approved by the boards of directors of each of Breeze, Merger Sub, and
TV Ammo.

 The
Merger Agreement provides that, among other things, at the closing (the "Closing") of the transactions contemplated by the
Merger Agreement, Merger Sub will merge with and into TV Ammo (the "Merger"), with TV Ammo surviving as a wholly-owned subsidiary
of Breeze. In connection with the Merger, Breeze will change its name to "True Velocity, Inc." The Merger and the other transactions
contemplated by the Merger Agreement are hereinafter referred to as the "Business Combination."

 The
Business Combination is expected to close in the second or third quarter of 2023, subject to customary closing conditions, including
the satisfaction of the minimum available cash condition, the receipt of certain governmental approvals and the required approval by
the stockholders of Breeze and TV Ammo.

 The
aggregate consideration to be received by the TV Ammo Equity Holders is based on a pre-transaction equity value of $1,185,234,565 and
results in a combined company equity value of $1,249,556,817. In accordance with the terms and subject to the conditions of the Merger
Agreement, at the Effective Time, (a) each share of issued and outstanding TV Ammo common stock, par value $0.01 ("TV Ammo
Common Stock"), shall be cancelled and converted into a number of shares of True Velocity common stock, par value $0.0001 ("True
Velocity Common Stock"), equal to the Exchange Ratio, (b) each option to purchase shares of TV Ammo Common Stock (each, a "TV
Ammo Option") shall be assumed and converted into an option to purchase a number of shares of True Velocity Common Stock (each,
a "True Velocity Option") equal to the number of shares of TV Ammo Common Stock subject to such TV Ammo Option, multiplied
by the Exchange Ratio, at an exercise price per share equal to the exercise price per share in effect immediately before the Effective
Time, divided by the Exchange Ratio, (c) each restricted stock unit in respect of shares of TV Ammo Common Stock (each, a "TV Ammo
RSU") shall be assumed and converted into a restricted stock unit in respect of a number of shares of True Velocity Common Stock
(each, a "True Velocity RSU") equal to the number of shares of TV Ammo Common Stock subject to such TV Ammo RSU, multiplied
by the Exchange Ratio, and (d) each warrant to purchase a number of shares of TV Ammo Common Stock (each, a "TV Ammo Warrant")
shall be converted into a warrant to purchase shares of True Velocity Common Stock (each, a "True Velocity Warrant") equal
to the number of shares of TV Ammo Common Stock subject to such TV Ammo Warrant, multiplied by the Exchange Ratio, at an exercise price
per share equal to the exercise price per share in effect immediately before the Effective Time, divided by the Exchange Ratio. The Exchange
Ratio will be equal to (i) the sum of (A) $1,185,234,565, plus (B) any amounts raised by TV Ammo after the date of the Merger Agreement
and prior to the Closing in Permitted Financings in excess of $50,000,000, plus (C) the aggregate dollar amount payable to TV Ammo upon
the conversion of all outstanding TV Ammo Convertible Notes and the exercise of all vested in-the-money warrants and vested in-the-money
options, divided by (ii) the number of fully-diluted shares of TV Ammo Common Stock outstanding as of the Closing, further divided by
(iii) an assumed value of True Velocity Common Stock of $10.00 per share. A pro rata portion of the shares of True Velocity Common Stock
received in exchange for the shares of TV Ammo Common Stock are subject to forfeiture if certain future stock-price based milestones
are not achieved as described below (the "Earnout Shares"). The number of Earnout Shares will be equal to the product of
(a) 15% and (b) the amount by which 118,523,456 exceeds the number of shares of True Velocity Common Stock issuable upon the exercise
or conversion of securities issued by TV Ammo in Permitted Financings after the date of the Merger Agreement and prior to the Closing.

 The
Earnout Shares will be issued at the Closing and subject to forfeiture. One-half of the Earnout Shares shall become fully vested and
no longer subject to forfeiture if, during the three-year period beginning at the Closing (the "Milestone Event Period"),
the combined company's common stock achieves a daily volume weighted average market price of at least $12.50 per share for any
20 trading days within a 30 consecutive trading day period ("Milestone Event I"). The other half of the Earnout Shares will
become fully vested and no longer subject to forfeiture if, during the Milestone Event Period, the combined company's common stock
achieves a daily volume weighted average market price of at least $15 per share for a similar number of days ("Milestone Event
II"). The 30 consecutive trading day periods used to satisfy Milestone Event I and Milestone Event II may not overlap; if both
Milestone Event I and Milestone Event II would be satisfied using the same 30 consecutive trading day period, Milestone Event II will
be deemed satisfied and the threshold closing sale price to achieve Milestone Event I shall be increased to $13.50. Any Earnout Shares
that remain unvested at the end of the Milestone Event Period will be forfeited. All of the Earnout Shares will become fully vested and
no longer subject to forfeiture upon the occurrence of a Subsequent Transaction.

 The
parties have agreed to take actions such that, effective immediately after the Closing of the Business Combination, Breeze's board
of directors shall consist of seven directors, consisting of two Breeze designees (at least one of whom shall be an "independent
director"), four TV Ammo designees (at least three of whom shall be "independent directors") and the chief executive
officer of the combined company. Additionally, certain current TV Ammo management personnel will become officers of Breeze. To qualify
as an "independent director" under the Merger Agreement, a designee shall both (i) qualify as "independent" under
the rules of the Nasdaq Stock Market and (ii) not have had any business relationship with either Breeze or TV Ammo or any of their respective
subsidiaries, including as an officer or director thereof, other than for a period of less than six months prior to the date of the Merger
Agreement.

 F- 10

 The
Merger Agreement contains representations, warranties and covenants of each of the parties thereto that are customary for transactions
of this type, including, among others, covenants providing for (i) certain limitations on the operation of the parties' respective
businesses prior to consummation of the Business Combination, (ii) the parties' efforts to satisfy conditions to consummation of
the Business Combination, including by obtaining necessary approvals from governmental agencies (including U.S. federal antitrust authorities
and under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act")), (iii) prohibitions on the
parties soliciting alternative transactions, (iv) Breeze preparing and filing a registration statement on Form S-4 with the Securities
and Exchange Commission (the "SEC") and taking certain other actions to obtain the requisite approval of Breeze's stockholders
to vote in favor of certain matters, including the adoption of the Merger Agreement and approval of the Business Combination, at a special
meeting to be called for the approval of such matters, and (v) the protection of, and access to, confidential information of the parties.

 In
addition, Breeze has agreed to adopt an equity incentive plan, as described in the Merger Agreement.

 The
obligations of Breeze and TV Ammo to consummate the Business Combination are subject to certain closing conditions, including, but not
limited to, (i) the expiration or termination of the applicable waiting period under the HSR Act, (ii) the approval of Breeze's
stockholders, (iii) the approval of TV Ammo's stockholders, and (iv) Breeze's Form S-4 registration statement becoming effective.

 In
addition, the obligations of Breeze and Merger Sub to consummate the Business Combination are also subject to the fulfillment (or waiver)
of other closing conditions, including, but not limited to, (i) the representations and warranties of TV Ammo being true and correct
to the standards applicable to such representations and warranties and each of the covenants of TV Ammo having been performed or complied
with in all material respects, (ii) delivery of certain ancillary agreements required to be executed and delivered in connection with
the Business Combination; and (iii) no Material Adverse Effect (as defined in the Merger Agreement) having occurred.

 The
obligation of TV Ammo to consummate the Business Combination is also subject to the fulfillment (or waiver) of other closing conditions,
including, but not limited to, (i) the representations and warranties of Breeze and Merger Sub being true and correct to the standards
applicable to such representations and warranties and each of the covenants of Breeze and Merger Sub having been performed or complied
with in all material respects, (ii) the shares of Breeze Common Stock issuable in connection with the Business Combination being listed
on the Nasdaq Stock Market, and (iii) Breeze having cash on hand (inclusive of proceeds from certain permitted financings) of at least
$30,000,000 (after deducting any amounts paid to Breeze stockholders that exercise their redemption rights in connection with the Business
Combination and net of certain transaction expenses incurred or subject to reimbursement by the Sponsor). If Breeze's cash on hand
is less than $30,000,000, (a) after the Breeze stockholder meeting to approve the Business Combination, Breeze may sell additional shares
of Breeze Common Stock to investors for not less than $10.00 per share, and (b) after the deadline for Breeze stockholders to elect to
redeem their Breeze Common Stock in connection with the Business Combination, Breeze may, with the consent of TV Ammo, enter into agreements
incentivizing redeeming stockholders to unwind their election to redeem. The Sponsor has agreed to forfeit up to 20% of its shares of
Breeze Common Stock to allow Breeze to offer shares in connection with any such incentive agreements.

 The
Merger Agreement may be terminated under certain customary and limited circumstances prior to the Closing of the Business Combination,
including, but not limited to, (i) by mutual written consent of Breeze and TV Ammo, (ii) by Breeze, on the one hand, or TV Ammo, on the
other hand, if there is any breach of the representations, warranties, covenant or agreement of the other party as set forth in the Merger
Agreement, in each case, such that certain conditions to closing cannot be satisfied and the breach or breaches of such representations
or warranties or the failure to perform such covenant or agreement, as applicable, are not cured or cannot be cured within certain specified
time periods, (iii) by either Breeze or TV Ammo if the Business Combination is not consummated by April 28, 2023, provided the failure
to close by such date is not due to a breach by the terminating party, (iv) by either Breeze or TV Ammo if a meeting of Breeze's
stockholders is held to vote on proposals relating to the Business Combination and the stockholders do not approve the proposals, and
(v) by Breeze if the TV Ammo stockholders do not approve the Merger Agreement.

 Under
certain circumstances as described further in the Merger Agreement, if the Merger Agreement is validly terminated by Breeze, TV Ammo
will pay Breeze a fee equal to the actual documented expenses incurred by Breeze in connection with the Business Combination of up to
$1,000,000.

 A
copy of the Merger Agreement is included as Exhibit 2.1 in our Current Report filed with the SEC on Form 8-K on November 1, 2022 and
is incorporated herein by reference, and the foregoing description of the Merger Agreement is qualified in its entirety by reference
thereto. The Merger Agreement contains representations, warranties and covenants that the respective parties made to each other as
of the date of the Merger Agreement or other specific dates. The assertions embodied in those representations, warranties and
covenants were made for purposes of the contract among the respective parties and are subject to important qualifications and
limitations agreed to by the parties in connection with negotiating such agreement. The representations, warranties and covenants in
the Merger Agreement are also modified in important part by the underlying disclosure schedules which are not filed publicly and which
are subject to a contractual standard of materiality different from that generally applicable to stockholders and were used for the
purpose of allocating risk among the parties rather than establishing matters as facts. Breeze does not believe that these schedules
contain information that is material to an investment decision.

 F- 11

 The
Merger Agreement contemplates that TV Ammo may enter into agreements to raise capital prior to the Closing of the Business Combination
for aggregate gross proceeds of up to $100,000,000 (the "Permitted Financing").

 Concurrently
with the execution of the Merger Agreement, Breeze, TV Ammo and the Breeze Initial Stockholders executed the Sponsor Support Agreement,
pursuant to which, among other things, the Breeze Initial Stockholders: (a) agreed to vote all of their shares of Breeze Common Stock
in favor of the Breeze Proposals, including the adoption of the Merger Agreement and the approval of the Transactions and the Extension
Proposal; (b) agreed to vote against any other matter, action, agreement, transaction or proposal that would reasonably be expected to
result in (i) a breach of any of Breeze's or Merger Sub's representations, warranties, covenants, agreements or obligations
under the Merger Agreement or (ii) any of the mutual or TV Ammo conditions to the Closing in the Merger Agreement not being satisfied;
(c) (i) waived, subject to and conditioned upon the Closing and to the fullest extent permitted by applicable law and the Breeze organizational
documents, and (ii) agreed not to assert or perfect, any rights to adjustment or other anti-dilution protections to which such Breeze
Initial Stockholder may be entitled in connection with the Merger or the other Transactions or the Extension Proposal; (d) agreed to
take, or cause to be taken, all actions and to do, or cause to be done, all things reasonably necessary under applicable laws to consummate
the Merger and the other Transactions on the terms and subject to the conditions set forth in the Merger Agreement prior to any valid
termination of the Merger Agreement; (e) agreed not to transfer or pledge any of their shares of Breeze Common Stock, or enter into any
arrangement with respect thereto, after the execution of the Merger Agreement and prior to the Closing Date, subject to certain customary
conditions and exceptions; and (f) waived their rights to redeem any of their shares of Breeze Common Stock in connection with the approval
of the Breeze Proposals and the Extension Proposal. Additionally, the Sponsor has agreed to: (a) forfeit for no consideration up to 20%
of the aggregate shares of Breeze Common Stock held by it if Breeze reasonably determines that the issuance of additional shares of Breeze
Common Stock to investors or Redeeming Stockholders (at a price per share not to be less than $10.00) would be reasonably required (i)
to cause the Breeze Cash on Hand to be at least equal to the Minimum Cash Amount or (ii) to secure any Additional Financing; (b) forfeit
for no consideration up to 20% of the aggregate shares of Breeze Common Stock held by it if, on the six month anniversary of the Closing,
the sum of (i) the Breeze Cash on Hand plus (ii) the funds requested or received under the At-the-Market Facility (or other similar equity
or hybrid equity-based instrument or facility) at or prior to such date is less than $50,000,000; and (c) assume and pay all Legacy Breeze
Transaction Expenses in full and indemnify Breeze, TV Ammo and their respective subsidiaries from any and all liabilities related thereto,
and to not sell or transfer any of its shares of Breeze Common Stock or distribute any of its assets unless and until such time as it
has assumed and paid in full all Legacy Breeze Transaction Expenses.

 The
foregoing description of the Sponsor Support Agreement is subject to and qualified in its entirety by reference to the full text of the
Sponsor Support Agreement, a copy of which is included as Exhibit 10.1 in our Current Report filed with the SEC on Form 8-K on November
1, 2022, and the terms of which are incorporated herein by reference.

 On
November 9, 2022, in accordance with the Merger Agreement, Breeze, TV Ammo and certain TV Ammo Equity Holders representing approximately
66.8% of the issued and outstanding shares of TV Ammo executed the Stockholder Support Agreement, pursuant to which, among other things,
such TV Ammo Equity Holders: (a) agreed to vote in favor of the adoption of the Merger Agreement and approve the Merger and the other
Transactions to which TV Ammo is a party; (b) agreed to approve, in accordance with the terms and subject to the conditions of the TV
Ammo organizational documents, the TV Ammo Preferred Conversion to take effect immediately prior to the Closing; (c) agreed to waive
any appraisal or similar rights they may have pursuant to the TBOC with respect to the Merger and the other Transactions; (d) agreed
to vote against any other matter, action, agreement, transaction or proposal that would reasonably be expected to result in (i) a breach
of any of TV Ammo's representations, warranties, covenants, agreements or obligations under the Merger Agreement or (ii) any of
the mutual or Breeze or Merger Sub conditions to the Closing in the Merger Agreement not being satisfied; and (e) agreed not to sell,
assign, transfer or pledge any of their shares of TV Ammo Common Stock or TV Ammo Preferred Stock (or enter into any arrangement with
respect thereto) after the execution of the Merger Agreement and prior to the Closing Date, subject to certain customary conditions and
exceptions.

 The
foregoing description of the Stockholder Support Agreement is subject to and qualified in its entirety by reference to the full text
of the form of Stockholder Support Agreement, a copy of which is included as Exhibit 10.2 in our Current Report filed with the SEC on
Form 8-K on November 1, 2022, and the terms of which are incorporated herein by reference.

 On
November 9, 2022, Breeze, TV Ammo, the Breeze Initial Stockholders and certain TV Ammo Equity Holders entered into a lock-up
agreement (the "Lock-Up Agreement"), pursuant to which the Breeze Initial Stockholders and such TV Ammo Equity Holders
have agreed, among other things, to refrain from selling or transferring their shares of True Velocity Common Stock for a period of
eight months following the Closing, subject to early release (a) of 10% of their shares of True Velocity Common Stock if the daily
volume weighted average closing sale price of True Velocity Common Stock quoted on the Nasdaq for any 20 trading days within any 30
consecutive trading day period exceeds $12.50 per share, (b) of an additional 10% of their shares of True Velocity Common Stock if
the daily volume weighted average closing sale price of True Velocity Common Stock quoted on the Nasdaq for any 20 trading days
within any 30 consecutive trading day period exceeds $15.00 per share; (c) of all of their shares of True Velocity Common Stock upon
the occurrence of a Subsequent Transaction; and (d) upon the determination of the True Velocity board of directors (including a
majority of the independent directors) following the six month anniversary of the Closing Date.

 F- 12

 On
November 9, 2022, Breeze, the Breeze Initial Stockholders and certain TV Ammo Equity Holders entered into an Amended and Restated Registration
Rights Agreement (the "Registration Rights Agreement"), which amended the terms of the Registration Rights Agreement entered
into by Breeze and the Breeze Initial Stockholders on November 23, 2020, pursuant to which, among other things, Breeze will be obligated
to file a registration statement to register the resale of certain securities of Breeze held by the Breeze Initial Stockholders and such
TV Ammo Equity Holders. The Registration Rights Agreement also provides the Breeze Initial Stockholders and such TV Ammo Equity Holders
with "piggy-back" registration rights, subject to certain requirements and customary conditions.

 The
foregoing description of the Lock-Up Agreement and the Registration Rights Agreement is subject to and qualified in its entirety by reference
to the full text of the form of Lock-Up Agreement, and the form Registration Rights Agreement, copies of which are attached included
as Exhibits 10.3 and 10.4, respectively, in our Current Report filed with the SEC on Form 8-K on November 1, 2022, and the terms of which
are incorporated herein by reference.

 Liquidity

 As
of December 31, 2022, the Company had $14,129 in cash held outside of the Trust Account and a working capital deficit of $5,345,736
(excluding franchise tax payable).

 The
Company's liquidity needs prior to the consummation of the Initial Public Offering were satisfied through the proceeds of $25,000
from the sale of the Founder Shares, and a loan of $300,000 under an unsecured and non-interest bearing promissory note (see Note 5).
Subsequent to the consummation of the Initial Public Offering, the Company's liquidity needs have been satisfied from the net proceeds
from the private placement held outside of the Trust Account.

 The
Company has incurred and expects to continue to incur significant costs in pursuit of its acquisition plans. These conditions raise substantial
doubt about the Company's ability to continue as a going concern for a period of time within one year after the date that the financial
statements are issued. Management plans to address this uncertainty through the Business Combination as discussed above. In addition,
in order to finance transaction costs in connection with an intended initial business combination, the Sponsor or an affiliate of the
Sponsor, or certain of the Company's officers and directors may, but are not obligated to, loan the Company funds as may be required
("Working Capital Loans"). The notes may be repaid upon completion of a Business Combination, without interest, or, at the
lender's discretion, up to $1,000,000 of the notes may be converted upon completion of a Business Combination into warrants at
a price of $1.00 per warrant. Such warrants would be identical to the Private Placement Warrants. There is no assurance that the Company's
plans to consummate the Business Combination or obtain Working Capital Loans will be successful or successful within the Combination
Period. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 Risks
and uncertainties

 Management
is currently evaluating the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that
the virus could have a negative effect on the Company's financial position, results of its operations, and/or search for a target
company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not
include any adjustments that might result from the outcome of this uncertainty.

 With
rising tensions around the world based on the current conflict between Ukraine and Russia, we may be unable to complete a business combination
if concerns related to this and other potential conflicts impact global capital markets, the ability to transfer money, currency exchange
rates, cyber attacks and infrastructure including power generation and transmission, communications, and travel. The outcome of these
conflicts or their impact cannot be predicted and may have an adverse impact in a material way on our ability to consummate a business
combination, or to operate a target business with which we ultimately consummate a business combination.

 On
August 16, 2022, the Inflation Reduction Act of 2022 (the "Inflation Reduction Act") was signed into law, which, among other
things, imposes a 1% excise tax on the fair market value of stock repurchased by a domestic corporation beginning in 2023, with certain
exceptions. Because the Company is a Delaware corporation and its securities trade on the Nasdaq Stock Market, the Company is a "covered
corporation" within the meaning of the Inflation Reduction Act, and while not free from doubt, it is possible that the excise tax
will apply to any redemptions of its common stock after December 31, 2022, including redemptions in connection with an initial Business
Combination and any amendment to its certificate of incorporation to extend the time to consummate an initial

 F- 13

Combination, unless an exemption is available. Consequently, the value of an investment in the Company's securities may decrease
as a result of the excise tax. In addition, the excise tax may make a transaction with the Company less appealing to potential Business
Combination targets, and thus, potentially hinder the Company's ability to enter into and consummate an initial Business Combination.
Further, the application of the excise tax in the event of a liquidation is uncertain absent further guidance.

 We
may maintain cash balances at third-party financial institutions in excess of the Federal Deposit Insurance Corporation (the "FDIC")
insurance limit. The FDIC took control and was appointed receiver of Silicon Valley Bank and New York Signature Bank on March 10, 2023
and March 12, 2023, respectively. The Company does not have any direct exposure to Silicon Valley Bank or New York Signature Bank. However,
if other banks and financial institutions enter receivership or become insolvent in the future in response to financial conditions affecting
the banking system and financial markets, our ability to access our existing cash, cash equivalents and investments may be threatened
and could have a material adverse effect on our business and financial condition.

 Note
2 — Summary of Significant Accounting Policies

 Basis
of presentation

 The
accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States
of America ("GAAP") and pursuant to the rules and regulations of the SEC.

 Emerging
growth company

 The
Company is an "emerging growth company," as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart
Our Business Startups Act of 2012 (the "JOBS Act"), and it may take advantage of certain exemptions from various reporting
requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not
being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley
Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from
the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments
not previously approved.

 Further,
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting
standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do
not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting
standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements
that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of
such extended transition period, which means that when a standard is issued or revised and it has different application dates for public
or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies
adopt the new or revised standard. This may make comparison of the Company's financial statements with another public company,
which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period
difficult or impossible because of the potential differences in accounting standards used.

 Use
of estimates

 The
preparation of the financial statements in conformity with GAAP requires the Company's management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of revenues and expenses during the reporting period.

 Making
estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of
a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating
its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ
significantly from those estimates.

 F- 14

 Cash
and cash equivalents

 The
Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.
The Company did not have any cash equivalents as of December 31, 2022 and December 31, 2021.

 Cash
and marketable securities held in Trust Account

 At
December 31, 2022 and 2021, substantially all of the assets held in the Trust Account were U.S. Treasury securities. The Company
accounts for its securities held in the Trust Account in accordance with the guidance in Accounting Standards Codification ("ASC")
Topic 320, "Debt and Equity Securities." These securities are classified as trading securities with unrealized gains/losses,
if any, recognized in the statement of operations.

stock subject to possible redemption

 All
of the 11,500,000 shares of common stock sold as part of the Units in the Initial Public Offering contain a redemption feature which
allows for the redemption of such Public Shares in connection with the Company's liquidation, if there is a shareholder vote or
tender offer in connection with the Business Combination and in connection with certain amendments to the Company's Amended and
Restated Certificate of Incorporation. In accordance with SEC and its staff's guidance on redeemable equity instruments, which
has been codified in Accounting Standards Codification ("ASC") 480-10-S99, redemption provisions not solely within the control
of the Company require common stock subject to possible redemption to be classified outside of permanent equity. Therefore, all of the
11,500,000 shares of common stock sold as part of the Units in the Initial Public offering have been classified outside of permanent
equity.

 The
Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to
equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable common stock
are recorded as charges to additional paid-in capital and, if necessary, accumulated deficit.

 As
of December 31, 2022, the common stock reflected in the balance sheet are reconciled in the following table:

 Common stock subject to possible redemption – December 31, 2020

 $
 116,725,000

 Plus:

 Common stock subject to possible redemption – December 31, 2021

 117,875,000

 Plus:

 Common stock subject to possible redemption – March 31, 2022

 119,025,000

 Plus:

 14,213

 Less:

 Common stock redeemed May 5, 2022

 (69,700,628
)

 Common stock subject to possible redemption – June 30, 2022

 49,338,585

 Plus:

 59,157

 Less:

 Common stock redeemed September 13, 2022

 (31,845,056
)

 Common stock subject to possible redemption – September 30, 2022

 17,552,686

 Plus:

 177,470

 Common stock subject to possible redemption – December 31, 2022

 $
 17,730,156

 Offering
Costs associated with the Initial Public Offering

 The
Company complies with the requirements of ASC 340-10-S99-1 and SEC Staff Accounting Bulletin Topic 5A – "Expenses of
Offering". Offering costs consist principally of professional and registration fees incurred through the balance sheet date
that are related to the Initial Public Offering. Offering costs directly attributable to the issuance of an equity contract to be
classified in equity are recorded as a reduction in equity. Offering costs for equity contracts that are classified as assets and
liabilities are expensed immediately. The Company incurred offering costs amounting to $4,099,907 as a result of the Initial Public
Offering (consisting of a $2,300,000 underwriting fee, $1,322,350 of representative founder share offering costs, and $477,557 of
other offering costs). The Company recorded $3,704,282 of offering costs as a reduction of equity in connection with the shares of
common stock and public rights included in the Units. The Company immediately expensed $395,625 of offering costs in
connection with the Public Warrants and Private Placement that were classified as liabilities.

 F- 15

 Warrant
liabilities

 The
Company evaluated the Public Warrants and Private Placement Warrants (collectively, "Warrants", see Note 7) in accordance
with ASC 815-40, "Derivatives and Hedging — Contracts in Entity's Own Equity", and concluded that a provision
in the warrant agreement related to certain tender or exchange offers precludes the Warrants from being accounted for as components of
equity. As the Warrants meet the definition of a derivative as contemplated in ASC 815, the Warrants are recorded as derivative liabilities
on the balance sheet and measured at fair value at inception (on the date of the Initial Public Offering) and at each reporting date
thereafter in accordance with ASC 820, "Fair Value Measurement" ("ASC 820"), with changes in fair value recognized
in the statement of operations in the period of change.

 Income
taxes

 The
Company follows the asset and liability method of accounting for income taxes under ASC 740, "Income Taxes". Deferred tax
assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements
carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured
using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered
or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included
the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be
realized.

 ASC
740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions
taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be
sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits
as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31,
2022 and 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material
deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.

 Net
income (loss) per share

 Net
income (loss) per share of common stock is computed by dividing net income (loss) by the weighted-average number of common shares outstanding
during the period. As the Public Shares are considered to be redeemable at fair value, and a redemption at fair value does not amount
to a distribution different than other shareholders, redeemable and non-redeemable shares of common stock are presented as one class
of shares in calculating net income (loss) per share of common stock. As a result, the calculated net income (loss) per share is
the same for redeemable and non-redeemable shares of common stock. At December 31, 2022 and 2021, the Company did not have any dilutive
securities and other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of
the Company. As a result, diluted income (loss) per share is the same as basic income (loss) per share for the periods presented.

 The
following table reflects the calculation of basic and diluted net income per common share (in dollars, except per share amounts):

 For the Twelve

Months Ended

 2022

 For the Twelve

Months Ended

 2021

 Numerator:

 Net income

 $

 $

 Denominator:

 Weighted average shares Common Stock

 9,294,000

 14,631,082

 Basic and diluted net income per share Common Stock

 $
 0.41

 $
 0.59

 F- 16

 Concentration
of credit risk

instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution,
which, at times may exceed the Federal Deposit Insurance Corporate coverage of $250,000. The Company has not experienced losses on these
accounts and management believes the Company is not exposed to significant risks on such accounts.

 Fair
value of financial instruments

 The
Company applies ASC 820, which establishes a framework for measuring fair value and clarifies the definition of fair value within that
framework. ASC 820 defines fair value as an exit price, which is the price that would be received for an asset or paid to transfer a
liability in the Company's principal or most advantageous market in an orderly transaction between market participants on the measurement
date. The fair value hierarchy established in ASC 820 generally requires an entity to maximize the use of observable inputs and minimize
the use of unobservable inputs when measuring fair value. Observable inputs reflect the assumptions that market participants would use
in pricing the asset or liability and are developed based on market data obtained from sources independent of the reporting entity. Unobservable
inputs reflect the entity's own assumptions based on market data and the entity's judgments about the assumptions that market
participants would use in pricing the asset or liability and are to be developed based on the best information available in the circumstances.

 The
carrying amounts reflected in the balance sheet for cash, prepaid expenses and accrued offering costs approximate fair value due to their
short-term nature.

 The
hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements)
and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:

 Level
1 — Assets and liabilities with unadjusted, quoted prices listed on active market exchanges. Inputs to the fair value measurement
are observable inputs, such as quoted prices in active markets for identical assets or liabilities.

 Level
2 — Inputs to the fair value measurement are determined using prices for recently traded assets and liabilities with similar underlying
terms, as well as direct or indirect observable inputs, such as interest rates and yield curves that are observable at commonly quoted
intervals.

 Level
3 — Inputs to the fair value measurement are unobservable inputs, such as estimates, assumptions, and valuation techniques when
little or no market data exists for the assets or liabilities.

 See
Note 10 for additional information on assets and liabilities measured at fair value.

 Recent
accounting pronouncements

 In
August 2020, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2020-06,
"Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity's
Own Equity (Subtopic 815-40)" ("ASU 2020-06") to simplify accounting for certain financial instruments. ASU 2020-06
eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments
and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity's own equity.
The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled
in an entity's own equity. ASU 2020-06 amends
the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. For
smaller reporting companies as defined by the SEC, ASU 2020-06 is effective for fiscal years beginning after December 15, 2023, including
interim periods within those fiscal years. The Company is currently assessing the impact, if any, that ASU 2020-06 would have on its
financial position, results of operations or cash flows.

 Management
does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material
effect on the Company's financial statements.

 Reclassification
 of Prior Year Presentation

prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on
the reported results of operations. An adjustment has been made to the Balance Sheet as of December 31, 2022 and December 31, 2021. This
change in classification does not affect previously reported amounts on the Balance Sheets presented or other statements herein.

 F- 17

 Note
3 — Initial Public Offering

to the Initial Public Offering, the Company sold 10,000,000 units at a price of $10.00 per unit (the "Units") on November
23, 2020, for an aggregate purchase price of $100,000,000. Each Unit consists of one share of the Company's common stock, $0.0001
par value, one Right (the "Rights") to receive one-twentieth (1/20) of one share of common stock upon the consummation
of an initial business combination and one redeemable warrant (the "Warrants"). In connection with the underwriters'
exercise of the over-allotment option on November 25, 2020, the Company sold an additional 1,500,000 Units, at a purchase price
of $10.00 per Unit. Each Warrant entitles the holder to purchase one share of common stock at a price of $11.50 per share. Each Warrant
will become exercisable on the later of 30 days after the completion of the Company's initial Business Combination or 18 months
from the closing of the Initial Public Offering and will expire five years after the completion of the Company's initial Business
Combination or earlier upon redemption or liquidation. However, if the Company does not complete its initial Business Combination on
or prior to the 18-month period allotted to complete the Business Combination, the Warrants will expire at the end of such period.

 Note
4 — Private Placement

 Simultaneously
with the closing of the Initial Public Offering, the Sponsor and I-Bankers purchased an aggregate of 5,425,000 Private Placement Warrants
at a price of $1.00 per Private Placement Warrant, for an aggregate purchase price of $5,425,000. Each Private Placement Warrant
is exercisable to purchase one share of common stock at a price of $11.50 per share. A portion of the proceeds from the sale of the Private
Placement Warrants were added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete
a Business Combination within the Combination Period, certain of the proceeds from the sale of the Private Placement Warrants will be
used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants will
expire worthless.

 Note
5 — Related Party

 Founder
Shares

 In
June 2020, the Sponsor purchased 100 shares of common stock (the "Founder Shares") for an aggregate purchase price of $25,000.
On July 15, 2020, the Sponsor effected a 28,750-for-1 forward stock split and, as a result, our initial shareholders held 2,875,000 Founder
Shares as of the date of our initial public offering.

 The
2,875,000 Founder Shares included an aggregate of up to 375,000 shares subject to forfeiture to the extent that the underwriters'
over-allotment option was not exercised in full or in part, so that the Sponsor will own, on an as-converted basis, 20% of the Company's
issued and outstanding shares after the Initial Public Offering (assuming the Sponsor does not purchase any Public Shares in the Initial
Public Offering). As a result of the underwriters' election to fully exercise their over-allotment option, 375,000 Founder Shares
are no longer subject to forfeiture. The Founder Shares will automatically convert into shares of common stock upon consummation of a
Business Combination on a one-for-one basis, subject to certain adjustments, as described in Note 6.

 The
Sponsor and each holder of Founder Shares have agreed, subject to limited exceptions, not
to transfer, assign or sell any of its Founder Shares until the earlier to occur of: (A) one year after the completion of a Business
Combination or (B) subsequent to a Business Combination, (x) if the last sale price of the Company's common stock equals or exceeds
$12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading
days within any 30-trading day period commencing at least 150 days after a Business Combination, or (y) the date on which the Company
completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the Company's stockholders
having the right to exchange their shares of common stock for cash, securities or other property.

 The
Company had agreed with each of its four independent directors (the "Directors") subsequent to incorporation of the Company
to provide them the right to each purchase 25,000 Founder Shares with a par value of $0.0001 of the Company from Breeze Sponsor, LLC
(the "Sponsor"). The Directors each exercised their right in full on July 6, 2021 and purchased 100,000 shares (25,000 per
each Director) of the Founder Shares from Sponsor for a total of $10 in the aggregate. Sponsor has agreed to transfer 15,000 shares of
its common stock to each of the Directors upon the closing of a Business Combination by the Company, with such shares currently beneficially
owned by Sponsor.

 The
sale or allocation of the Founders Shares to the Company's Directors, as described above, is within the scope of FASB ASC Topic
718, "Compensation-Stock Compensation" ("ASC 718"). Under ASC 718, stock-based compensation associated with equity-classified
awards is measured at fair value upon the grant date. The fair value of the 100,000 shares purchased by the Company's
Directors was $401,000 or $4.01 per share. The compensation expense related to these share purchases was recorded in full
on the grant date of July 6, 2021 for a total of $401,000. This
expense is included within operating and formation costs on the statement of operations for the year ended December 31, 2021.

 F- 18

 Administrative
Support Agreement

 The
Company entered into an agreement whereby, commencing on November 23, 2020 through the earlier of the Company's consummation
of a Business Combination and its liquidation, the Company will pay an affiliate of the Sponsor a total of $5,000 per month for office
space, utilities and secretarial and administrative support services. For the year ending December 31, 2022 and 2021 the Company incurred
$60,000, and $60,000, respectively, in fees for these services, of which such amounts are included in accounts payable and accrued expenses
in the accompanying balance sheets.

 Related
Party Loans

 In
order to finance transaction costs in connection with an intended initial Business Combination, the Sponsor or an affiliate of the Sponsor,
or certain of the Company's officers and directors may, but are not obligated to, loan the Company funds as may be required ("Working
Capital Loans"). Such Working Capital Loans would be evidenced by promissory notes. The notes would either be repaid upon consummation
of a Business Combination, without interest, or, at the lender's discretion, up to $1,000,000 of notes may be converted upon consummation
of a Business Combination into warrants at a price of $1.00 per warrant. Such warrants would be identical to the Private Placement Warrants.
In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to
repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loan.

 On
February 1, 2022 (as amended), the Company signed a Promissory Note with Sponsor, with a Maturity Date of March 26, 2023, for a total
of up to $1,500,000. On October 1, 2022, the Company signed an Amended Promissory Note with Sponsor, with a Maturity Date of September
26, 2023 for a total of up to $4,000,000. As of December 31, 2022, the amount outstanding under this Promissory Note was $2,800,209 for
direct working capital, and $236,628 for monthly SPAC extension funds for the month of September 2022 through December, 2022 for a total
of $3,036,837 from Sponsor. The Promissory Note is non-interest bearing and payable on the earlier of (i) the consummation
of an initial Business Combination, or (ii) September 26, 2023.

 The
Company had 12 months from the closing of the Initial Public Offering to consummate its initial Business Combination. However, by resolution
of its board, requested by the Sponsor, the Company extended the period of time to consummate a Business Combination two times, each
by an additional three months (for a total of up to 18 months to complete a Business Combination). The Sponsor deposited additional funds
into the Trust Account in order to extend the time available for the Company to consummate its initial Business Combination. The Sponsor
deposited into the Trust Account for each three-month extension, $1,150,000 ($0.10 per share) on or prior to the date of the applicable
deadline. For each one-month extension on September 26, October 26, November 26, and December 26, 2022, $59,157 ($0.035 per share) per
extension, up to an aggregate of $236,627, or approximately $0.14 per share. The payments were made in the form of a loan. The loans
are non-interest bearing and payable upon the consummation of the Company's initial Business Combination. If the Company completes
an initial Business Combination, it will repay such loaned amounts out of the proceeds of the Trust Account released to it. If the Company
does not complete a Business Combination, it will not repay such loans. Furthermore, the letter agreement with the Company's initial
stockholders contains a provision pursuant to which the Sponsor has agreed to waive its right to be repaid for such loans out of the
funds held in the Trust Account in the event that the Company does not complete a Business Combination.

 Representative
and Consultant Shares

to the underwriting agreement (the "Underwriting Agreement") between the Company and I-Bankers Securities (the "Representative"),
on November 23, 2020, the Company issued to the Representative and its designee 250,000 shares of common stock and separately agreed
to issue the Company's Consultant 15,000 shares of common stock for nominal consideration in a private placement intended to be
exempt from registration under Section 4(a)(2) of the Act. In August 2021, the Company issued to the Consultant such Consultant Shares.
The Company accounts for the Representative Shares and Consultant Shares as a deferred offering cost of the Initial Public Offering.
Accordingly, the offering cost will be allocated to the separable financial instruments issued in the Initial Public Offering based on
a relative fair value basis, compared to total proceeds received. Offering costs allocated to the Warrants will be expensed immediately
in the statement of operations, while offering costs allocated to the redeemable Public Shares will be deferred and subsequently charged
to temporary stockholders' equity upon the completion of the Initial Public Offering.

 The
Company estimated the fair value of the Representative Shares and Consultant Shares to be $1,322,350 based upon the price of the
common stock issued ($4.99 per share) to the Representative and Consultant. The holders of the Representative Shares and Consultant
Shares have agreed not to transfer, assign or sell any such shares until the later of (i) 30 days after the completion of a Business
Combination and 180 days pursuant to FINRA Conduct Rule 5110(e)(1) following the effective date of the Registration Statement to
anyone other than (i) the Representative or an underwriter or selected dealer in connection with the Offering, or (ii) a bona fide
officer or partner of the Representative or of any such underwriter or selected dealer. Additionally, pursuant to FINRA Conduct Rule
5110(e), the Representative Shares and Consultant Shares will not be the subject of any hedging, short sale, derivative, put or call
transaction that would result in the economic disposition of the securities by any person for a period of 180 days immediately
following the effective date of the Registration Statement.

 In
addition, the holders of Representative Shares and Consultant Shares have agreed (i) to waive their redemption rights with respect to
such shares in connection with the completion of a Business Combination and (ii) to waive their rights to liquidating distributions from
the Trust Account with respect to such shares if the Company fails to complete a Business Combination within the time specified in the
certificate of incorporation.

 F- 19

 Note
6 — Commitments

 Registration
and Stockholder Rights

to a registration rights and stockholder agreement entered into on November 23, 2020, the holders of the Founder Shares, Private
Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans (and any shares of common stock issuable
upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans and upon
conversion of the Founder Shares) will be entitled to registration and stockholder rights requiring the Company to register such securities
for resale (in the case of the Founder Shares, only after conversion to the Company's common stock). The holders of the majority
of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities.
In addition, the holders have certain "piggy-back" registration rights with respect to registration statements filed subsequent
to the completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule
415 under the Securities Act. The Company will bear the expenses incurred in connection with the filing of any such registration statements.
In the case of the private placement warrants and representative shares issued to I-Bankers Securities, the demand registration rights
provided will not be exercisable for longer than five years from the effective date of the registration statement in compliance with
FINRA Rule 5110(g)(8)(C) and the piggyback registration right provided will not be exercisable for longer than seven years from the effective
date of the registration statement in compliance with FINRA Rule 5110(g)(8)(D). The Company will bear the expenses incurred in connection
with the filing of any such registration statements.

 Underwriting
Agreement

 The
Company granted the underwriters a 45-day option from the date of Initial Public Offering to purchase up to 1,500,000 additional Units
to cover over-allotments, if any, at the Initial Public Offering price less the underwriting discounts and commissions. On November 25,
2020, the underwriters fully exercised their over-allotment option to purchase an additional 1,500,000 Units at $10.00 per Unit.

Combination Marketing Agreement

 The
Company has engaged I-Bankers Securities, Inc. as an advisor in connection with a Business Combination to assist the Company in holding
meetings with its stockholders to discuss the potential Business Combination and the target business' attributes, introduce the
Company to potential investors that are interested in purchasing the Company's securities in connection with a Business Combination,
assist the Company in obtaining stockholder approval for the Business Combination and assist the Company with its press releases and
public filings in connection with the Business Combination. The Company will pay I-Bankers Securities, Inc. a cash fee for such services
upon the consummation of a Business Combination in an amount equal to 2.75% of the gross proceeds of Initial Public Offering, or $3,162,500.

 Note
7 — Warrants

 Public
Warrants may only be exercised for a whole number of shares. No fractional shares are issued upon exercise of the Public Warrants. The
Public Warrants are exercisable on the later of (a) 30 days after the consummation of a Business Combination or (b) 12 months from the
closing of the Initial Public Offering. The Public Warrants will expire five years from the consummation of a Business Combination or
earlier upon redemption or liquidation.

 We
will not be obligated to deliver any shares of common stock pursuant to the exercise of a warrant and will have no obligation to settle
such warrant exercise unless a registration statement under the Securities Act with respect to the shares of common stock underlying
the warrants is then effective and a prospectus relating thereto is current, subject to our satisfying our obligations described below
with respect to registration. No warrant will be exercisable for cash, and we will not be obligated to issue any shares to holders seeking
to exercise their warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws
of the state of the exercising holder, or an exemption is available. Notwithstanding the foregoing, if a registration statement covering
the shares of common stock issuable upon exercise of the public warrants is not effective within a specified period following the consummation
of our initial business combination, warrant holders may, until such time as there is an effective registration statement and during
any period when we shall have failed to maintain an effective registration statement, exercise warrants on a cashless basis pursuant
to the exemption provided by Section 3(a)(9) of the Securities Act, provided that such exemption is available. If that exemption, or
another exemption, is not available, holders will not be able to exercise their warrants on a cashless basis.

 F- 20

 We
have agreed that as soon as practicable, but in no event later than 15 business days, after the closing of our initial business combination,
we will use our reasonable best efforts to file, and within 60 business days after the closing of our initial business combination, to
have declared effective, a registration statement relating to the shares of common stock issuable upon exercise of the warrants and to
maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration of the warrants
in accordance with the provisions of the warrant agreement. Notwithstanding the above, if our common stock is at the time of any exercise
of a warrant not listed on a national securities exchange such that it satisfies the definition of a "covered security" under
Section 18(b)(1) of the Securities Act, we may, at our option, require holders of public warrants who exercise their warrants to
do so on a "cashless basis" in accordance with Section 3(a)(9) of the Securities Act and, in the event we so elect,
we will not be required to file or maintain in effect a registration statement, but will use our best efforts to qualify the shares under
applicable blue sky laws to the extent an exemption is not available.

 Once
the warrants become exercisable, we may call the warrants for redemption:

 in
 whole and not in part;

 at
 a price of $0.01 per warrant;

 upon
 not less than 30 days' prior written notice of redemption (the "30-day redemption period") to each warrant holder;
 and

 if,
 and only if, the reported last sale price of the common stock equals or exceeds $18.00 per share for any 20 trading days within a
 30-trading day period ending on the third trading day prior to the date we send to the notice of redemption to the warrant holders.

 We
may not redeem the warrants when a holder may not exercise such warrants.

 In
addition, if (x) we issue additional shares of common stock or equity-linked securities for capital raising purposes in connection
with the closing of our initial business combination at an issue price or effective issue price of less than $9.20 per share of common
stock (with such issue price or effective issue price to be determined in good faith by our board of directors and, in the case of any
such issuance to our initial stockholders or their affiliates, without taking into account any founder shares held by our initial stockholders
or such affiliates, as applicable, prior to such issuance), (the "Newly Issued Price") (y) the aggregate gross proceeds from
such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of our initial business
combination on the date of the consummation of our initial business combination (net of redemptions), and (z) the volume weighted
average trading price of our common stock during the 20 trading day period starting on the trading day after the day on which we consummate
our initial business combination (such price, the "Market Value") is below $9.20 per share, the exercise price of the warrants
will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00
per share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market
Value and the Newly Issued Price.

 The
warrants may be exercised upon surrender of the warrant certificate on or prior to the expiration date at the offices of the warrant
agent, with the exercise form on the reverse side of the warrant certificate completed and executed as indicated, accompanied by full
payment of the exercise price (or on a cashless basis, if applicable), by certified or official bank check payable to us, for the number
of warrants being exercised. The warrant holders do not have the rights or privileges of holders of common stock and any voting rights
until they exercise their warrants and receive shares of common stock. After the issuance of shares of common stock upon exercise of
the warrants, each holder will be entitled to one vote for each share held of record on all matters to be voted on by stockholders.

 No
fractional shares will be issued upon exercise of the warrants. If, upon exercise of the warrants, a holder would be entitled to receive
a fractional interest in a share, we will, upon exercise, round down to the nearest whole number of shares of common stock to be issued
to the warrant holder.

 The
private placement warrants (including the common stock issuable upon exercise of the private placement warrants) will (with limited exceptions)
not be transferable, assignable or salable until 30 days after the completion of our initial business combination and they will not be
redeemable by us so long as they are held by the original holders or their permitted transferees. Otherwise, the private placement warrants
have terms and provisions that are identical to those of the warrants being sold as part of the public units. If the private placement
warrants are held by holders other than the original holders or their permitted transferees, the private placement warrants will be redeemable
by us and exercisable by the holders on the same basis as the warrants included in the units being sold in our IPO.

 F- 21

 The
Sponsor and I-Bankers Securities purchased from the Company an aggregate of 5,425,000 Warrants at a price of $1.00 per Warrant (a
purchase price of $5,425,000), in a private placement that occurred simultaneously with the completion of the Initial Public Offering
(the "Private Placement Warrants"). Each Private Placement Warrant entitles the holder to purchase one share of common
stock at $11.50. The purchase price of the Private Placement Warrants were added to the proceeds from the Initial Public Offering to
be held in the Trust Account pending completion of the Company's initial Business Combination. The Private Placement Warrants
(including the common stock issuable upon exercise of the Private Placement Warrants) will not be transferable, assignable or
salable until 30 days after the completion of the initial Business Combination and they will be non-redeemable so long as they are
held by the original holders or their permitted transferees. If the Private Placement Warrants are held by someone other than the
original holders or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by
such holders on the same basis as the Warrants included in the Units being sold in the Initial Public Offering. Otherwise, the
Private Placement Warrants have terms and provisions that are substantially identical to those of the Warrants being sold as part of
the Units in the Initial Public Offering.

 If
the Company does not complete a Business Combination, then the proceeds will be part of the liquidating distributions to the public stockholders
and the Warrants issued to the Sponsor and I-Bankers Securities will expire worthless.

 As
of December 31, 2022 and 2021, there were 11,500,000 Public Warrants and 5,425,000 Private Placement Warrants outstanding. The Company
classifies the outstanding Public Warrants and Private Placement Warrants as warrant liabilities on the balance sheet in accordance with
the guidance contained in ASC 815-40.

 The
warrant liabilities were initially measured at fair value upon the closing of the Initial Public Offering and subsequently re-measured
at each reporting period using a Monte Carlo model. The Public Warrants were allocated a portion of the proceeds from the issuance of
the Units equal to its fair value. The Company recognized gains in connection with changes in the fair value of warrant liabilities of
$5,923,750 and $10,378,500 within change in fair value of warrant liabilities in the statement of operations for the years ended December
31, 2022 and 2021, respectively.

 Note
8 — Stockholders' Deficit

 Preferred
Stock — The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 per share with such
designations, voting and other rights and preferences as may be determined from time to time by the Company's board of directors.
At December 31, 2022 and 2021, there were no shares of preferred stock issued or outstanding.

Stock — The Company is authorized to issue 100,000,000 shares of common stock with a par value of $0.0001 per share. Holders
of common stock are entitled to one vote for each share. At December 31, 2022 and 2021, there were 3,140,000 and 3,140,000 shares
of common stock issued and outstanding, respectively, excluding 1,690,196 and 11,500,000 shares of common stock subject to possible redemption.

 Rights

 Except
in cases where the Company is not the surviving company in a Business Combination, each holder of a Right will automatically receive
one-twentieth (1/20) of a share of common stock upon consummation of the Business Combination, even if the holder of a Right converted
all shares held by him, her or it in connection with the Business Combination or an amendment to the Company's certificate of incorporation
with respect to its pre-business combination activities. In the event that the Company will not be the surviving company upon completion
of the Business Combination, each holder of a Right will be required to affirmatively convert his, her or its Rights in order to receive
the one-twentieth (1/20) of a share of common stock underlying each Right upon consummation of the Business Combination. No additional
consideration will be required to be paid by a holder of Rights in order to receive his, her or its additional share of common stock
upon consummation of the Business Combination. The shares issuable upon exchange of the Rights will be freely tradable (except to the
extent held by affiliates of the Company). If the Company enters into a definitive agreement for a Business Combination in which the
Company will not be the surviving entity, the definitive agreement will provide for the holders of Rights to receive the same per share
consideration the holders of shares of common stock will receive in the transaction on an as-converted into common stock basis.

 The
Company will not issue fractional shares in connection with an exchange of Rights. As a result, the holders of the Rights must hold Rights
in multiples of 20 in order to receive shares for all of the holders' Rights upon closing of a Business Combination. If the Company
is unable to complete an initial Business Combination within the required time period and the Company liquidates the funds held in the
Trust Account, holders of Rights will not receive any of such funds with respect to their Rights, nor will they receive any distribution
from the Company's assets held outside of the Trust Account with respect to such Rights, and the Rights will expire worthless.
Additionally, in no event will the Company be required to net cash settle the Rights. Accordingly, the Rights may expire worthless.

 F- 22

 Note
9 — Income Taxes

 The
Company's net deferred tax assets are as follows:

 2022

 2021

 Deferred tax assets:

 Net operating loss carryforwards

 $
 23,712

 $
 36,963

 Capitalized start-up costs

 598,616

 302,805

 Unrealized gain on investments

 —

 (2,107
)

 Total deferred tax assets

 622,328

 337,661

 Valuation allowance

 (622,328
)

 (337,661
)

 Deferred tax assets, net of valuation allowance

 $
 —

 $
 —

 The
income tax provisions for the year ended December 31, 2022 and 2021 consists of the following:

 For the

 2022

 For the

 2021

 Federal

 Current

 $
 2,089

 $
 —

 Deferred

 (284,667
)

 (267,403
)

 State

 Current

 —

 —

 Deferred

 —

 —

 Change in valuation allowance

 284,667

 267,403

 Income tax provision

 $
 2,089

 $
 —

 As
of December 31, 2022, and December 31, 2021, the Company had available a U.S. federal operating loss carry forward of approximately $112,915
and $176,014, respectively, that may be carried forward indefinitely.

 In
assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of
the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future
taxable income during the periods in which temporary differences representing future deductible amounts become deductible. Management
considers the scheduled reversal of deferred tax assets, projected future taxable income and tax planning strategies in making this assessment.
After consideration of all the information available, management believes that significant uncertainty exists with respect to future
realization of the deferred tax assets and has therefore established a full valuation allowance. As of December 31, 2022 and
2021, the valuation allowance was $622,328 and $337,661, respectively.

 A
reconciliation of the U.S. federal income tax rate to the Company's effective tax rate at December 31, 2022 and 2021 is as
follows:

 2022

 2021

 Statutory U.S. Federal income tax rate

 21.00
 %

 21.00
 %

 Change in fair market value of warrant liabilities

 (32.82
)%

 (25.00
)%

 Previous tax year adjustment

 1.91
 %

 —

 Non-deductible transaction costs

 2.46
 %

 1.00
 %

 Change in valuation allowance

 7.51
 %

 3.00
 %

 Income tax provision

 0.06
 %

 0.00
 %

 The
Company's effective tax rates for the periods presented differ from the expected (statutory) rates due to changes in fair value
of warrants, incentive stock option compensation and the recording of full valuation allowances on deferred tax assets. The Company files
income tax returns in the U.S. federal and Texas jurisdictions, both of which remain open and subject to examination.

 F- 23

 Note
10 — Fair Value Measurements

 The
following table presents information about the Company's financial assets that are measured at fair value on a recurring basis
at December 31, 2022, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair
value:

 Description

 Level 1

 Level 2

 Level 3

 Assets

 Investment held in Trust Account:

 Marketable securities held in Trust Account – U.S. Treasury Securities Money Market Fund

 $
 17,730,969

 $
 —

 $
 —

 Liabilities

 Warrant liability – Public Warrants

 $
 805,000

 $
 —

 $
 —

 Warrant liability – Private Placement Warrants

 $
 —

 $
 —

 $
 379,750

 The
following table presents information about the Company's financial assets that are measured at fair value on a recurring basis
at December 31, 2021, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair
value:

 Description

 Level 1

 Level 2

 Level 3

 Assets

 Investment held in Trust Account:

 Marketable securities held in Trust Account - U.S. Treasury securities Money Market Fund

 $
 117,931,556

 $
 —

 $
 —

 Liabilities

 Warrant liability - Public Warrants

 $
 4,830,000

 $
 —

 $
 —

 Warrant liability - Private Placement Warrants

 $
 —

 $
 —

 $
 2,278,500

 The
Company utilized a Monte Carlo simulation model for the initial valuation the Public Warrants. The subsequent measurement of the Public
Warrants as of December 31, 2022 and 2021 is classified as Level 1 due to the use of an observable market quote in an active market under
the ticker BREZW. The quoted price of the Public Warrants was $0.07 and $0.42 per warrant as of December 31, 2022 and 2021, respectively.

 The
Company utilizes a Modified Black-Scholes model to value the Private Placement Warrants at each reporting period, with changes in fair
value recognized in the statement of operations. The estimated fair value of the Private Placement warrant liability is determined using
Level 3 inputs. Inherent in a binomial options pricing model are assumptions related to expected share-price volatility, expected life,
risk-free interest rate and dividend yield. The Company estimates the volatility of its common stock based on historical volatility that
matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve
on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed
to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates
to remain at zero.

 The
aforementioned warrant liabilities are not subject to qualified hedge accounting.

 Transfers
to/from Levels 1, 2 and 3 are recognized at the end of the reporting period.

 The
following table provides the significant inputs to the Modified Black Scholes model for the fair value of the Private Placement Warrants:

 As of

2022

 As of

2021

 Stock price

 $
 10.43

 $
 10.21

 Strike price

 $
 11.50

 $
 11.50

 Probability of completing a Business Combination

 25.2
 %

 %

 Dividend yield

 —

 —

 Term (in years)

 5.32

 5.40

 Volatility

 0.5
 %

 6.7
 %

 Risk-free rate

 3.99
 %

 1.3
 %

 Fair value of warrants

 $
 0.07

 $
 0.42

 F- 24

 The
following table presents the changes in the fair value of warrant liabilities:

 Private

 Placement

 Public

 Warrant

 Liabilities

 Fair value as of December 31, 2021

 $
 2,278,500

 $
 4,830,000

 $
 7,108,500

 Change in valuation inputs or other assumptions

 (1,898,750
)

 (4,025,000
)

 (5,923,750
)

 Fair value as of December 31, 2022

 $
 379,750

 $
 805,000

 $
 1,184,750

 Note
11 — Subsequent Events

 The
Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements
were issued. Based upon this review, the Company did not, except as described in these financial statements and below, identify any other
subsequent events that would have required adjustment or disclosure in the financial statements.

 The
amended Trust Agreement authorizes the Company's Board of Directors to extend the time to complete the Business Combination
up to six (6) times for an additional one (1) month each time (for a maximum of six one-month extensions), upon the deposit into the
Trust Account of $0.035 for each outstanding public share by the Sponsor or its designees on or prior to September 26, 2022 or such other
date as may be extended. Breeze executed its first one month extension on September 22, 2022 depositing $59,157 in the Trust Account. Breeze
executed the second, third, and fourth one month extensions through January 26, 2023. On January 25, 2023 and February 23, 2023, Breeze
executed the fifth and sixth one month extensions depositing $59,157 in the Trust Account for each monthly extension through March 26,
2023. The Company has scheduled a meeting of its stockholders for March 22, 2023 to consider (i) a proposal to amend
the Company's A&R COI to authorize the Company to extend the date of March 26, 2023, up to six (6) times for an additional
one (1) month each time (ultimately until as late as September 26, 2023).

 On
March 22, 2023, the Company held a stockholders' meeting at which a proposal to approve the extension of time to consummate the
closing of a Business Combination Agreement to September 26, 2023 was approved. The Company provided its stockholders with the opportunity
to redeem all or a portion of their Public Shares at the time of this stockholders' meeting. The stockholders who elected to redeem
their shares did so for a pro rata portion of the amount then in the Trust Account ($10.56 per share), plus any pro rata interest earned
on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations. In connection with the
extension proposal, 509,712 shares of the Company's common stock were redeemed for $5,395,929, with 4,320,484 shares of common
stock remaining outstanding after Redemption; 1,180,484 of the 4,320,484 shares of common stock remaining outstanding after redemption
(the "Public Shares") are owned by the public stockholders. The public stockholders will continue to have the opportunity
to redeem all or a portion of their Public Shares upon the completion of an initial business combination at a per-share price, payable
in cash, equal to the aggregate amount on deposit in the Trust Account as of two business days prior to the consummation of the initial
business combination, including interest (which interest shall be net of taxes payable) divided by the number of then outstanding public
shares, subject to the limitations described herein.

the redemptions, approximately $12.5 million remained on deposit in our Trust Account.

 At
the meeting of the Company held on March 22, 2023, the Company's stockholders approved (i) a proposal to amend the Company's
Amended and Restated Certificate of Incorporation (the "A&R COI") to authorize the Company to extend the date of March
26, 2023, up to six (6) times for an additional one (1) month each time (ultimately until as late as September 26, 2023)
by which the Company must (a) consummate a merger, capital stock exchange, asset, stock purchase, reorganization or other similar
business combination, which we refer to as our initial business combination, or (b) cease its operations except for the purpose
of winding up if it fails to complete such initial business combination, and redeem all of the shares of common stock of the Company
included as part of the units sold in the Company's initial public offering that was consummated on November 25, 2020, and
(ii) a proposal to amend the Trust Agreement to authorize the Extension and its implementation by the Company. The amended Trust
Agreement authorizes the Company's Board of Directors to extend the time to complete the Business Combination up to
six (6) times for an additional one (1) month each time (for a maximum of six one-month extensions), upon the deposit into the Trust
Account of $0.035 for each outstanding public share by the Sponsor or its designees on or prior to September 26, 2023 or such other date
as may be extended.

 F- 25

 true FY 0001817640

 2022-01-01
 2022-12-31

 brez: CommonStockParValue00001PerShareMember

 2022-01-01
 2022-12-31

 brez: RightsExchangeableIntoOnetwentiethOfOneShareOfCommonStockMember

 2022-01-01
 2022-12-31

 brez: WarrantsEachWholeWarrantExercisableForOneShareOfCommonStockAtAnExercisePriceOf1150PerWholeShareMember

 2022-01-01
 2022-12-31

 2022-06-30

 2023-03-24